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ABSTRACT
As the number and age of human couples turning to assisted reproductive
technology (ART) continues to increase, it is essential for clinicians to understand
infertility threats related to both female and male patients. The objective of this
study was to evaluate the association between age, environment, and
reproductive success in male patients having participated in assisted
reproductive technology. In corresponding experiments, male infertility variables
such as; age, lifestyle exposures, body mass index (BMI), and infertility length
with current partner (ILCP) were investigated. A retrospective collection of clinical
male patient data from 2011 to 2014 was evaluated. Thirty-five variables were
collected from an original sample of 132 patients and correlated for relationships
related to male fertility. A negative relationship was observed between pregnancy
and male age, IVF pregnancy and male age, male age and semen volume, and
male age and semen progressive motility. A negative correlation was also
revealed among alcohol usage and semen volume and alcohol usage and total
motile sperm/specimen. Additionally, a positive correlation was observed
between ILCP and percent normal semen.
The goal of the following study, the clinician survey, was to evaluate and
compare differences in opinions. Questions pertained to male infertility factors
and fertility clinic practices. Clinicians responded with the following opinion rates;
67.9% felt semen analysis was an effective predictor, 32.7% reported no idea if
DNA fragmentation was a predictor, 58.5% were in agreement that male age had
somewhat significance, 80.1% responded that genetics and/or epigenetics
xix

displayed somewhat or significant influence (41.5% and 39.6%), 58.5% believed
male exposure/environmental factors displayed significance, 53.9% felt access to
more male information would enable better care. The most commonly seen
descriptive variable clinicians reported was ILCP (70.8%), the most important
semen characteristic was sperm count (84.6%), the most commonly seen
urological variable was vasectomy (77.8%), smoking was the most commonly
seen environmental exposure (74.5%), and medication use was the most
commonly seen medical variable (84.8%). Clinicians described that 39.1% of
patient charts were <25.0% completed and 63.0% of clinicians acknowledged
that the industry was not providing adequate male reproductive information to
infertility patients.
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CHAPTER I: INTRODUCTION
Rationale
As the 20th century transformed into the 21st, a cultural shift in society
identified a need and an occasion for increased research on the effect of
reproductive threats associated with advanced paternal age and paternal
environmental exposure factors. Both of which may contribute negatively to male
reproductive success. Despite a number of maternal studies in the second half of
the 20th century, research investigating the role of paternal age in adverse birth
outcome is limited. Consideration and identification of specific paternal factors
will aid in increased semen quality, increased fertility rates, increased pregnancy
rates, and decreased number of still births and fetal abnormalities.
The past few decades have revealed an increase in the amount of human
couples turning to assisted reproductive technology (ART) procedures. Research
has shown that this increase is due in large part to the newly established trend of
postponing childbirth. Couples in the United State have progressively delayed
starting families because of societal changes, cultural expectations, career
aspirations, and financial situations.
This rise in ART patients can largely be attributed to the increased number
of infertility treatments in older patients. The use of infertility treatments has risen
dramatically in the past 20 years; between 1996 and 2003, the number of human
ART cycles performed in the United States nearly doubled from 64,681 to
122,872 (Institute of Medicine (US) Committee on Understanding Premature
Birth and Assuring Healthy Outcomes, 2007). In 2013, Chandra and colleagues
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clarified that, although treatment use has been raised, infertility rates have
actually decreased from 8.5 to 6.0% of married women between 1982 and 2010.
The authors explained that because couples are waiting longer to start families,
fertility issues or delays may be involved with the increase in infertility treatments
but should not be associated with a rise in infertility rate.
Regardless of the cause of this influx in infertility treatments, the
association of increased maternal age and the risk of higher reproductive failure
has been well established. Conversely, the link between paternal age and birth
outcome has received far less attention. There are several factors at fault for the
hindrance of studying paternal age.
A large amount of attention has traditionally been focused on maternal
influences on fetal growth. In 2008, Chen and colleagues pointed out that, to
date, maternal influence has universally been considered of more importance
than paternal influence. Additionally, research has demonstrated that the
biological father is unknown in some cases, further hindering the investigation of
paternal effects. In the 2006, paternal age was missing from the U.S. vital
statistic records for 39.0% of unmarried women, but only 0.4% of married women
(Basso and Wilcox, 2006). Furthermore, from an epidemiological standpoint, it is
more convenient to study the effects of maternal factors on birth outcomes.
Pregnant women generally make frequent prenatal care visits to their physician
or hospital, thereby facilitating the collection of information on maternal
characteristics that may affect birth outcomes (Chen et al., 2008).
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Recent research has revealed that as males age and are exposed to
detrimental factors semen quality can decrease. Although it is possible for men to
father children into old age, the genetic quality of sperm, as well as its volume
and motility, typically decrease with age and negative environmental factors.
Therefore, it is important to note that currently semen quality is the primary
measurement of the ability of sperm to accomplish fertilization. It is the sperm
cells in the semen that are of importance, and therefore semen quality involves
both sperm quantity and quality. Decreased semen quality is a major factor of
male infertility.
Notably, fifty percent of the embryonic genome is derived from paternal
deoxyribonucleic acids (DNA) in the sperm cell. In contrast to paternal DNA

contribution to successful fertilization, increased sperm DNA damage can
adversely affect embryo quality. These detrimental effects can be observed
starting at day-2 of early embryonic development and can continue to be
detected following embryo transfer; resulting in reduced implantation and
pregnancy rates (Simon et al., 2014).
Statement of the Problem
Regardless of age, human sperm samples are very heterogeneous and
include a low amount of truly functional gametes (Sousa et al., 2011). Although
all sperm may look the same to a casual observer, human ejaculates are varied,
and subpopulations of sperm with distinct biochemical and physiological
characteristics can be identified in every sample (Sousa et al., 2011). It is
actually believed that only a very small percentage of sperm is able to achieve
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fertilization (Holt and Van Look, 2004; Holt, 2005). This produces a challenge for
the accumulation of substantial and consistent data on human male sperm
parameters. Exposing the heterogeneous nature of human sperm as one of the
major challenges researchers are facing in the industry today when trying to
better characterize and isolate a particular useable subpopulation.
Although researchers, such as Sousa et al. (2011), have demonstrated
advanced fractionation techniques to obtain subpopulations with improvements in
certain sperm parameters, a subpopulation including only fertile sperm has never
been isolated. This is mainly due to the fact that we are still not able to
completely describe what makes a competent spermatozoon (Sousa et al.,
2011).
Research has shown that paternal semen influences on reproduction are
quite important. It is believed that approximately half of the couples that turn to
assisted reproductive techniques do so because of male infertility factors.
Therefore, due to the increasing proportion of couples participating in ART
procedures, predicting outcomes is of ever increasing importance. Although
researchers have established a number of unfavorable factors from maternal
influence, male factor infertility is still relatively understudied. Scientists have
increasingly acknowledged that male factors provide a significant amount to the
successful treatment of an infertility couple. Since pregnancy rates following in
vitro fertilization (IVF) are still quite low, prognostic information for both the male
and female is very helpful in making clinical decisions (Brincat et al., 2014).
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In 1993, Giwercman et al. reported data that clearly indicated semen
quality had markedly decreased during the period 1938-1990, and concurrently
the incidence of some genitourinary abnormalities including hypospadias,
maldescent, and cancer had increased. Researchers explained that such a
significant increase in the occurrence of gonadal abnormalities over a relatively
short period of time was more likely to be due to environmental factors rather
than genetic factors.
Generally, it has been believed that pollution, smoking, alcohol, and
sexually transmitted diseases play a role in male infertility. In addition,
researchers have proposed that increased male age, body mass index, previous
illnesses, medication, steroidal and hormonal usage, and trauma to the testicles
have also contributed to the decrease in quality of a man’s sperm. As more
information is being established on how the effect of male age and the
environment have contributed to sperm quality, many patients want to know how
to ‘fix’ this problem.
While it is still assumed that the medical risks may be smaller for older
fathers, the increase in couples becoming parents later in life emphasizes the
issue that male age and exposure should be taken seriously. According to a
2014 Centers for Disease Control and Prevention report, approximately six
million couples in the United States are infertile. Research has shown that in
about one third to one half of these couples, a male sperm factor is partially or
completely responsible.
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In 2004, it was reported that 24 in every 1,000 men aged 40 to 44 fathered
a child (Centers for Disease Control and Prevention, 2014). That number was up
almost 18.0% from the decade before. Meanwhile, only three out of every 1,000
men aged 55 and older had fathered live births. As men are attempting
fatherhood later in life, 1.2 million men seek help for infertility, and those are just
the cases that are reported. Fifteen percent of these men are accurately
diagnosed with male factor infertility using a semen analysis (Guzick et al.,
2001).
Chandra and colleagues (2013) reported that among men from 2006 to
2010, some form of infertility was reported by 9.4% of men aged 15 to 44 and by
12.0% of men aged 25 to 45. These statistics demonstrate that as couples are
waiting longer to conceive advanced age should be a concern for both parents.
These findings demonstrate the importance of knowing the mutual contributions
of both the male and female patient. However, that information is not yet widely
recognized outside of the human infertility industry. To date, statistics for
‘infertility’, listed online by the CDC have overwhelmingly contained female
fertility problems and only minimally addressed male factors.
The last century endured witness to science curriculums educating
millions of students that there is not an identified specific male age associated
with the senescence of reproduction. In recent years, researchers have found
some success in demonstrating a gradual decline in male fertility as age
increased. Different from the acute onset of menopause in females, male
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infertility research demonstrated a gradual change in the reproductive system
associated with advanced age.
Exact biological mechanisms of reproductive alterations in older males
have been difficult for researchers to identify and vary among individuals.
Consequently, there is little being done to replace the previous ideas of limited
male reproductive influence with the education of this advanced theory. In fact,
extreme cases of advanced male reproductive success are actually being more
highly publicized; not just from media outlets but from boasting physicians as
well. As a result, the small amount of data on the detrimental effects of advanced
male reproductive age, have been unsuccessful in protecting outrages cases
from continually being pursued by some male patients and some physicians.
In addition to male age, infertility patients should receive just as much
information on the further risks of male factors as they receive on female factors.
Many research studies show that this is not the case. Two obvious explanations
for this problem are the lack of male patient data reported to be properly
addressed and the lack of patient knowledge and/or minimization of the male role
on human reproductive success.
When most people hear the term preconception health, they only think of
the female. However, preconception health is important for the male, as well.
There are things men can do to improve their own health, as well as the health
benefits of their female partner and future children. Ethically, it is in the best
interest of the industry and the patients to give as much information as possible
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on male infertility factors. Additionally, patients need to be educated on the
benefits of participating in male preconception health.
Just as overall health, lifestyle, and age can affect female reproductive
success, the same factors have been shown to affect male semen quality and
reproductive success. Male gametes are extremely delicate and susceptible to
factors that affect normal semen production. By reducing the health and/or
number of sperm male reproduction can be affected. Also reported to impact
sperm production is; heavy alcohol use, drug use, advanced age, and
environmental toxins. Health problems such as mumps, serious conditions like
kidney disease or hormone problems, medications, and radiation treatment
and/or chemotherapy for cancer (Office on Women’s Health, 2012) can initiate
abnormal sperm production. In addition, obesity among men has been
associated directly with increasing male infertility (Sallmén et al., 2006; Frey et
al., 2008).
Adding to the problem, a 2014 Center for Disease Control and Prevention
consensus illustrated that the percentage of male data reported to analyze was
much less than the amount of female data available. The group suggested that
the lower number of available data was a reflection of the difference in reporting
from the male perspective. Clinicians are currently observing the same problem
in their private practices. Lack of completed male data reports can hinder
treatment practices.
Regardless of the lower percentages of infertility service usage actually
reported among men, similar infertility associations have been identified as those
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seen in women, such as; advanced male age, marital status, and other
demographic characteristics (Centers for Disease Control and Prevention, 2014).
This further demonstrates the need to convey male infertility factors to ART
couples and encourage proper male patient record documentation.
For both male and female patients, advanced age is a reality when having
children later in life. As with most things in life, there are pros and cons of being
older parents. However, many professionals in the industry believe that a double
standard has come into play for male versus female patients. History shows that
on average females live longer and that the burden of most treatment and follow
up care is carried by the female patient.
When examining the ethics surrounding the gain in new data connected to
male infertility, other issues have begun to arise. Many infertility clinics implement
female cutoff ages. However, this same standard does not apply for a
comparable percentage of male patients. Even as knowledge in this area is
increased, the medical and ethical concerns should remain the same. The overall
welfare of the offspring and the proper treatment of both the male and female
patient are of top concern.
The results of the online clinician survey, created by the researcher,
further demonstrated the various discrepancies in human fertility treatment. Since
there is little regulation beyond quality control in fertility laboratory settings, there
is currently a considerable amount of treatment variations. Although much may
be miniscule, when it comes to determining the best application practices any
differences can create controversial results and recommendations.
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Significance of the Study
The researcher, in conjunction with an outside private facility, has the
technology and resources to establish specific factors which will then become
indicators for further research. This study will create new, available data to be
used by the human fertility industry.
Over the past decades, the majority of infertility research data obtained
has mainly been focused on female factors. As previously mentioned and to be
discussed in further depth in Chapter II, couples are waiting longer to start their
families. This trend has created an increased need to focus additional research
on male infertility factors. As we gain more knowledge on the significance of male
factors it is necessary to present these findings and to further the research in
these areas to provide better treatment for infertility couples.
Data obtained from the completion of this study is intended to provide
useful information to physicians, physiologists, clinical staff, administrators, policy
makers, health care providers, sperm donors, and infertility couples. The findings
can be beneficial to researchers and human infertility professionals, as well. The
data can serve as a resource for both the clinical and investigative systems as
they adapt their practices to meet the personal needs of individual infertility
couples. Finally, couples facing infertility can gain meaningful knowledge on
lifestyle factors and lifestyle changes that can improve their fertility success rates
and enhance their infertility treatment.
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CHAPTER II: REVIEW OF LITERATURE
Reproductive Physiology
For the human species to continue surviving, it is necessary to produce
fertile offspring. This is necessary to continue the existence of the species and to
pass on genetic information from generation to generation. The process is
accomplished through normal reproduction. Organisms generate new individuals
of the same kind through a sexual or asexual process. Human reproduction is
any form of sexual reproduction resulting in the conception of a child.
In Homo sapiens, the natural capability to produce offspring is
characterized as fertility. Under both genetic and environmental control, fertility is
influenced by male and female gamete production, fertilization, and gestational
term. The natural capability of a couple to produce live offspring is considered
successful reproduction; therefore a lack of success is considered infertility.
Research has demonstrated a number of biological and environmental
factors that can possibly lead to the infertility of females, males, or both members
of the couple. In humans and other similar mammalian species, to become
pregnant is a complex processes that requires many balancing parts. Any step
that is disrupted throughout the process may lead to an unsuccessful
reproductive experience.
Assisted Reproductive Technology, known as ART, are techniques used
to aid in achieving reproductive success. Artificial methods to obtain human
pregnancy involve the treatment of human oocytes, sperm, and/or embryos.
However, the availability of this assisted therapy has not always existed and is
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considered a young field in the discipline of science. There is much research left
to be done and an endless amount of additional knowledge to be gained.
History of Reproductive Physiology
The birth of modern reproductive and developmental biology took place as
early as the 17th century. Spermatozoa were first reportedly discovered, by Anton
Leeuwenhoek (1632-1723), using a homemade lens magnified 300 fold. In 1780
scientist Lazzaro Spallazani performed the first recorded successful artificial
insemination (AI) by developing a technique to artificially inseminate a dog.
By the 19th century, significant progress in the scientific knowledge of
mammalian reproduction and development was being reported. Important
contributions to this progress were the discovery of the ovum by Karl von Baer
(1792-1876). His observations of the stages of embryogenesis, led to the
remarkable descriptions made by Edouard Van Benden (1845-1910) of oocyte
development in rabbits and bats (see Alexandre, 2001) half of a century later.
Albert Brachet furthered these advancements by his report of keeping a rabbit
blastocyst alive and developing in blood plasma for 48 hours outside of the
mother’s body (1912, 1913).
The second half of the 20th century saw an advancement in mammalian
embryology when a handful of scientists such as; Biggers, McLaren, and Whitten
reported the development of murine oocytes in a chemically defined culture
medium (McLaren and Biggers, 1958; Whitten, 1957). The successful production
of murine offspring, after the transfer of in vitro cultured embryos was reported by
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McLaren and Biggers (1958). This development led to first the successful in vitro
offspring of several species, including humans.
Mid-decade, Austin (1951) and Chang and Pincus (1951) reported a major
technological barrier to in vitro fertilization (IVF); the process of sperm
capacitation. Sperm capacitation normally occurs in the female reproductive tract
and renders sperm cells capable of fertilizing ova. However, in 1954, Thibault
and colleagues successfully accomplished IVF by using sperm cells recovered
from the uterine milieu of mated does.
In 1959, Chang reported the birth of the first live mammalian, a rabbit,
following in vitro fertilization, thus opening the way to assisted procreation.
Finally, by 1975, it became evident that ejaculated rabbit spermatozoa could in
fact be in vitro capacitated, enabling in vitro fertilization, and the development of
resulting embryos into live offspring (Bracket and Oliphant, 1975).
In 1978, biologist Robert G. Edwards and gynecologist Patrick Steptoe
produced the first human baby by in vitro fertilization (Steptoe and Edwards,
1978). In February of 1979, the researchers presented their results to the Royal
College of Obstetricians and Gynecologists in London. With their study finally
published in 1980, Edwards and colleagues described that the intentions of their
research were to recover pre-ovulatory oocytes by laparoscopy, fertilize them in
vitro using spermatozoa from the husband, grow the embryos in culture three or
four cleavage divisions, and then place them in the mother’s uterus (Edwards et
al., 1980). This paper was the first of its kind in a series of papers presenting the
researchers’ observations, methods of treatment, and results. Many of the
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applied human embryo culture protocols and resulting implantation rates have
remained relatively the same as those described by Edwards and collaborators in
1980.
Human Reproduction
In humans, the processes of ovulation and fertilization must occur within a
specific time frame inside of the female reproductive tract to achieve conception.
The female ovaries cyclically develop and release a mature, competent oocyte
through ovulation. A complicated process that involves purposeful destruction of
follicular tissue, ovulation is initiated by a hormonal surge to expel an unfertilized
oocyte (Senger, 1999). In 1981, Wright and Bondioli described the series of
fertilization events in specific order; (1) contact with and penetration of the
cellular investments of an ovulated oocyte by a spermatozoon; (2) penetration of
the oocyte’s zona pellucida; (3) fusion of the spermatozoon and oocyte external
membranes; pronuclei fusion (syngamy); and (4) alignment of their respective
chromosomes on the first cleavage spindle. Ultrastructure studies have
documented each of these physiological events (Austin, 1968; Bedford, 1970;
Zamboni, 1971; Gould, 1975; Gwatkin, 1977).
The primary structures of in the human female reproductive tract include
the ovaries, oviducts, uterus, cervix, vagina, and external genitalia, all of which
play a vital role in maintaining and sustaining gestation. These structures are
described in great detail in P. L. Senger’s 1999 textbook, Pathways to Pregnancy
and Parturition. In the same publication, Senger (1999) outlined the primary
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components of the male reproduction system as well. These male reproductive
structures will be described in detail in the next section of this review of literature.
In humans, the moment of conception begins at fertilization, with the
fusion of viable male and female gametes to produce a new organism. Human
fertility is dependent on a number of factors; age, nutrition, sexual behavior,
culture, instinct, endocrinology, timing, economics, way of life, and emotions, to
achieve each successful conception.
Male Reproduction
Concern has increased on the impact of the environment on public health,
including reproductive ability (Carlsen et al., 1992). Arising controversy from
separate reviews have claimed that the quality of human semen has declined
(Nelson and Bunge, 1974; James, 1980; Leto and Frensilli, 1981; Bostofte et al.,
1983; Osser et al., 1984; Menkveld et al., 1986; Murature et al., 1987; Bendvold,
1989; Li et al., 1991; Swan et al., 1997; Swan et al., 2000). However, only little
attention has been invested in these warnings, possibly because the suggestions
were based on data from selected groups of men recruited from infertility clinics
(Bostofte et al., 1983; Osser et al., 1984; Menkveld et al., 1986; Bendvold, 1989),
from among semen donors (Leto and Frensilli, 1981), or from candidates for
vasectomy (Nelson and Bunge, 1974).
However, this specific selection of male samples is intentional because of
the lack of availability on male infertility information in other areas. The limited
sample groups mentioned in the previous studies are actually the most
assessable groups from which to gain research on male infertility, even though
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that information is still incomplete as compared to available research on female
infertility. It is worthy to note, however, that in 1987 the World Health
Organization reported that the lower reference value for a ‘normal’ sperm count
has changed from 60x106/ml in the 1940’s (Hammen, 1944; MacLeod and Heim,
1945) to the percent value of 20x106/ml (World Health Organization, 1987).
In 1992, Carlsen and collaborators concluded that data on semen quality
collected systematically from reports published worldwide indicated clearly that
sperm density has declined significantly during 1938-1990, although they could
not conclude whether or not the decline is continuing. Simultaneously, the group
pointed out that the incidence of some genitourinary abnormalities; including
testicular cancer and possibly maldescent and hypospadias have increased. The
researchers (Carlsen et al., 1992) inferred that such remarkable changes in
semen quality and the occurrence of genitourinary abnormalities over a relatively
short period were probably due to environmental rather than genetic factors.
Furthermore, the researchers proposed that some common paternal influences
are assumed to be responsible both for the decline in sperm density and for the
increase in cancer of the testis, hypospadias, and cryptorchidism (Carlsen et al.,
1992).
The male reproductive system is regulated by interplay between the
nervous system, the endocrine system and the reproductive gonads. The
hypothalamus is the neural control center for reproductive hormones and the
endocrine system relies on these hormones to cause responses in target tissues.
An important regulator of the spermatogenic process, involving the interplay
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between the hypothalamus, pituitary and testicles, is the hypothalamus pituitaryaxis (HTP). The presence of specialized neurons in the hypothalamus release
the gonadotropin-releasing hormone (GnRH) in a pulsatile manner, stimulating
the production of the two pituitary hormones, luteinizing hormone (LH) and
follicle-stimulating hormone (FSH), which are the functional link between the
brain and the testes. FSH targets the Sertoli cells which play a major role on
sperm germ cell development and LH acts on the Leydig cells stimulating
testosterone production.
To understand the importance of semen quality, it is essential to
understand that the male reproductive system is made up of a number of
components that must all be activated at the appropriate time. In addition, at any
step along the spermatogenesis process, harmful factors can hinder normal
sperm production. The key components of the male reproductive system
described by Senger (1999) are as follows:
Spermatic Cord
The function of the spermatic cord is to provide vascular, lymphatic and
neural connection to the body, to provide the countercurrent heat exchanger and
to house the cremaster muscle (Senger, 1999). All of these components are
essential in the production of viable spermatozoa by preventing disruptions from
affecting the function of the testes.
The spermatic cord extends from the body cavity into the scrotum and
attaches to the dorsal pole of the testes, suspending the testes in the scrotum.
Abnormal sperm production or sperm function is correlated with the anatomical
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function of the spermatic cord and can account for a majority of male infertility
problems. Undescended testicles, genetic defects, health problems including
diabetes, prior infections such as mumps, trauma or prior surgeries on the
testicles or groin inguinal region can all affect sperm production (Mayo Clinic,
2014).
The design of the spermatic cord is to create an environment that lowers
the temperature of the venous blood traveling through the testicular veins, and
subsequently the testicular arteries. As previously mentioned, the spermatic cord
suspends the testis in the scrotum, allowing for venous blood to be cooled by
direct heat loss through the skin of the scrotum. Within the spermatic cord a
network of veins are tightly intermingled with a highly coiled spermatic artery.
Through countercurrent heat exchange, the warmer arterial blood temperature is
cooled by the lower venous blood temperature, maintaining testicular
temperature at about 4 to 6ºC cooler than the rest of the male body (Senger,
1999).
Maintenance of low testicular temperature is imperative for
spermatogenesis to occur. Any disruption or modification of this cooling system
will severely compromise; if not completely suppress sperm production. A
number of male infertility problems can originate from increased testicular
temperatures, whether it is from the male’s occupation, a sedentary lifestyle or a
high fever, increased testicular temperature can damage sperm cells.
In his textbook, Senger (1999) explained that researchers reported
exposure of the scrotum to hot temperatures for periods of 16 hours a day did not
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influence the number of spermatozoa. However, a reduction in motility and
percentage of live spermatozoa occurred when the testes were heated for only
eight hours per day.
In addition, frequent exposure to heat, such as in saunas or hot tubs, has
been shown to elevate testicular temperature and impair sperm production (Shefi
et al., 2007). The groups’ findings also demonstrated that after heat exposure
semen quality varied biologically among individuals and could actually be
reversed in some infertile men (Shefi et al., 2007). Unfortunately, the results of
common male exposure studies, such as this one, remain unknown to the
majority of the population. This critically support the fact that it is important for
male partners to understand the effects of heat exposure as it relates to
successful pregnancy rates.
Testes
The human male gonads have two important functions: (1) they produce
the hormone testosterone, which produces the deep male voice, beard, and sex
drive; and (2) they produce sperm (National Institute for Occupational Safety and
Health, 1996). Serving as the manufacturing and assembly site for the process of
spermatogenesis, it is in the testes where male gamete production takes place.
The process of spermatogenesis summarizes all events that transform basic
spermatogonia into highly specialized mature spermatozoa within the male
gonads (Wistuba et al., 2007). Before a gamete can leave the testis, it passes
through several stages of maturation. The process includes mitotic multiplication
and propagation of the spermatogonial stem cells (SSCs), meiotic recombination
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of genetic material and testicular maturation of spermatozoa (Ehmcke et al.,
2006).
Mammalian testes interplay between three systems within the male body,
the reproductive system, the nervous system and the endocrine system.
Considered the primary reproductive organ in the male, producing both
spermatozoa and the androgen testosterone, the testes consist of two major
compartments, the seminiferous tubules and the interstitium.
The seminiferous tubules are the place of spermatogenesis and are part
of the tubular compartment of the parenchyma, a cellular mass of connective
tissue, of the testicles. The seminiferous tubules also produce a fluid, which
serving as a vehicle in which spermatozoa are suspended and facilitating in their
removal from the testes (Senger, 1999). The interstitium is responsible for blood
supply, immunological responses and contains Leydig cells that mediate
endocrine signals of the pituitary to the testis and back to other body functions
(Wistuba et al., 2007).
In the fully developed mammalian testis, the majority of undifferentiated
cells of the germ line are type A spermatogonia (Wistuba et al., 2007). This
population of cells also includes the SSCs. Wistuba et al. (2007) described these
as the most important cells for spermatogenesis because their task is to provide
both self-renewal of the SSCs and type B spermatogonia . Type B
spermatogonia differentiate and develop into primary spermatocytes. The
primary oocytes undergo meiosis and secondary spermatocytes are produced
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with reduced genomic content. Another genomic reducing step next leads to the
development of haploid spermatids (Wistuba et al., 2007).
In addition to the structural mechanisms of the testes, which produce a
protein called testes determining factor, the convoluted seminiferous tubules are
responsible for the production of Sertoli cells. The basic function of the Sertoli
cells is to nourish the developing sperm through the various stages of
spermatogenesis. Activated by FSH, Sertoli cells are specifically located in the
only place in the testes where spermatozoa are produced. Anchored to the basal
compartment of the seminiferous epithelium, Sertoli cells surround the
developing population of germ cells. Here a blood-testis barrier is formed from
the peritubular cells surrounding the seminiferous tubule and the Sertoli cell
junctional complexes to prevent immunologic destruction of developing germ
cells.
Considering the primary role that the testes play in male reproduction,
there are a number of associated malfunctions that can contribute to infertility.
Enlarged veins in the testes can increase blood flow and heat, affecting the
number and shape of sperm. National Institute of Occupational Safety and Health
(2006) described how reproductive hazards can actually reduce the number of
sperm produced and/or cause damage to sperm morphology and motility. Just
this year, Lotti and colleagues (2015) published a study in which infertile males
smokers showed lower ejaculate and ultrasound-derived seminal vesicles
volume in the testes, despite higher testosterone levels, when compared with
non-smokers. Similarly to women, damage related to cancer and its
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treatments, including radiation or chemotherapy can be detrimental to male
fertility. In a bi-gender evaluation, Mϋller (2003) described the impact of cancer
therapy on not only the female but the male reproductive axis.
Epididymis
After an approximate 72 day process, sperm cells exit the Sertoli cell
junction of the seminiferous tubule and enter into the outer structure of the
testicles, the epididymis (National Institute of Occupational Safety and Health,
2006). This environment is necessary for spermatozoa to acquire motility and
potential fertility. If the sperm are not ejaculated from the epididymis they
eventually die and are absorbed by the body.
While controlling their exit from the male reproductive system the
epididymis also serves a storage reservoir for spermatozoa. Organized into three
distinct regions known as the head (caput), the body (corpus) and the tail
(cauda), the epididymal duct is responsible for rhythmic contractions, forcing
spermatozoa into the tail. The number of sperm in the distal tail can be altered
dramatically by the frequency of ejaculation. Therefore, spermatozoa spending
an unusually long time in the epididymal tail may be of poor quality when
compared to sperm from males ejaculated routinely, contributing to their lack of
viability (Senger, 1999).
In 2006, researchers described a male infertility factor associated with this
site (National Institute of Occupational Safety and Health, 2006). The group
explained that hazardous chemicals may collect in the epididymis, seminal
vesicles, or prostate. These chemicals can kill the sperm, change the way in
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which they swim, or attach to the sperm and be carried to the oocyte or unborn
child (National Institute of Occupational Safety and Health, 2006).
Further research supported that insufficient sperm delivery could usually
be traced back to male infertility issues of the epididymis. Premature or
retrograde ejaculation, semen entering the bladder instead of emerging through
the penis during orgasm, certain genetic diseases, such as cystic fibrosis,
structural problems, such as blockage of the sperm containing epididymis, or
damage or injury to the reproductive organs are common examples of male
infertility related to compromised sperm delivery (Mayo Clinic, 2014).
The vas deferens of the epididymis are the site of vasectomy procedures
in males who want to be unproductive. Medical data has demonstrated that in the
cases of men who have previously undergone a vasectomy and desire a return
of fertility, can undergo a surgical procedure known as a vasectomy reversal for
sperm to be used in assisted reproductive techniques. Similarly, in the cases of
men with ejaculatory problems, fertile spermatozoa can be removed from the
epididymis and used for artificial insemination (Nagler and Jung, 2009).
Accessory Sex Glands
When a man ejaculates, the mature sperm cells move through the vas
deferens, past the seminal vesicles, and the prostate gland (National Institute of
Occupational Safety and Health, 1996). During this time the accessory sex
glands are responsible for the final altering, packaging, addition of metabolic
substrates, and surface coatings for transport of the spermatozoa. Senger (1999)
explained that with the help of the epididymis, accessory sex glands produce
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secretions which contribute to the liquid, non-cellular portion of semen known as
the seminal plasma. Seminal plasma is not required for fertility, but is important in
natural insemination where a fluid vehicle for delivery of the sperm is needed.
Male Semen Characteristics
In one of many reviews, Wistuba and colleagues (2007) echoed that
spermatogenesis is a highly organized process that requires complex endocrine
as well as genomic regulation. This process is supported and mediated by
somatic cell types, the Sertoli cells in the tubules and the peritubular myoid cells,
and the Leydig cells in the testicular interstitium (Wistuba et al., 2007). During the
process of spermatogenesis, the initial cells created are called spermatogonia,
following mitosis they become primary spermatocytes that divide meiotically into
two secondary spermatocytes. Through Meiosis II each secondary spermatocyte
divides into two spermatids that develop into mature spermatozoa, known as
sperm cells.
The mammalian sperm cell is composed of a head, a midpiece, and a tail.
The head contains the nucleus, the genetic material that contributes the paternal
deoxyribonucleic acid (DNA), and is surrounded by the acrosome. Sperm cells
come in two types, ‘female’ and ‘male’. Sperm cells that give rise to female (XX)
offspring after fertilization differ in that they carry an X-chromosome, while sperm
cells that give rise to male (XY) offspring carry a Y-chromosome.
The acrosome contains enzymes that play a key role in the fertilization of
the oocyte. Sperm is unable to fertilize an oocyte by natural means if the
acrosomal cap and/or the enzymes are not produced. The cap consistently
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comes off during the acrosome reaction just prior to fertilization, releasing
enzymes that help dissolve the zona pellucida of the oocyte and expose sperm
receptors that can then bind the sperm to the oocyte.
Behind the chromosome containing head is a thickened region
encompassing the cellular mitochondria called the midpiece. In the case of
sperm, the mitochondria are the engines that drive the propeller-like tail to give
the sperm its forward motion or motility. The tail flagellates, which propels the
sperm cell, at about 1 to 3 mm/minute in humans, by whipping in an elliptical
cone movement (Ishijima et al., 1986). In a 2011 study, Sousa and colleagues
suggested that one of the differences in sperm fertilization ability between
ejaculates may be attributed to the number of sperm in the ejaculate with
functioning mitochondria.
For the purposes of this literature review, the characteristics of
spermatozoa will be described in common averages, despite the specific
variability found among human male samples in the available literature.
Research has demonstrated that the mean values for human sperm head
dimensions in length are 4.3 μm, width 2.9 μm, area 10.3 μm 2, and perimeter
12.5 μm (Bellastella et al., 2010). These averages are closely related to the 2010
WHO criteria described for normal semen which are as follows; head length
4.1μm, width 2.8 μm, and ratio 1.5 (World Health Organization, 2010).
To claim that there has been controversy over the years in generating a
specific normal human spermatozoa reference range would be one of the biggest
understatements of the infertility industry. Selecting for normal spermatozoa is
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plagued with difficulties, the assessment of 'oval', 'smooth', 'irregular', and
'asymmetric' is extremely subjective (Menkveld, 2010; Auger, 2010). In a 2010
report, Bellastella and collaborators added to the list of researchers who have
described that semen samples from different men containing spermatozoa of
different sizes.
Researchers proposed that these differences reflect the stresses affecting
the spermatozoa, during smearing and air drying of the semen sample that are
known to produce swelling of immature sperm heads (Yeung, et al., 1997; Soler
et al., 2000), apparent loss of cytoplasmic droplets (Cooper et al., 2004), and cell
shrinkage (Katz et al., 1986). The group of researchers explained that the
response of the cells to these stresses may be characteristic of each individual
male. Under evaluation circumstances, spermatozoa with expanded postacrosomal regions were also detected in human semen (Ludwig and Frick,
1990). Bellastella et al. (2010) emphasized that if these samples are less mature
spermatozoa, detecting them would be of value in diagnosing epididymal
dysfunction.
Another factor hindering the evaluation of semen in vitro is that, due to its
alkaline nature, a sperm cell does not gain full hypermotility until it reaches the
female vagina where the alkaline pH is neutralized by acidic vaginal fluids. This
gradual process takes 20 to 30 minutes inside the female reproductive tract. In
assisted reproductive technology the challenge has been for researchers to
create the same final development environment in vitro.
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The sensitivity of the sperm production process is magnified due to the
characterization of the sperm cell. The spermatozoon contains a minimum
amount of cytoplasm and has the most densely packed DNA known in
eukaryotes. Compared to mitotic chromosomes in somatic cells, sperm DNA is at
least six fold more highly condensed (Ward and Coffey, 1991). As previously
mentioned the production and storage of sperm cells inside the male gonads
takes 70 to 74 days from start to finish. Therefore, at any point during this time
the testicular assembly line can produce sperm with defects from a number of
factors.
Male Semen Evaluation
In 1929, Macomber and Sanders published one of the earliest
assessments of sperm concentration in human semen and reported a median of
approximately 100 million spermatozoa per milliliter, using blood pipettes and an
unidentified counting chamber. In the following decades, systematic studies were
undertaken with the examination of semen from men whose partners were
interesting discrepancy between results of different centers that surfaced since
then has been reviewed by Zukerman et al. (1977) and MacLeod and Wang
(1979), especially concerning what should be taken as discriminating values for
fertility.
In most normal domestic animals, the evaluation of sperm reveals a
generally homogeneous population in individual species. Man, however, is in a
small group of species generating semen specimens that exhibit extreme
heterogeneity or pleomorphism of sperm morphology between (Menkveld et al.,
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1990; Menkveld, 1991; Mortimer, 1994) and even within (Hartmann et al., 1964)
specific individuals. Just as the sperm homogeneity observed in animals
simplifies the process of determining and defining normality of spermatozoa, the
opposite is the case with human spermatozoa. Researchers have unsuccessfully
tried to define a ‘fertile’ group or ‘fertile’ individual among human populations
(Freund, 1966; Mortimer, 1994). However, inaccurate drawings and increased
emphasis on the description of abnormal spermatozoa more than normal
spermatozoa (Freund, 1966; Hellinga, 1976; Comhaire et al., 1994) consequently
led to an unclear definition of morphologically normal sperm cells with no
definitive criteria (Page and Holding, 1951).
In the 1980s, Menkveld (1987) introduced a new concept for the
evaluation of sperm morphology, ‘normal spermatozoan’. However, investigators
continued to recognize that the morphological data of semen being reported was
center-dependent, and highly dependent on the method used to determine the
percentage of normal forms, indicating that these differences were procedural
(World Health Organization, 1999). This continued to emphasize the need of
having clear sperm categorization guidelines applied consistently throughout the
industry.
In 1995, Menkveld and Kruger stressed that for a spermatozoon to be
considered as morphologically normal by ‘strict’ criteria, the normal biological
variations should be kept as small as possible to ensure repeatable evaluation.
Thus, the ‘complete’ spermatozoon must be normal as described by the
standards of Menkveld (1987, 1991) and Menkveld et al. (1990). This strict
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criteria is in contrast with other liberal evaluation systems (Freund, 1966;
Eliasson, 1971; Mortimer, 1985; Comhaire et al., 1994) that use lower reference
limits to categorize abnormal sperm. The researchers pointed out that in these
more generous liberal evaluations, all spermatozoa that are not classified as
abnormal will be regarded as normal, resulting in two sperm populations
(Menkveld and Kruger, 1995). Therefore, just because a sperm is not abnormal,
considering it normal may lead to a faulty classification of the fertility potential of
a specific male.
In the same study, Menkveld and Kruger (1995) described the
characteristics that a sperm cell must exhibit to be considered morphologically
normal by strict criteria. The sperm head must have a smooth oval configuration
with a well-defined acrosome comprising 40.0 to 70.0% of the anterior sperm
head. Normal head dimensions are head length and width between 3.0 to 5.0 µm
and 2.0 to 3.0 µm, respectively, as suggested by Eliasson (1971). No neck,
midpiece, and/or tail defects must be present. The midpiece must be slender,
axially attached, ≤ 1μm in width, and approximately 1.5 times the head length
(Menkveld and Kruger, 1995). Tails must be straight, uniform, slightly thinner
than the midpiece, uncoiled, and ± 45 μm long (Menkveld and Kruger, 1995).
In their report, Menkveld and Kruger (1995) reaffirmed that most
researchers are in agreement when describing morphological evaluation of
human spermatozoa as one of the most controversial semen parameters. The
importance of morphology is seen in terms of its role in establishing male fertility
potential, and its role as a prognostic parameter for fertilizing ability in vivo
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(Menkveld et al., 1990) or in assisted reproduction (Fraser and DasGupta, 1993;
Kruger, 1994). Adding to the controversy, sperm reference ranges continue to
change from decade to decade and vary from one publication to another.
Therefore, although semen analysis is routinely used to evaluate the male
partner in infertile couples, sperm measurements that discriminate between
fertile and infertile men are not well defined (Guzick et al., 2001). A typical semen
analysis is used to grade the quality of a sperm sample; the number of sperm per
milliliter of ejaculate, as well as the morphology and motility of the sperm are
measured. Common morphological defects observed are double heads, double
tails, abnormally sized acrosomes, missing acrosomes, kinked tails, missing
heads, missing acrosomes, short tails, and abnormally sized heads.
Currently the majority of sperm samples are graded under one of two
grading criteria: Kruger’s Strict criteria, as described above, or The World Health
Organization criteria. In a 2010 report titled, ‘World Health Organization reference
values for human semen characteristics’, Cooper et al. described the updated
WHO guidelines. The following lower one-sided reference limits, with 95.0%
confidence, were generated from men whose partners had been trying to get
pregnant less than or equal to 12 months: semen volume, 1.5 ml; total sperm
number, 39 million per ejaculate; sperm concentration, 15 million per ml; vitality,
58.0% live; progressive motility, 32.0%; total motility, 40.0%; and morphologically
normal forms, 4.0% (Cooper et al., 2010).
Research has shown that a number of factors may influence the accuracy
of a semen analysis results; in addition results for a single man can have a large
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amount of natural variation over time. Advanced research has clarified that male
age and reproductive threats can contribute to the malformation of sperm cells,
hindering the capability of fertilization, and male reproduction (Moline et al.,
2000). For this reason, Weschler (2002) had previously suggested that a
subfertile result must be confirmed with at least two further analyses.
As couples wait longer to have children, it is important to acknowledge
that paternal factors provide an equal emphasis on reproductive success.
Essentially, it is just as important to understand the characteristics of the semen
in these infertile men and how to correctly distinguish and treat them for
increased fertility.
Human Infertility
Infertility is an increasing public health issue in the United States that
affects women, men, and couples. In a 2014 national report, the Centers for
Disease Control and Prevention (CDC) explained that, depending upon the
underlying cause, infertility can be treated by gynecologists, urologists, and
reproductive endocrinologists using a range of medical options, including advice
on the timing of intercourse, drugs to stimulate ovulation, surgery, and ART
procedures (Centers for Disease Control and Prevention, 2014).
In the past two decades, there has been an explosion of interest in the
scientific advancement of human reproduction and assisted conception. It has
been theorized that the increase in assisted reproductive technology rates is due
to the present societal trend of parents delaying childbirth. There is an ongoing
debate among researchers over the fact that human fertility is actually declining
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or that fertility treatments are increasing because couples are waiting longer to
conceive, needing more assistance at an advanced age.
As opposed to our parents’ generation, a majority of individuals today are
focused more on their careers in their 20’s and 30’s, while waiting to start families
later in life. As a result men and women are attempting to conceive at an older
age with increased years of possible exposure. For couples who do end up
experiencing infertility, a collective progression of medical treatments is available
through assisted reproductive technology and research continues to evolve daily.
For a human pregnancy to occur, every part of the complex reproductive
process has to take place at just the right time. Females release at least one
mature oocyte from one or both ovaries to be picked up by the fallopian tube.
Males produce mature, viable spermatozoa that swim up the female cervix,
through the uterus and into the fallopian tube to fertilize the newly released
oocyte(s). The fertilized oocyte then travels down the fallopian tube to the uterus,
where it implants and grows into a fetus. History has shown that a number of
known and unknown factors can disrupt this process at any step.
Infertility is defined by the World Health Organization (2014) as a disease
of the reproductive system characterized by the failure to achieve a clinical
pregnancy after 12 months or more of regular, unprotected sexual intercourse,
excluding reasons such as breastfeeding or postpartum amenorrhea. In the U.S.,
a commonly used definition of infertility is when a woman under 35 has not
conceived after 12 months of contraceptive-free sexual intercourse and a woman
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over 35 has not conceived after 6 months of contraceptive-free sexual
intercourse (Cooper et al., 2010).
The reasons for infertility can involve one or both partners and can be
congenital and present from birth and/or from environmental or lifestyle factors.
In some instances, a cause for infertility is never found and it is possible that a
combination of several minor factors in both partners underlie these unexplained
fertility problems. Therefore, the more knowledge we gain on the factors that
affect human fertility, the more tools we will have to decipher the problem.
Prior studies have shown a strong paternal effect of sperm DNA damage
on in vitro fertilization outcome, including reduced fertilization, reduced embryo
quality and cleavage rates, reduced numbers of embryos developing into
blastocysts, increased percentage of embryos undergoing developmental arrest,
and reduced implantation and pregnancy rates (Simon et al., 2014). The quality
of the semen sample is also responsible for the advancement of certain maternal
gestational factors, such as the development of the placenta. In addition, recent
research has shown that damaged or aged sperm possibly poses later health
risks for the offspring of older fathers.
Understanding male sperm production is important in appreciating the
vulnerability of the sperm to environmental and chemical exposures. One
common misunderstanding is that the male manufactures millions of sperm daily,
therefore, activities engaged in weeks or months earlier do not have an effect
upon the sperm quality. Although the human male does produce millions of
sperm daily, it takes approximately 72 days to actually create and store the
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sperm within the testicles. Therefore, there is over two months of time before
conception that the male can be exposed to environmental circumstances that
could slow or harm the healthy genetic development of the sperm cell
(Pressinger, 1997). In addition, as the reproductive age of the human male
increases, researchers have become less confident in the well accepted theory
of an infinite male fertility period.
Closer evaluation has suggested a number of hypotheses as to why male
reproductive senescence occurs. For example, some researchers have
speculated that programed gene expression changes are responsible. While
others have proposed it is due to cumulative damages caused by biological
processes. However, whether senescence as a biological process can be slowed
down, halted, or even reversed; is a subject of current speculation and research.
Rather than becoming aged, as the term cellular senescence suggests, it is
hypothesized that these specific sperm cells are representative of a change in
cell state.
Unlike virtually every other cell in the body, sperm cells have no defense
mechanism. Any toxin that damages a sperm cell causes it to generate high
levels of free radicals that can damage surrounding cells as well. Determining the
factors that lead to increased semen damage will help to initiate more effective
treatment plans that may include: taking supplemental antioxidants, improved
healthier lifestyle, varicocele repair, medication revaluation, and avoidance of
various types of heat and chemical exposure.
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Recommendations already include suggestions for males to avoid
exposure to some common work and environmental toxins like: organic solvents,
oil products, processed foods, chlorinated and fluorinated water, paint,
photographic supplies, irradiation, heat, combustion engine exhaust fumes, and
heavy metals. The past 10 years have shown an increase in studies linking weak
or defective sperm to employment in occupations with exposure to chemicals and
pesticides (Strohmer et al., 1993).
Dependent upon patient diagnosis, couples may start fertility treatment
with partially assisted reproductive techniques and progress to more advanced
methods as treatment progresses. One of the first methods commonly
implemented is ovarian stimulation, a hormonally controlled procedure in which
females receive drug treatments to induce ovulation through the production of
multiple follicles. At the time of ovulation, either sexual intercourse is performed
by the couple or the use of additional assisted reproductive techniques, such as
artificial insemination, are implemented. AI can be performed through intrauterine
insemination (IUI) of the sperm into the female reproductive tract using artificial
means other than sexual intercourse.
The next level of treatment is the most frequently used procedure in
assisted reproductive technology. In vitro fertilization, or IVF, is the joining of
sperm and oocytes outside of the body in production of a fertilized zygote.
Following three to five days of in vitro culture, the embryo(s) are transferred into
the female reproductive tract. Embryo transfer (ET) is performed on a
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corresponding date with the cyclic female uterus by using artificial means to
implant the fertilized embryo.
In some instances, a further assisted reproductive technique may be
implemented. Intracytoplasmic sperm injection (ICSI), most commonly used for
male infertility problems, is an in vitro fertilization procedure that occurs outside
of the body where micromanipulation of a single sperm cell is injected into the
oocyte. As with IVF, the developing embryo is transferred through artificial means
into the female reproductive tract after three to five days of development.
The Use of Assisted Reproductive Technology
The Society for Assisted Reproductive Technology (SART) reported that
in 2012, of the group’s 379 member clinics in the United States, 165,172 assisted
reproductive cycles were performed (Society of Assisted Reproductive
Technology, 2013). These procedures resulted in the birth of 61,740 babies, an
increase of more than 2000 infants from 2011. Although the use of ART is still
relatively rare as compared to the potential demand, its use has double over the
past decade. In 2012, the American Society of Reproductive Medicine reported
an estimated 3.9 million babies born in the U.S., the number of IVF babies
constituting over 1.5% of all births in the U.S. (American Society of Reproductive
Medicine, 2014). This was the largest number of cycles, of babies and
percentage of babies born through IVF ever reported (American Society of
Reproductive Medicine, 2014).
Numerous previous analyses have shown that women in the United States
who make use of medical help for fertility problems are a highly selective group
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among those who have fertility problems. Data from nationally representative
surveys, primarily the National Survey of Family Growth, but also clinic-based
studies, have shown that fertility-impaired women who use infertility services are
significantly more likely to be married, non-Hispanic white, older, more highly
educated and more affluent than nonusers (Chandra and Stephen, 2008; Greil et
al., 2011; Hirsch and Mosher, 1987; Kalmuss, 1987; Nachtigall, 2006; Staniec
and Webb, 2007; Stephen and Chandra, 2000; Wilcox and Mosher, 1993).
Reasons for the disparities in use of infertility services may include access
barriers such as the significant cost of medical services for infertility and the lack
of adequate health insurance to afford the necessary diagnostic or treatment
services (William, 1997; Smith et al., 2011). Unlike the extensive infertility
healthcare in other countries, such as Denmark, currently only 15 U.S. states
have passed insurance mandates to cover ART. Unfortunately, there is evidence
to suggest that these mandates have done nothing to better the difference in
rates of infertility treatment by race or ethnicity and socioeconomic status (Bitler,
2012).
After a 1995 review, Schmidt and colleagues assumed that about 50.0%
of all Danish couples experiencing infertility seek ART treatment. In Denmark, the
number of initiated treatments with IVF and ICSI performed at public and private
fertility clinics has increased by 83.0%, from approximately 6,000 per year to
more than 11,000 per year, within the last 10 years (Schmidt, 2006; The Danish
Fertility Society, 2009). However, infertility treatment is widely available in
Denmark within both the public and private healthcare systems (Nyboe Anderson
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et al., 2005). The public system has offered all infertile couples up to three in vitro
fertilization treatments free of charge.
However, Aitken (2014) explained that ART treatments are often delivered
without critically considering the underlying causes of the condition or seriously
contemplating the long-term consequences of the current enthusiasm for such
therapy. Critical factors supporting the need of couples to engage in ART can
range from advanced maternal age to a variety of lifestyle factors, such as
smoking and obesity, which are known to compromise the developmental
potential of the oocyte and DNA integrity in the spermatozoa.
Advanced Age and Human Infertility
As the societal trend for older parents to have children increases, health
concern about age-associated risks of infertility, abnormal pregnancies, and birth
defects remain a top concern. In a 2008 publication, Maheshwari claimed that
since the 1980’s infertility rates in humans have increased by 4.0%, mostly from
problems with fecundity due to an increase in age.
Conversely, in a national survey conducted from 1982 to 2010, Chandra
and colleagues (2013) reported that infertility rates have actually decreased
among U.S. women of childbearing age from 8.5 to 6.0%. One explanation of this
common contradiction may arise from data that showed an increase in actual
fertility treatments. It is quite possible that although fertility ‘treatments’ have
increased because many couples are having children later in life, it is debatable
that infertility ‘rates’ among humans are increasing as well.
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Presently, the most common difference in fertility being observed among
couples is age. Research shows that individuals need more help in their 40’s to
obtain pregnancy than in their 20’s. The reasons behind this increased uptake in
ART treatments are complex. Aitken (2014) proposed that this was a
consequence of the high incidence of spontaneous male infertility and the
advanced age at which couples are now attempting to start their families. His
2014 research demonstrated that age has a dramatic effect on the human
capacity to reproduce (Aitken, 2014).
A growing body of literature has been compiled on the influence of
maternal age on adverse fetal birth outcomes (Abel et al., 2002; Astolfi and
Zonta, 1999; Croen et al., 2007; de la Rochenbrochard and Thonneau, 2002;
Salihu et al., 2003; Salihu et al., 2008). Such studies have produced a wealth of
evidence of an association between advanced maternal age and increased risks
of fetal loss, preterm delivery, and small size for gestational age (Astolfi et al.,
2006; Astolfi and Zonta, 1999; Fretts and Usher, 1997; Nahum and Stanislaw,
2002; Raymond et al., 1994; Salihu et al., 2008). Both in general and in relation
with specific pathologies, researchers have shown that female age induced an
overall reduction in the chance of bearing a child, and in particular a healthy child
(Cnattingius et al., 1992; Fretts et al. 1995; Bianco et al., 1996; Dollberg et al.,
1996; Breart, 1997; Faden et al., 1997; Horta et al., 1997; Tarin et al., 1998;
Gilbert et al., 1999; Pattenden et al., 1999; Astolfi and Zonta, 2002).
The pressure of the modern career-minded women to meet their twin
goals of having a family and achieving their professional aspirations makes
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delaying child bearing inevitable (Aitkin, 2014). This trend is observed in the
number of first births to US women aged 35 to 39 years that increased by 36.0%
between 1991 and 2001 and the rate among women aged 40 to 41 increased by
a staggering 70.0% (Heffner, 2004).
Lansac (1995) demonstrated that female fecundity declines precipitously
by the fourth decade of life due to oocyte loss, increased risks of miscarriage,
trisomies, and/or chromosomal defective offspring. A decade later, Aitken (2014)
likewise supported the idea that female fertility declines precipitously between the
ages of 35 and 42 years. Although, coming from both historical records and data
generated by assisted conception clinics, the Human Fertilization and
Embryology Authority (2010) claimed the decline can be seen as controversial.
Studies that have examined paternal age as a risk factor for adverse birth
outcomes have yielded mixed results as well. Although some studies found an
association between advanced paternal age and increased risk of spontaneous
abortion (de la Rochenbrochard and Thonneau, 2002; Kleinhaus et al., 2006;
Slama et al., 2005), preeclampsia (Harlap et al., 2002), stillbirth (Nyboe
Anderson et al., 2004; de la Rochenbrochard and Thonneau, 2002),
schizophrenia (Kϋhnert and Nieschlag, 2004; Malaspina et al., 2001), autism
(Reichenberg et al., 2006), low birth weight (Tough et al., 2003), and other birth
defects (Kϋhnert and Nieschlag, 2004; Savitz et al., 1991; Yang et al., 2007),
other studies found no evidence of a relationship between advanced paternal
age and adverse fetal birth outcomes (Abel et al., 2002; Chen et al., 2008;
Nahum and Stanislaw, 2003; Parker and Schoendorf, 1992).
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This midlife decline in human fertility sets our species apart from all other
primates, where mortality and reproductive lifespan are coincident and very few
individuals experience reproductive senescence before death (Alberts et al.,
2013). The reason for this is unknown but may simply be that we have, as a
consequence of improvements in primary health care, managed to push the
limits of human mortality beyond the lifespan of the primordial follicle population
(Aiken, 2014) or the age associated ability to produce quality spermatozoa
(Singh et al., 2003; Schmid et al., 2007; Das et al., 2013).
In a 2007 study, Yang et al. explained that although the association
between maternal age and the risks of birth defects has been well studied, the
role of paternal age has received relatively little attention. As early as 1912,
Weinberg hypothesized a genetic component in the effect of advanced age
suggesting that sporadic cases of achondroplasia, a genetic disorder, could be
associated with paternal ageing. However, it was not until the past decade that
research has become more heavily focused on male age as a factor in human
infertility. In 2013, Chandra and Wu acknowledged that among men, some form
of infertility was reported by 9.4% of those aged 15 to 44 and by 12.0% of those
aged 25 to 45 from 2006 to 2010.
The current societal trend for older parents to have children has raised
public health concern and encouraged more research to be designed on male
age-associated risks of abnormal pregnancies and birth defects. Although
spermatogenesis continues well into male senescence and some men of
advancing age can father children, in two separate studies, Kidd and colleagues
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(2001) and Slotter and colleagues (2004) both engaged the subject of male
fecundity declining with age. It is well known that men have been able to father
children well in to their 90’s, therefore it seems difficult to contrast the loss of
fertility due to advanced age in men versus women (Kidd et al., 2001; Slotter et
al., 2004). However, the risks of abnormal pregnancies and heritable effects
associated with advancing paternal age are poorly understood, thus increasing
the development of interest in exploring this outcome.
Research has demonstrated that older men produced more sperm with
DNA damage as a consequence of age-associated increased oxidative stress in
their reproductive tracts (Barnes et al., 1998; Barroso et al., 2000). In 1997,
Kodama and colleagues reported an association between oxidative DNA damage
in sperm and male infertility.
Studies that followed showed that as men age the quality of their gametes
deteriorates (Singh et al., 2003; Schmid et al., 2007; Das et al., 2013). As a
result, the spermatozoa of ageing males contain much more DNA damage than
their younger counterparts. Studies on the Brown Norway rat and the
senescence accelerated mouse (SAM) both suggested that the origin of this agedependent increase in DNA damage in the germ line is oxidative, reflecting the
general relationship between oxidative stress and ageing observed in most
biological systems (Paul et al., 2011; Smith et al., 2013).
Alternately, apoptotic functions of spermatogenesis may be less effective
in older males resulting in the release of more sperm with DNA damage
(Brinkworth et al., 1997; Print and Loveland, 2000). Brinkworth and Schmid
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(2003) reported that the testes of older male mice have lower apoptotic
frequencies than young adults. It was shown that oxidative stress significantly
increased the frequencies of apoptotic spermatocytes in young male mice while
reducing testicular apoptosis in older males (Barnes et al., 1998).
In 2002, Morris and colleagues reported that sperm DNA damage was
positively correlated with donor age and with impairment of post-fertilization
embryo cleavage following ICSI, indicating an overall decline in the integrity of
sperm DNA in older men. Aitken and colleagues (2003) explained that oxidative
stress can damage sperm DNA, as well as mitochondrial and nuclear
membranes. Consistent with the hypothesis of the importance of oxidative
damage to sperm, it was reported that high antioxidant intake was associated
with better semen quality, especially motility within the same study group
(Eskenazi et al., 2005).
In 2007, Schmid and colleagues found associations between male age
and sperm DNA strand damage in a non-clinical sample of active healthy nonsmoking workers and retirees. Sperm of older men had significantly higher
frequencies of sperm with DNA damage measured under alkaline conditions,
which is thought to represent alkali-labile DNA sites and single-strand DNA
breaks (Schmid et al., 2007). At the conclusion of the study, Schmid and
colleagues (2007) determined that age-related increases in sperm DNA damage
predict that men who delay fatherhood may have increased risks of unsuccessful
and abnormal pregnancies as a consequence of fertilization with damaged
sperm.
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Research has also demonstrated that increased sperm DNA damage has
been associated with chromosomal abnormalities, developmental loss and birth
defects in mouse model systems (Marchetti et al., 1997; Haines et al., 1998;
Hughes et al., 1999; Marchetti et al., 2004), and with increases in the percentage
of human embryos that fail to develop after ICSI (Morris et al., 2002). Previous
studies have explained that each successive fragmentation introduces a slight
risk of error in the genetic material of the new sperm, and this is then passed on
to the child (Wyrobek et al., 2006).
Previous studies have also demonstrated that as the age of the father
increased, the risk of miscarriage and, if the pregnancy does carry to term,
disease in the offspring, increased in parallel (Aitken and Krausz, 2001; Aitken et
al., 2004; Kleinhaus et al., 2006). There is a sum of epidemiological evidence
that have suggested the incidence of abnormal reproductive outcomes and
heritable defects increase with paternal age (Tarin et al., 1998; de la
Rochebrochard and Thonneau, 2002), including pregnancy loss (Risch et al.,
1987; de la Rochebrochard and Thonneau, 2002), developmental and
morphological birth defects (Lian et al., 1986), gene mutations (Crow, 2000;
Tiemann-Boege et al., 2002), various aneuploidy and chromosomal syndromes
(Slotter et al., 2004), and diseases of complex aetiology, such as prostate cancer
(Zhang et al., 1999).
Research published from the Columbia University School of Public Health
in 2006 suggested that women who become pregnant by older men are at far
greater risk of having a miscarriage (Kleinhaus et al., 2006). The researchers
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noted that the risk of miscarriage appeared to rise along with the father's age,
regardless of the mother’s age. Even after a range of other risk factors which
contribute to miscarriage were taken into account, such as smoking during
pregnancy and maternal diabetes, the risk was still higher (Kleinhaus et al.,
2006).
This study analyzed data from a survey of nearly 14,000 pregnant women
undertaken in Jerusalem between 1964 and 1976 (Kleinhaus et al., 2006). The
group also demonstrated that the risk of losing the pregnancy was 60.0% higher
when the father was 40 or older, compared to when he was 25 to 29 years old.
The risk of losing the pregnancy was approximately three times greater when the
man was between 35 and 39 years of age, than if he were younger than 25
(Kleinhaus et al., 2006).
Advanced age has been a significantly studied factor in the fertility of
human females, and more recently additional attention has been focused males.
Evidence has suggested that men may in fact have a biological time clock slightly
similar to that of women. However, men seem to have a gradual rather than
abrupt change in fertility and the potential ability to produce viable offspring.
Aside from age, there are a number of other possible factor(s) in humans
that play a role in the infertility of a couple. However, it is extremely important to
note, that research has proven about 40.0% of the issues involved with infertility
are due to the man, another 40.0% are due to the woman, and 20.0% result from
complications with both partners (Hudson, 1987).
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Environmental Lifestyle Factors and Male Infertility
In a 2014 research article that evaluated lifestyle and male fertility,
Jurewicz and colleagues explained that semen quality in the adult male can be
affected by a number of environmental and lifestyle factors. The group explained
that the increasing trend in male infertility observed in recent years may be
associated at least in part with these factors, which are compounded by a
change in lifestyle. Lifestyle associated exposures including cigarette smoke,
alcohol, caffeine, use of mobile phones, and body mass index (BMI) have been
studied in relation to male semen quality (Fejes et al., 2005; Jensen et al., 2010;
Magnusdottir et al., 2005; Ramlau-Hansen et al., 2007; Li et al., 2009).
Additional research demonstrated that between 10.0% and 15.0% of all
couples experience fertility problems due to a variety of causes (Schmidt et al.,
1995; Eugster and Vingerhoets, 1999; Juul et al., 1999), and infertility is
increasing in the industrialized countries, possibly due to social and behavioral
factors along with environmental exposures (Skakkebaek et al., 2006). Present
research has shown that external factors linked to lifestyle negatively affect
spermatogenesis, both at the central and gonadal levels (Rato et al., 2014).
It has been shown that epidemiological and controlled animal studies in
the lab suggested that paternal nutritional and toxicological exposures, as well as
age, impact the health of the male and the health of his children. These studies
suggested a potential trans-generational impact of paternal effects (Curley et al.,
2011).
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Male exposures, in isolation from female exposures, have been shown in
experimental studies to be capable of affecting the entire spectrum of the
reproductive health endpoint (Olshan and Faustman, 1993) through mechanisms
involving sperm. Such effects most likely occurred from male exposures in the
three months prior to conception (Schrader and Kesner, 1993). This suggestion
parallels the human spermatogenesis timeframe, approximately 72 to 74 days,
including the transport of sperm through the ductal system.
An important lifestyle-dependent factor that adversely affects
spermatogenesis is obesity (Jurewicz et al., 2014). Several studies have shown
up to a threefold higher incidence of obesity in infertile men than in those with
normal semen quality (Hammoud et al., 2008a; Magnusdottir et al., 2005).
Also, studies on caffeine intake and semen quality have shown
contradictory results. Some researchers suggested no associations (Oldereid et
al., 1992; Ramlau-Hansen, 2008), whereas others found reduced sperm
concentration as well as reduced total sperm count and motility (Jensen et al.,
2010; Sobreiro et al., 2005). Several studies also examined the effect of smoking
and alcohol drinking on sperm parameters, but their results were inconsistent
(Jurewicz et al., 2014). Additional studies (Marinelli et al., 2004; Povey et al.,
2012) but not all (Li et al., 2011; Ramlau-Hansen et al., 2007; Vine, 1996)
suggested that smoking and alcohol had a limited effect on semen quality. Other
studies have shown factors such as smoking, alcohol and caffeine consumption
to be associated with increased genetic damage in blood cells (Park and Kang,
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2004; Glei et al., 2005, Wyrobek et al., 2005a), but little is known about their
effects on genetic damage in sperm (Wyrobek et al., 2005b).
Nevertheless, growing reviews of male subfertility have highlighted how
aspects of male lifestyle may significantly increase the risk of subfertility (Li et al.,
2011; Sadeu et al., 2010). These reviews further suggested that higher age,
smoking, alcohol consumption, and psychological stress were risk factors for
poor semen quality (Li et al., 2011; Sadeu et al., 2010).
BMI and Male Infertility
The World Health Organization (2014) defines obesity as a BMI ≥ 30
kg/m2. The Journal of the American Medical Association reported that obesity is a
public health disorder that affects more than 34.9%, 78.6 million, of U.S. adults
(Ogden et al., 2014). In addition, infertility is a public health disorder that affects
10.0% of the worldwide population (Monmandi et al., 2013). Despite one third of
infertility cases being attributed to male factors, studies on the impact of BMI on
male fertility are still very limited and controversial as compared to the multiple
studies evaluating the impact of overweight in women’s fertility (Monmandi et al.,
2013).
Research has demonstrated increased evidence that female obesity has a
negative effect on assisted reproductive technology outcomes (Bellver et al.,
2010; Luke et al., 2011; Pasquali et al., 2003). Excessive weight in women
undergoing ART treatments has been associated with lower pregnancy rates,
lower live birth rates, fewer normally fertilized oocytes and the need for higher
doses of gonadotropins (Bellver et al., 2010; Luke et al., 2011; Maheshwari et al.,
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2007; Shah et al., 2011). Notably, recent studies have demonstrated the effects
of overweight and obesity on reproductive health in which both members, male
and female, are at an increased risk of subfertility (Ramlau-Hansen et al., 2007).
As obesity has become a more serious health problem in the western
world, researchers speculated that it is partly to blame for the decline in male
fertility. The average U.S. male has a BMI of 29, which is highly overweight
(Centers for Disease Control and Prevention, 2012). Some investigators agreed
that high BMI levels may reduce male fertility and associated it with reduced
semen quality and hormone alterations (Jensen et al., 2004; Kort et al., 2006;
Fejes et al., 2005; Fejes et al., 2006). In addition, overweight men may be at
greater risk of erectile dysfunction (Fung et al., 2004), which could lead to
reduced fertility.
In 2008, researchers found a higher incidence of oligozoospermiea and a
greater prevalence of low progressive sperm count in male patients with
increased BMI levels (Hammoud et al., 2008b). Additional research
demonstrated that overweight and obesity in males have been associated with
poorer semen quality (Sermondade et al., 2012), higher sperm DNA damage
(Chavarro et al., 2010; Kort et al., 2006; Tanrikut et al., 2010), and infertility
(Sallmén et al., 2006). In 2011, from a sample of 2,035 male patients, Shayeb
and colleagues reported that obese men were more likely to have lower semen
volume and fewer morphologically normal spermatozoa than men with normal
BMI.
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Determined through data obtained from a large patient sample size, Belloc
and colleagues (2014) reported that semen volume decreased from 3.3±1.6 to
2.7±1.6 mL when BMI increased from normal, 20 to 25 kg/m2, to extreme male
obesity, >40 kg/m2, respectively. In addition, the group reported decreased
semen concentration from 56.4±54.9 to 39.4±51.0 million/mL, total sperm count
from 171±170 to 92±95 million, and progressive motility from 36.9±16.8 to
34.7±17.1% when male BMI increased from normal to extreme obesity (Belloc et
al., 2014). The percentage of cases with azoospermia and cryptospermia also
significantly increased in connection to higher BMI levels (Belloc et al., 2014).
However, morphology was not affected as reported by the group.
As BMI becomes an increasingly debated topic among male fertility, more
than one cause of its relationship with couples’ reproductive success is being
investigated. Some research has shown that obesity has been associated with
significant disturbance in the hormonal environment that can affect the
reproductive system.
In 2007, Nguyen and collaborators demonstrated that excess weight may
be linked with altered testosterone, estradiol levels, poor semen quality, and
infertility (Nguyen et al., 2007). When research participants were divided into
eight categories of male BMI patients, a trend of increased male infertility and
increased male BMI was observed (Nguyen et al., 2007). Nguyen and colleagues
(2007) explained that more research is needed to see if weight loss improves
fertility for men with high BMI levels.
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Additional research indicated that male BMI is inversely related to
androgens levels and positively related to estrogens (E2) levels resulting in a
hormonal profile consistent with hypogondotropic hyperestrogenic
hypoandrogenemia (Hammoud et al., 2008a; Giagulli et al., 1994; Chavarro et
al., 2010). The higher E2 levels are reported to have a deleterious effect on
endogenous gonadotropin secretion as they interfere with GnRH pulsatility
(Hammoud et al., 2008a; Akingbemi, 2005).
The specific relationship between male BMI and ART outcomes have
been examined even less extensively. Due to the scarce and controversial
literature (Keltz et al., 2010; Colaci et al., 2012) available on this topic, it is
difficult to correctly assess the origins of differences between these research
studies. These discrepancies continue to support the importance of further
evaluating the relationship between male obesity and ART outcomes.
In 2010, Keltz and colleagues conducted a retrospective analysis that
showed that couples with an overweight or obese male partner, BMI >= 25
kg/m2, undergoing traditional IVF had lower clinical pregnancy rates than couples
with a lean male. However, they did not find this same association in ICSI cycles
(Keltz et al., 2010).
In 2012, Colaci and co-workers claimed to initiate the first prospective
study that addressed the relationship between male BMI and ART outcomes in
which these associations were adjusted for the most important female
characteristics that are known to have a critical effect on the overall outcome
(Weghofer et al., 2005; Chung et al., 2003; Omland et al., 2005; Dunson et al.,
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2004). The group actually reported higher fertilization rates among obese men
than among normal weight men in conventional IVF cycles and found no
significant associations between male BMI and the proportion of poor quality day3 embryos, slow embryo cleavage rate, or accelerated embryo cleavage rate
(Colaci et al., 2012).
The findings of Colaci and colleagues (2012) were in agreement with
Bakos and colleagues (2011) who reported no association of male BMI with
overall fertilization rate or day-3 in vitro embryo quality. However, in their 2011
study, Bakos et al. found a significant reduction of blastocyst development and
lower pregnancy rate associated with increasing male BMI. In support of those
results, a recent animal study concluded that male obesity was related to
reduced embryo cleavage, decreased development to the stage of blastocyst,
lower implantation rate, and lower fetal development (Mitchell et al., 2011).
Samavant and colleagues performed a preliminary study in 2014 and
demonstrated that the acrosome reaction in sperm is impaired in obese men.
The study showed a reduced response to progesterone and an elevated
spontaneous acrosome reaction (Sp-AR), associated with altered circulating
levels of E2 and sperm cholesterol content in males with higher BMI levels
(Samavant et al., 2014).
In addition, practitioners have contested that as BMI increased the DNA
fragmentation rate of sperm increased as well, creating a dramatic reduction of
sperm quality (Kort et al., 2006; Chavarro et al., 2010; Fariello et al., 2012; La
Vignera et al., 2012). As previously mentioned the more sperm with fragmented
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DNA, the higher the chances of miscarriage and lower the chances of conception
(Sakkas and Alvarez, 2010).
Adding to the controversy, in 2015 Schliep and colleagues reported that
weight status did not influence fecundity among couples undergoing infertility
treatment. However, the group stressed that given the limited and conflicting
research on BMI and pregnancy success among IVF couples, further research
designed to include other adiposity measures is needed (Schliep et al., 2015).
Although the influence of male BMI on fertility remains controversial and
understudied, there does seem to be some multifactorial relationship, therefore,
additional studies are needed to determine the association.
Male Environmental Exposures
Caffeine
Studies on caffeine intake and semen quality have shown contradictory
results as well; some suggested no associations (Oldereid et al., 1992; RamlauHansen, 2008). Others found caffeine exposure reduced sperm concentration,
total sperm count, and sperm motility (Jensen et al., 2010; Sobreiro et al., 2005;
Vine, 1996). In their 1999 study, Sarkaria and colleagues demonstrated that
caffeine is an efficient inhibitor of DNA double-strand repair, which may explain
the increased double-strand DNA damage in sperm after high-dose caffeine
consumption.
In 2007, Schmid and colleagues found that men with caffeine consumption
of about three cups per day had significantly higher frequencies of sperm with
DNA damage as measured under neutral, but not alkaline conditions compared
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to men with less caffeine consumption. Whereas, in 2014 Jurewicz et al. reported
that drinking coffee one to six times per week was related to an increase in the
percentage of motile sperm but also in sperm head abnormalities. The group
additionally associated drinking coffee every day with an increase in sperm neck
abnormalities (Jurewicz et al., 2014). However, it was noted that the estimation of
caffeine intake based on self-report can be a problem because cups of coffee
vary in strength related to brewing and brand and caffeine is present in many
products that would not necessarily be recognized and reported during the
interview (Jurewicz et al., 2014).
Chemical Exposure
As early as 1972, it was shown that paternal exposure to mutagenic
compounds increased the rate of spontaneous abortions in animals (Epstein et
al., 1972). However, in humans this relationship remains relatively unclear. For
vinyl chloride (Infante et al., 1976), anesthetic gases (Tomlin, 1979),
dibromochloropropane (Kharrazi et al., 1980), chloroprene (Sanotsky, 1976),
smelter work (Beckman and Nordström, 1982), waste water exposures (Morgan
et al., 1984), and organic solvents (Taskinen et al., 1989), effects on human
fertility have been suggested, but the data either have been contradictory or
remain unconfirmed.
In 1983, Donner et al. reported that rubber chemicals contained several
microbial mutagens and Lindbohm and colleagues (1983) reported an increased
risk of abortion observed among women exposed to rubber chemicals. An
excessive rate of spontaneous abortion was also found among the wives of
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workers in a waste water treatment plant of a petroleum refinery (Morgan et al.,
1984) and among the wives of workers exposed to organic solvents (Taskinen et
al., 1989).
Researchers also found an association with male infertility among some
paternal occupations: metal-plate and constructional steel workers, crushers and
grinders, sewage, workers caring for fur-bearing animals (Lindbohm et al., 1984),
and mechanics and repairers of motor vehicles (McDonald et al., 1989). In a
1991 study, Lindbohm and colleagues evaluated 25 specific mutagens or groups
of mutagens. Paternal exposure to ethylene oxide, rubber chemicals, solvents
used in petroleum refineries, and solvents used in manufacture of rubber
products were the only four chemicals that the group found to be associated with
an increased risk of spontaneous abortion. However, Lindbohm and colleagues
(1991) were unable to separate the routes of exposure; harmful substances
transmitted to the pregnant woman by contact with clothes or by semen leading
to secondary maternal exposure.
Among the chemicals, Lindbohm and colleagues (1991) acknowledged
that ethylene oxide had been identified as a mutagen by almost all mutation
assays, including the dominant lethal assay (International Agency for Research
on Cancer, 1988). Exposure to this chemical has also been associated with
spontaneous abortion in women who use ethylene oxide to sterilize hospital
instruments (Hemminki et al., 1982).
Several studies have addressed the pesticide dibromochloropropane as a
proven cause of male infertility. A report by Kharrazi et al. (1980) suggested a
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threefold increased risk of miscarriage in the offspring of exposed males.
Additional studies indicated a decrease in the proportion of male offspring after
paternal exposure (Goldsmith et al., 1984; Potashnik et al., 1984).
Dibromochloropropane exerts its effects through direct testicular toxicity, which is
not known to occur from other more commonly used pesticides (Kharrazi et al.,
1980).
In 1993, Moses described studies of both maternal and paternal pesticide
exposure in relation to such endpoints as infertility, miscarriage, stillbirth, preterm
delivery, low birth weight, and birth defects. For miscarriage, Olshan and
Faustman (1993) published clear experimental evidence of a paternal effect. In
addition, epidemiologic literature offered at least some replicated indications of
an environmental contribution to human infertility (Savitz et al., 1994).
A 1996 report from the National Institute for Occupational Safety and
Health (NIOSH) identified a number of workplace substances such as, lead and
radiation as reproductive hazards for men. The study explained that the harmful
substances can enter the body by inhalation, contact with the skin, or ingestion, if
workers do not properly wash their hands before eating, drinking or smoking.
In 1997, Savitz et al. claimed that despite the generally favorable health
experience of farmers, potential adverse reproductive health effects associated
with pesticides were of concern. The group identified five activities that were
presumed to involve direct pesticide exposure: mixing or applying crop
herbicides, crop insecticides and fungicides, livestock chemicals, yard herbicides,
and building pesticides (Savitz et al., 1997). The results of the study provided
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some indication that male farm activities may influence the risk of preterm
delivery, particularly when occurring in combination with reported applications of
specific chemicals on the farm (Savitz et al., 1997).
The overall implication of the study results of Savitz and colleagues (1997)
added to the interest in a possible role of male pesticide exposure in adverse
pregnancy outcome and directed attention to both preterm delivery and
miscarriage. With their refined measures of exposure and outcome, the
researchers pointed out that detailed consideration of male pesticide exposure in
relation to sperm function and genetic alterations would help to bridge
experimental and epidemiologic studies (Savitz et al., 1997).
The blood-testis barrier is a defense mechanism that has been shown to
protect testicular cells from direct exposures to high levels of hazardous
chemicals in the blood (Cheng and Mruk, 2012). Vigeh et al. (2011) supported
this theory with their review of lead toxicity on reproductive hormones. The group
suggested that lead’s main influence on male reproduction probably occurred by
altering the reproductive hormonal axis and the hormonal control on
spermatogenesis, rather than by a direct toxic effect on the seminiferous tubules
of the testes. In a previous study, Wong and collaborators (2004) discovered that
cadmium, as well, caused changes on the blood-testis barrier before inducing
vascular changes.
Effects of cadmium on the blood-testis barrier are well document in the
literature (Hew et al., 1993; Chung and Cheng, 2001, Cheng and Mruk, 2002). In
1993, researchers proposed that cadmium may promote disruption of Sertoli cell

57

tight junctions (Hew et al., 1993). Chung and Cheng (2001) proposed that
cadmium reduced tight junction proteins responsible for cell adhesion that
participate in intercellular sealing (Cheng and Mruk, 2002) expression in Sertoli
cells.
Cigarette Smoke
Reviewing another common environmental exposure, Vršanská and
colleagues (2003) explained that in addition to being widely recognized as a
health exposure hazard, smoking cigarettes also affected reproductive health.
The link between smoking and female fertility disorders, including poor embryo
development following in vitro fertilization treatment and even infertile offspring
has been well established (Zenzes, 2000). Smoking has also been associated
with delayed conception, in human females, (Baird and Wilcox, 1985) and a
reduced number of retrieved oocytes leading to premature menopause (Bolumar
et al., 1996).
Supporting the notion that smoking has contributed to the worldwide
decline in semen quality; male studies that examined environmental factors and
paternal fertility have demonstrated an association between cigarette smoke and
sperm concentration. In 1992, Carlsen and collaborators systematically reviewed
61 studies of semen quality conducted over 50 years and found that mean sperm
concentration worldwide fell by half from 113x106/ml in 1940 to 66x106/ml in
1990. In 1993, Giwercman et al. concluded that such a fast decline in semen
quality was probably due to environmental, rather than genetic factors. The group
suggested that in utero exposure to environmental oestrogens, pollution and
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lifestyle exposures, including cigarette smoking were possible causes of this
decline in quality (Giwercman et al., 1993).
In a 1996 paper, through meta-analysis of studies previously between
1981 and 1982, Vine showed that smokers’ sperm concentration was on average
about 15.0% lower than that of non-smokers. Two decades later, Lotti and
colleagues (2015) confirmed that male smokers showed lower ejaculate and
lower ultrasound-derived seminal vesicles volume, despite higher testosterone
levels, when compared with non-current smokers.
Cadmium, a heavy metal previously discussed as an environmental
exposure, is present in tobacco as well. Stassen et al. (1990) demonstrated that
smoking cigarettes, and most likely second hand smoke inhalation, represented
a primary source of inhaled cadmium. Investigators have hypothesized that
second hand smoke has caused a significant decline in the fertility ability of men
(Cheng and Mruk, 2012). Researchers explained that cadmium is a known
teratogen and carcinogen that accumulates over a period of years and is easily
incorporated in the reproductive tissues such as gonads and uterus (Pařízek et
al., 1969; Hamada et al., 1998).
In a 2009 murine study, Oliveira and colleagues, reported that short term
effects of cadmium resulted in an increased fraction of sperm with abnormal
morphology, premature acrosome reaction, and reduced motility. Late term
effects included a drastic reduction of sperm cell numbers and sperm motility, as
well as, an increased detection of DNA fragmentation (Oliveira et al., 2009).
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Previously, in a 2000 study, Telisman et al. reported decreased male
fertility related with occupational exposure to cadmium. In addition, an
association was observed, by Xu and colleagues (2003), between the presence
of cadmium in seminal plasma and decreased sperm quality and increased
sperm oxidative damage. In 2007, Ozmen and colleagues detected a cadmium
based correlation between progressive motility and human sperm cells. In the
same study, the group observed a relationship between DNA fragmentation and
acrosome integrity in sperm cells exposed to cadmium (Ozmen et al., 2007).
The Centers for Disease Control and Prevention (2006) suggested that
cigarette smoke leads to infertility through a combined effect of decreased sperm
motility with active paternal smoking, decreased tubal patency with active
maternal smoking, and/or second hand smoke exposure. The observed
relationship between lifestyle exposures and the adverse effects on male
reproductive health has increased the need for further smoking related studies.
Heat Exposure
Research has demonstrated that an increase in testicular temperature is
considered another environmental exposure that has a negative effect on male
fertility. In 2007, Shefi and investigators described that increased testicular heat,
such as in saunas or hot tubs, elevated the testicular temperature and impaired
sperm production. In 2014, Rato and colleagues further described such
sensitivity to increased testicular heat, that even a sedentary lifestyle should be
considered a potential confounder for reduced sperm count because of the
increase scrotal heat.
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Senger (1999) explained that researchers found that exposure of the
scrotum to hot temperatures for periods of 16 hours a day did not influence the
spermatozoal numbers. However, a reduction in motility and percentage of live
spermatozoa occurred when the testes were heated for only eight hours per day.
Additionally, the group observed that when 16 hours per day of heat was applied
to the scrotum the survival of embryos produced by normal females was reduced
(Senger, 1999).
Male Infertility Length with Current Partner
In a 2005 publication, Wright and colleagues were in agreement that the
rising number of children born after assisted reproductive technology is a
reflection of the increasing number of couples seeking treatment for infertility.
Recent studies have emerged stating that underlying infertility and time to
pregnancy is a proposed risk factor for adverse pregnancy outcomes,
independent of maternal age (Zhu et al., 2006).
About 10.0 to 20.0% of couples who are trying to become pregnant
experience a waiting period to pregnancy longer than 12 months, which is the
clinical definition of infertility in most industrialized countries (Juul et al., 1999). A
2000 study suggested that the older a man was the higher his infertility length
with current partner (ILCP) or the longer it may take his partner to conceive,
regardless of her age (Ford et al., 2000). The authors’ claimed that women with
partners five or more years older have less chance of conceiving within a year of
trying than those whose partners are the same age, or younger (Ford et al.,
2000).
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The investigation, through a large population study, was conducted by
Ford and colleagues in 2000 to evaluate the effect of paternal age on time to
conception. The group reported that older men were significantly less likely than
younger men to impregnate their partners in ≤6 or in ≤12 months. Interestingly,
the average male age in which fertility expressed a significant decline was similar
to that of previous research studies on women.
The independent effects of female ageing on fertility among the general
population have been clearly demonstrated using donor insemination as a model
(Federation CECOS et al., 1982). After age 30 years, a slow decline has been
observed in females and it rapidly increased after 40 years; now the main limiting
factor in the treatment of infertility (Hull et al., 1996; Templeton et al., 1996;
Spandorfer et al., 1998). However, a decline in male fertility with age has never
been confirmed or quantified by studies in the general population. Male fertility
remains difficult to measure directly except in small and atypical populations such
as couples attending fertility clinics. In addition, quantification of the effect of
advanced male age is confounded by many other factors. Weinstein and Stark
(1994) acknowledged that studies on the ageing of a male can be compromised
by the ageing of his partner and/or the decline in coital frequency associated with
prolonged co-habitation.
Ford and colleagues (2000) took those effects into consideration and after
adjustment the results of their study demonstrated a statistically significant
increase with advancing male age in the proportion of couples who took longer
than 6 or 12 months to conceive. The average age of the men who took >6
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months to impregnate their wives was 31.8±5.75 years compared with 30.8±5.27
years in men who took ≤6 months (Ford et al., 2000). In addition, the group
discovered that men who took >12 months were also significantly older,
32.6±5.91 years, than men who took ≤12 months, 30.9±5.32 years (Ford et al.,
2000).
From their 2000 study, Ford et al. reported that the odds of conceiving
within six months of trying decreased by 2.0% for every year that the man is
older than 24 years, and for conception within a year decreased by 3.0% for each
year. The group came to the conclusion that the probability of an ultimately fertile
couple taking >12 months to conceive nearly doubles from approximately 8.0%
when the man is <25 years to approximately 15.0% when he is >35 years. The
authors proposed that these results suggested a larger decline in male fecundity
with advancing age than reported in earlier population studies.
There are a number of researchers that believe time to conception can be
a useful epidemiological marker of fertility. Even so, it has to be used with caution
because it ignores couples who fail to conceive and is subject to a number of
sources of bias (Baird et al., 1986; Joffe and Li, 1994; Olsen et al., 1998; Spira,
1998; Tuntiseranee et al., 1998).
Significance of Male Infertility Research
It is important to note that 10.0% of couples attempting to have children
suffer from infertility. According to a 2001 report from Guzick and colleagues,
each year 1.2 million men seek help for infertility and 15.0% are accurately
diagnosed with male factor infertility using a semen analysis. Seventy percent of
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IVF cycles fail for reasons unknown. However, sperm is suspected to contribute
significantly to this failure rate.
Heightened by current societal trends to delay parenthood, understanding
the effects of male age on semen quality is especially relevant for men attending
reproductive clinics. The reliance on modern technologies, especially among
marginally fertile older men is steadily increasing (Schmid et al., 2007). Although,
ICSI and IVF have enhanced the probability of achieving fatherhood, they also
circumvent the natural barriers against fertilization by damaged sperm (Maher et
al., 2003; Singh et al., 2003). Further research needs to be done to better
understand the mechanisms that are involved in the decline of sperm quality and
fertilization capabilities, with regards to advanced male age and environmental
lifestyle exposures.
Reproductive Clinician Perspective
Due to the increased proportion of infertile couples adopting to conceive
by in vitro fertilization, predicting outcomes is of ever increasing importance in the
human fertility industry (Brincat et al., 2014). Clinicians agree, since pregnancy
rates following IVF are still quite low, prognostic information is very helpful in
clinical decisions. Brincat and colleagues (2014) explained that although
significant research is available on the maternal influence, updated male factor
infertility research is still relatively unavailable for clinician application.
A new concern addressing the human fertility industry is the lack of
adequate information clinicians are giving to patients on male infertility factors.
Investigators from various industries have conveyed a number of sources that
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have led to this phenomenon in male fertility treatment. However, most clinicians
agree on two major issues that hinder sufficient male participation and treatment;
a lack of consistent and current male infertility data and the deficiency in personal
medical information provided by male patients. Both of these concerns are
significant contributors to less efficient clinical treatment of male infertility factors.
Additionally, this supports the current discrepancy in the treatment process
experienced individually by the male and the female within the infertility couple.
Researchers have explained that male patients appeared to be more likely
to confide in and desire information and emotional support from infertility
clinicians rather than from friends or mental health professionals (Glover et al.,
1994; Hammarberg et al., 2010; Brucker and McKenry, 2004). Therefore, if
patients are not getting adequate information on male infertility factors from their
doctor visits they are highly unlikely to learn about fertility issues and lifestyle
exposure factors through additional resources.
In a 2010 review of research, Dancet and colleagues discovered that in
only 5.0% of studies concerning patients’ perspectives on fertility care focused
specifically on the male perspective. Throsby and Gill previously broached this
subject in a 2004 study of the male experience and ART. The pair reported that
the normative assumption about the importance of child bearing and rearing
coupled with the focus of ART treatment on the woman’s body have reduced the
visibility and awareness of the male experiences of childlessness (Throsby and
Gill, 2004).
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Coupled with the abundant research on the natural behavioral differences
observed between males and females, male reproductive studies have reinforced
that men are more likely to avoid issues concerning their personal infertility.
Hjelmstedt et al. (1999) found that significantly more men, approximately 50.0%,
than women had not shared their infertility issues with another person. The group
interpreted the study results as a reflection of the inherent male frustrations of
being in a situation that is poorly understood and in which assured treatments are
availably researched or described to the patient.
Greil and colleagues (2010) explained that men can be affected by
infertility in several ways: through receiving a diagnosis of their own infertility,
through being the partner of a woman who is infertile, or through being part of a
couple with unexplained infertility. Although the psychological and social aspects
of infertility, fertility treatment with ART, and infertility-related childlessness have
been investigated comprehensively in women, the psychosocial consequences of
infertility for men are less well understood (Greil et al., 2010). Therefore, with
continued research, clinicians would have the ability to provide male patients with
answers to the unknown factors and encourage improvements in their
environmental lifestyles to enhance their personal reproductive success.

66

CHAPTER III: RETROSPECTIVE STUDY
EXAMING MALE INFERTILITY; THE ASSOCIATION BETWEEN
AGE, ENVIRONMENT, AND REPRODUCTIVE SUCCESS IN MALE
PATIENTS THAT HAVE PARTICIPATED IN ASSISTED
REPRODUCTIVE TECHNOLOGY
Introduction
In high-income countries, approximately 15.0% of heterosexual couples
experience difficulties conceiving when pregnancy is desired, and in up to half of
these couples, infertility is attributable to the male partner (Skakkebaek et al.,
1994). Inhorn (2009) explained that in the world’s resource constrained low and
lower-middle income countries, the prevalence of infertility in couples is thought
to be higher because of undetected and untreated reproductive-tract infections.
Research has proposed several theories on the exact mechanisms that
are responsible for the age-related decline in male fertility. Yet, scientists are still
unable to determine exact mechanisms that are to be blamed (Belloc et al.,
2014). One obstacle to overcome is the natural heterogeneous nature of human
sperm. Semen samples in humans are so variable that it has been difficult for
investigators to define the exact mechanisms.
In addition to age, there are a growing number of male infertility factors
that are receiving new interest from reproductive scientists. Recent research has
reported controversial results on a number of possible male infertility factors such
as; lifestyle exposures, BMI, and ILCP. However, the fact that the exact
associations have not been found has done nothing to deter the ever rising
popularity of assisted reproductive physiology treatments.
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In 2011, a total of 151,923 ART procedures performed in the U.S. were
reported to the Centers for Disease Control and Prevention (2012). These
procedures resulted in the birth of 61,610 infants. In line with the rising ART
procedures is the rising age of couples receiving infertility treatment.
A number of studies demonstrated that as female age increased, fertility
rates decreased. Yet, little research attention has been focused on male related
infertility factors. The few studies performed; claim that 40.0 to 50.0% of infertility
problems experienced by couples originate from paternal factors. Considering
that statement, male age and lifestyle need to be equally factored into the
equation.
To date, research has identified these potential predictors: fertilization,
age, reactive oxygen species, sperm quality parameters, and DNA fragmentation
(Brincat et al., 2014). Predictors under investigation which have shown promising
signs in data include: folate and homocysteine, anti-mullerian hormone
measurement, environmental factors, body mass indexes, smoking, male age,
stress, some subsets of antisperm antibodies, and epigenetic features (Brincat et
al., 2014). However, no definitive predictive value of these and more male
infertility factors have been isolated to accurately gauge reproductive success.
In a 1998 review, Tarin and colleagues explained that late spermatids and
immature and mature spermatozoa do not have a DNA repair system. Moreover,
the activities of antioxidant enzymes within the seminal plasma and spermatozoa
from older men may be reduced, thus, contributing to the reason that
spermatozoa of older men are more vulnerable to mutational changes.
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These detrimental effects can lower the overall sperm count by stopping
or slowing the actual production of sperm. The fewer the normal sperm that are
present the less likely it is that the oocyte will be successfully fertilized. In
addition, these adverse factors can cause decreased mobility, abnormal
morphology, and/or other DNA damage. Many defects can contribute to impaired
fertilization so ideally, the fewer sperm with problems, the more likely that the
sample has good fertilizing potential (Menkveld and Kruger, 1995).
Male and female gametes each contribute 23 DNA storing chromosomes
at fertilization. Therefore, any damage, breaks, or changes in DNA can result in
the inability of the sperm to fertilize the oocyte. If the altered sperm cell does in
fact fertilize the oocyte, then development of the embryo and fetus may be
affected, causing miscarriage or possible health problems for the offspring
(National Institute for Occupational Safety and Health, 1996).
Investigators perform semen analysis testing to diagnose and manage
male infertility. However, the limitations of conventional testing methods have
been well documented. The most commonly evaluated parameters are sperm
volume, sperm morphology and sperm motility. Recently, a number of more
sophisticated assays including; measurements of sperm DNA fragmentation
rates, seminal oxidative stress, and antioxidant capacity have been identified
(Barazani et al., 2014). However, they are not a standard in the evaluation of
male infertility and many clinics do not test for such additional parameters.
Previous research has led to the need of implying a female cutoff age. As
researchers are discovering semen quality is a large contributor to reproductive
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success, further research will help to determine if cutoff ages need to be applied
for males as well. Theoretically, if cutoff age limits were currently mandated
under federal law, having age limits for females and not males would be
considered sex discrimination. We can only assume that these issues and more
will arise in the next decade.
Purpose and Objectives of the Study
This study was designed to investigate the effect of male age and
environmental lifestyle factors on the reproductive outcome of patients who had
previously participated in clinical fertility treatments. Prior research has
demonstrated that advanced female age, among other female factors, is directly
related to reproductive success. However, there has been a limited amount of
research performed on the effects of advanced paternal age and male lifestyle
factors on reproductive success. This study was designed as part of a two
component project to address these influences.
Reproductive clinicians are being confronted with elevated pressure to
produce successful fertility treatments for an increasing number of couples. As
older age and environmental factors are being shown to reduce reproductive
success rates, more information regarding this problem is necessary to
implement more efficient practices of infertility treatment programs.
In the first study, reproductive success will be determined through a
combination of outcome variables; semen analysis, including sperm volume,
concentration, morphology, motility, and percent normal, and biochemical
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pregnancy rates. The type of reproductive treatment administered will be
recorded as IVF or ICSI.
The original purpose of this study was to evaluate possible correlations
between male age and environmental lifestyle factors that posed a threat to male
fertility. Originally, data on approximately 50 variables were attempted for
collection from male electronic medical records; they were subsequently
narrowed down based on various factors. The selected variables were isolated
for two specific reasons; they were listed in the review of literature and they
provided the most consistent data available in the male medical charts. The
following list of specific objectives was designed by the researcher to evaluate
any possible correlations:
1. To describe clinical and study sample data on infertility patients who
have participated in retrospective ART treatments from 2011 to 2014 at a
private human fertility clinic in the southwestern region of the United
States on the following selected characteristics.
2. To determine if there is a relationship between the age and reproductive
success rate of male infertility patients who have participated in ART
treatments at a private human fertility clinic in the southwestern region of
the United States as measured by a randomized retrospective evaluation
of patient charts from 2011 to 2014.
3. To determine if there is a relationship between environmental lifestyle
factors such as; male occupation, cigarette smoking, alcohol use, caffeine
use, recreational drug use, hot/bath tub use, steroid use, high fever,
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and/or chemical exposure, and reproductive success rate of male infertility
patients who have participated in ART treatments at a private fertility clinic
in the southwestern region of the United States as measured by a
randomized retrospective evaluation of patient charts from 2011 to 2014.
4. To determine if there is a relationship between male body mass index
(BMI) and reproductive success of male infertility patients who have
participated in ART treatments at a private fertility clinic in the
southwestern region of the United States as measured by a randomized
retrospective evaluation of patient charts from 2011 to 2014.
5. To determine if there is a relationship between infertility length with
current partner and reproductive success in male infertility patients who
have participated in ART treatments at a private fertility clinic in the
southwestern region of the United States as measured by a randomized
retrospective evaluation of patient charts from 2011 to 2014.
Materials and Methods
Research Design
The primary purpose of this retrospective study was to determine if a
relationship existed between advanced male age infertility factors and human
reproductive success. After a review of the literature, the researcher chose to
investigate three additional variables of controversy; male environmental lifestyle
exposures, male BMI, and infertility length with current partner.
A retrospective study was conducted using anonymous data from patients
who had previously participated in ART cycles. The samples included patients
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treated from 2011 to 2014 at a private human fertility clinic in the southwestern
region of the United States. Reproductive success was determined by assessing
biochemical pregnancy rates and semen analysis.
The study was designed to address research findings from the review of
literature and available patient data observed retrospectively. The following
objectives were written in the form of research hypotheses to be tested:
1. Human males who have previously participated in clinical ART
treatments from 2011 to 2014 will have decreased reproductive success
rates as male age increased in these patients.
2. Human males who have previously participated in clinical ART
treatments from 2011 to 2014 will have decreased reproductive success
rates based on cigarette smoking.
3. Human males who have previously participated in clinical ART
treatments from 2011 to 2014 will have decreased reproductive success
rates based on alcohol usage.
4. Human males who have previously participated in clinical ART
treatments from 2011 to 2014 will have decreased reproductive success
rates based on caffeine usage.
5. Human males who have previously participated in clinical ART
treatments from 2011 to 2014 will have decreased reproductive success
rates as BMI levels increased in these patients.
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6. Human males who have previously participated in clinical ART
treatments from 2011 to 2014 will have decreased reproductive success
rates as ILCP increased in these patients.
The dependent variables for this study were biochemical pregnancy rates
and semen quality. Commonly evaluated semen parameters used to determine
quality were; volume, concentration, motility, progressive motility, percent normal,
and total motile sperm per specimen. Independent variables were male age and
male environmental lifestyle factors such as; urological history, chemical
exposure, male BMI, and infertility length with current partner.
Approval to conduct this study was obtained from the Louisiana State
University Institutional Review Board, IRB# E8892 (Appendix A). Exemption was
granted under the compliance of the guidelines for human retrospective studies.
In addition, a request to waive patient consent forms was approved by the IRB
for reasons that; the type of research presented no risk of harm to the subjects
and there would be no way to trace the study data back to the individual
participant(s) (Appendix B). In addition, there was a high possibility that some
participants may not be accessible to sign the consent waiver as they were no
longer patients of the clinic.
In August of 2014, a study collaboration agreement was discussed
amongst the primary researcher and the laboratory director of a private human
fertility clinic located in a largely populated area of the southwestern region of the
United States. The specific clinic was selected for a number of reasons; the
utilization of advanced electronic patient records, proven clinical success rates, a
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high volume of diversified patients among a large area, and the consistency of
the same technician performing semen evaluations and assisted fertility
procedures.
In a positive association, The Society for Assisted Reproductive
Technologies (SART) has reported more than once that the current study clinic
consistently outperformed the national average. According to the recently
released SART report on 2013 IVF cycles, or procedures involving IVF, the study
clinic once again achieved one of the highest IVF success rates in the nation. In
2013, SART reported that the national average pregnancy of women under the
age of 35 was 47.7% (Society for Assisted Reproductive Technology, 2013); the
collaborating clinic reported an average of 58.3% (Society for Assisted
Reproductive Technology, 2013). The clinic also reported success rates for
women ages 35 to 37 at 43.2% and women between the ages of 38 to 40 at
59.5%, significantly higher than respective national figures, 39.2% and 28.5%
(Society for Assisted Reproductive Technology, 2013).
With IRB and private clinic approval, the retrospective study was designed
around initial clinical patient consultations. Each patient and their partner were
asked to complete an electronic questionnaire. Both males and females were
requested to examine approximately 50 questions on lifestyle factors; such as
physical characteristics, medical history, fertility history, urological factors,
infertility length with current partner, gender specific questions, and a history of
various exposures. The descriptive information collected from these
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questionnaires was incorporated into each new patient’s secured electronic
medical records.
Population and Sample
The population of the study was defined as male infertility patients and
their partners who have previously participated in fertility treatment(s). The
patients specifically went through ART treatment cycles from 2011 to 2014, at a
private human fertility clinic in the southwestern region of the United States. In a
retrospective analysis of the total population, the average female age was 35
years old and a pregnancy rate of 55.0% was observed by the researcher.
A sample of 132 randomly selected female patients was obtained from the
original population of ART participants. Matching male partner data was
subsequently collected from patient electronic medical records. The random
sample of females was each assigned an identification number. Then male
partner information was collected and assigned a corresponding identification
number.
Instrumentation and Data Collection
In September of 2014, e-mail correspondence between the Researcher,
the Reproductive Laboratory Director, and the Medical Director was exchanged
regarding the study proposal and IRB approval. On December 16, 2014 the
researcher e-mailed the fertility clinic a signed copy of a confidentiality and
nondisclosure agreement designed specifically for this study (Appendix C). In
addition, a copy of the IRB approval form and project summary were forwarded
to the clinic. On January 20, 2015, at the invitation of the lab director, the
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researcher visited the human fertility clinic to further present the purpose and
rationale of the retrospective study and to discuss lab protocol. In agreement, the
group decided that the most useful and accurate patient information would be
obtained from cycles performed from June 2011 to December 2014. This time
period would provide the most complete electronic medical records. At the
conclusion of this meeting, the confidentiality and nondisclosure agreement was
verified and additionally signed by the Medical Director.
The initial study proposal was to include a multi-center population of male
patients; however, the group decided that the diversity of the population in this
particular clinic, the normal to above normal average success rates, and the
consistency of using the same evaluator would produce generalizable results.
Additionally, in the review of literature, the researcher examined a large
population of studies that came from individual clinics.
Over the next two months, the researcher traveled to the fertility clinic for
three to four days at a time to securely collect patient data. This was done to
ensure that the sample patient identification was kept anonymous. The laboratory
directory generated a discrete list of all female patients who had partaken in a
treatment cycle or multiple cycles in the previous six years, listing only patient
identification number, retrieval date, female age, peak E2 at hCG, βhCG levels
on day 14, and the observation of a gestational sac(s).
Variables associated with male infertility factors were initially collected
following a review of related literature and analysis of the specific clinic survey
questionnaire. Original variables collected were; male and female age and
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biochemical pregnancy status. From the female patient medical charts fertility
partners were identified as male, female, or donor. The date and type of the ART
treatment was collected in addition to the date of semen collection and
characteristics analyzed. Descriptive male factors such as; height, weight, male
BMI, infertility length with current partner, pregnancy history, medication history,
and longtime illness history, were also collected. Urological and environmental
lifestyle variables collected included; male occupation, patient and partner
smoking history, male caffeine and alcohol consumption, history of vasectomy,
hormone treatment, impotence, testicular abnormalities, white blood cell count in
semen, male recent high fever, male hot/bath tub use, steroid use, recreational
drug use, and male chemical exposure.
Through an extensive review of the female electronic patient records of
the randomly selected sample, available data was collected and couples were
recorded by their corresponding sample numbers. Patient numbers were
recorded into an excel spread sheet with female age and the presence of a
biochemical pregnancy. Male information was added to the document and
identification numbers were recorded as one complete sample. For example, a
female sample number 111 was correlated to male partner number 111.111 and
their data were recorded jointly as a sample couple.
Data Collection
Pregnancy status based on gestational sac(s) presence, were observed
by an ultrasound technician at an eight week gestational sonogram of the female
patient. The presence of one or more gestational sacs confirmed a biochemical
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pregnancy. For this study one or more gestational sacs were recorded as a
positive biochemical pregnancy and zero sacs observed were recorded as nonpregnant.
Date of semen collection and cycle treatment was recorded as month,
day, and year. This allowed the researcher to calculate the correct male age at
the time of semen collection. Abstinence time period before collection was
recorded in number of days. Semen parameters were recorded from male
electronic patient records. Semen evaluation scores were previously recorded by
the clinical andrologist, using the WHO reference values of human semen
characteristics 5th edition in combination with the Kruger Strict Criteria for;
volume, concentration, motility, progressive motility, Strict morphology percent
normal, number of round cells, pH, and total motile sperm per specimen sample
(Table 3.1).
Height and weight were recorded as self-reported by the patient. Male BMI
levels were automatically calculated by the clinic evaluation form or by the
researcher from supplemental male patient data. BMI levels were recorded as
underweight, normal weight, overweight, or obese. According to the CDC
(Centers for Disease Control and Prevention, 2015), overweight refers to an
excess amount of body weight that may come from muscles, bone, fat, and
water, whereas obesity refers to an excess amount of body fat.
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Table 3.1. Semen was analyzed using the following parameters and range of
references (Cooper et al., 2010).
Semen Parameters

Normal Range of Reference

Volume (ml)

1.5 to 5.0 ml

Concentration (million/ml)

>=15 million/ml

Motility (%)

>=40.0%

Progressive Motility

>=3 on 0 to 4 scale

Strict Morphology Percent Normal

>=4.0%

Round Cells

<1 million

Ph

7.2 to 8.5

Motile Sperm/Specimen

>=16 million

Length of infertility with their current partner was determined by the
number of months without conception and/or live birth. When evaluating male
BMI levels and ILCP, donor samples were automatically removed because no
data was obtained for those patients. Additional samples were removed for ILCP
in same sex partners.
Environmental lifestyle exposures were recorded to analyze data on
occupation, male smokers, male alcohol use, male caffeine use, male
recreational drug use, history of male hot/bath tub use, male steroid use, history
of recent high fever, and male chemical exposure. In addition, male chart
completion rate was recorded for the samples that were analyzed for the clinic
evaluation. This data collection addressed two purposes of the study; one was to
investigate the presence of a relationship between these variables and male
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reproductive success and the second was to evaluate the amount of missing
male data.
Occupation was originally recorded as specific job type and then grouped
into categories of job exposure to possible harmful variables. This data was
collected for two purposes as well. The first was an attempt to obtain a large
enough sample size to evaluate a relationship between occupation and male
reproductive success. The second was to again, identify the number of missing
male sample data.
Cigarette smoking was recorded as smoker or non-smoker for the male
patient and their partner. Alcoholic beverages were recorded as the number of
drinks the male patient consumed daily, weekly, or socially. The number of
caffeinated beverages was recorded as the amount consumed by the male
patient per day, per week, or per month. Data was also recorded for male usage
of recreational drugs, hot/bath tub use per week, recent high fever, steroids for
body building, and chemical exposure.
History of sexually transmitted disease and treatment were recorded as
the type of disease(s) and current status. Impotence, history of hormone
treatment, history of vasectomy, and surgical history were recorded. In addition,
undescended testicles, trauma to the testicles, painful swelling or torsion of the
testicles were recoded. History of white blood cells in the semen and history of
prostate infection were recorded for male patients with available data. Herbal
remedies or vitamins, medications, and long standing medical illness(s), as well
as, special diet were recorded for male patients when data was available.
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The researcher then reviewed the expansive data set for inadequate study
samples. Samples were removed if they fell into one or more of the following
categories; canceled cycle, no partner identified, and/or the patient quit. Due to
the nature of the fertility industry, incomplete patient data is commonly seen,
especially in males. Based on the specific data available for study participants,
the researcher elected to create two sub-samples containing separate variables.
Although, a large number of participants were in both sub-samples, a few
additional samples were included or excluded based on their available data. To
increase clarity for the reader, the sub-samples will be identified as biochemical
pregnancy sample and semen sample from this point forward.
The biochemical pregnancy sample consisted of 102 sample couples.
Twenty samples were excluded from the original sample for the following
reasons; the sample consisted of couples with missing biochemical pregnancy
data, the use of biopsy ICSI for patient ART procedure, missing male age data,
and some samples of donor sperm. In the cases of donor sperm, same sex
female couples were removed; however, same sex male couples were retained if
one of the partners semen sample was used for treatment. The average female
age in the biochemical pregnancy sample was 35 years old, the average male
age was 38 years old, and biochemical pregnancy was recorded at 44.0%. Males
ranged in age from 26 years old to 52 years old and females ranged in age from
24 years old to 44 years old.
In the semen sample, 104 patients were included based on their available
data of semen analysis parameters. Since the current study defined reproductive
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success in two ways; biochemical pregnancy observation and semen analysis,
21 male patients who lacked pregnancy data but contained complete semen
sample data, where included in this population. The sample variables included;
semen characteristics, male age, lifestyle exposures, urological history, BMI, and
ILCP. Average male age and range did not change among samples.
A normal characteristic of the human fertility industry is the lack of
complete data for collection and/or analysis of patient samples. The semen
sample contained more missing variable data than the biochemical pregnancy
sample. However, that was to be expected due to the fact that not all sperm
donors reported abstinence length and certain semen evaluation parameters are
not available once the sperm has been frozen and thawed.
Data Analysis
The unit of observation, for evaluating male infertility factors, was
reproductive success, defined by two dependent variables; biochemical
pregnancy and semen analysis. As previously mentioned, patients were divided
into two sub-samples, n = 102 and n = 104, based on the availability of patient
data. Both samples were used to evaluate the relationships of each objectives
listed below. Due to lack of response data, sample size ranged in some of the
variables.
Since, the availability of male data unreported was a variable of interest;
the researcher identified the samples that had missing data due to collection
constraints, not because of the lack of patient response. Those cases were not
included in specific variable evaluations. In contrast, data that were obviously
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missing because of a lack of patient response were retained to evaluate the
response rate of male data collection.
The researcher developed the following objectives to accomplish this
portion of the study:
1. To describe clinical and study sample data on infertility patients who
have participated in retrospective ART treatments from 2011 to 2014 at a
private human fertility clinic in the southwestern region of the United
States on the following selected characteristics:


Male and Female Age



Biochemical Pregnancy Rates



ART Procedure Implemented



Semen Analysis



Male BMI Rates



Male Occupation



Patient and Partner Smoking History



Male Alcohol Usage



Male Caffeine Consumption



Male Hot/Bath Tub Exposure



Male Chemical Exposure



Male Medication Usage



Male Infertility Length with Current Partner

IBM SPSS was used to run descriptive statistics for Objective 1. Data was
collected upon initial random sampling from the study clinic female patient list;
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subsequently, male data was collected after being matched with the correct
female identification number. Mean, sample size, standard deviation, frequency,
and normal distribution were used to characterize the study samples.
Descriptive statistics were also utilized to identify data with relevant
sample sizes for further analysis, additionally bringing to light the number of
incomplete male patient records. The mean male age at collection was 38 years
old and using IBM SPSS was found to be normally distributed (Appendix F.1).
Biochemical Pregnancy Sample
Biochemical pregnancy rate for the sample of 102 patients was 44.0%,
regardless of female age or art procedure. A one-sample t-test (Appendix F.2)
showed no significant difference between the average pregnancy rate of the
study sample, 44.0%, and the average ART pregnancy rate of the national
population, 39.0% (Society for Assisted Reproductive Technology, 2013). The
average female age of the 102 study sample patients was 34.5 years old.
Females ranged in age from 24 to 44 years old with a standard deviation of 4.6
years.
Of the 102 samples, 72 contained data for the type of ART treatment
performed, IVF or ICSI. This difference in sample size is from research collection
constraints not missing data. ART procedures were evaluated for frequency and
were found randomly equivalent; 36 IVF cycles and 36 ICSI cycles. The mean for
the 72 samples was .50 and the standard deviation was .50. For IVF, 15 patients
were recorded as not pregnant and 21 patients were recorded as biochemically
pregnant. For ICSI, 14 patients were recorded as not pregnant and 22 patients
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were recorded as biochemically pregnant. The type of treatment cycle was held
constant for Objective 2, after the researcher observed a common trend in
positive pregnancy data in older males and ICSI rates.
Semen Sample
When descriptive statistics were obtained for the 104 samples of semen
analysis data, the average male age at collection was 38 years, ranging from 26
to 52 years old with a standard deviation of 6.14 years. The semen descriptions
that follow will identify the sample size for each variable, as well. Once semen is
frozen and then thawed out, certain characteristics cannot be obtained or no
longer provide relevant results. Different sample sizes were seen for abstinence,
progressive motility, percent normal, and pH, due to donor records and frozen/
thawed semen records.
Abstinence contained 93 samples that reported an average time period of
three days. Patients reported a range in abstinence from 1 to 21 days and a
standard deviation of 2.58 days. Out of all of the 104 samples reported, average
semen volume was 2.6 ml. Semen volume ranged from .2 to 8.5 ml with a
standard deviation of 1.62 ml. Semen concentration was also available for 104
samples and demonstrated an average of 39.14 ml/million, with a notable
standard deviation of 32.20 ml/million and a reported range of 0 to
144.00.ml/million. Average motility, also with104 samples recorded, was 47.1%.
Range in motility varied from 0 to 84.0% with a standard deviation of 18.44. Out
of 100 samples, progressive motility showed a 2.7 average measured on a scale
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of 0 to 4. The progressive motility range reported included the entire scale from 0
to 4 with a standard deviation of .85.
For percent normal, 90 samples were available with a reported average of
5.8%, a reported range of 0 to 15%, and a calculated standard deviation of 3.64.
With 90 samples, pH average was recorded at 7.6. The minimum pH level
recorded was 7.2 and the maximum pH level recorded was 7.8 with a standard
deviation of .16. Out of 104 samples, total sperm per specimen showed an
average of 52.8 million, with a range of 0 to 403.2 million, and a standard
deviation of 61.8. Out of the 72 samples that contained biochemical pregnancy
rates in combination with semen factors, a 60.0% average was recorded, which
is abnormally high compared to the national average but not compared to the
clinic average.
Male BMI data was available for 70 respondents with the average level
being 29, an identical reflection of the national average of male BMI rates which
are currently reported at 29 (Flegal et al., 2012; Ogden et al., 2012), confirmed
by a one-sample t-test (Appendix F.3). The range in BMI level recorded was
19.93 to 45.23 with a standard deviation of 5.9. The researcher converted BMI to
categorical data for better analysis of the results. BMI levels were distributed
throughout four commonly observed groups as seen in Table 3.2. The four levels
of 70 samples were coded and first evaluated for frequency and then for bivariate
correlating relationships using SPSS.
Sixty participants contained data recorded on ILCP, averaging 38 months.
With a reported maximum ILCP at 210 months and a minimum at 0 months the
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standard deviation was calculated at 39.8 months. When the researcher
evaluated the large range in data, outliers and unqualified data samples were
removed. Still, the remaining data left to be evaluated contained 49 samples with
an average ILCP of 42 months, a range of 12 months to 150 months and a
standard deviation of 32.7. The researcher chose to categorize the data into
groups to try and obtain a better correlation analysis. In addition, let it be noted
that a high lack of male patient response to this variable led to approximately
50.0% of the data being obtained from female partner electronic medical records.

Table 3.2. Male BMI Level Classification (Centers for Disease Control and
Prevention, 2015).
BMI Classification
Below 18.5

Underweight

18.5 to 24.9

Normal Weight

25.0 to 29.9

Overweight

30.0 or Greater

Obesity

Occupation was first evaluated for frequency; and, of the 37 samples
recorded out of a sample size of 83, only three occupations listed more than one
frequency. Seven of the male participants filled out evaluations but were
identified for specifically skipping that question. The reason the researcher
recorded it as a skipped question instead of missing data was to further identify
the relationship between male response rates and possibly sensitive but
informative questions.
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For that reason, occupation data was combined into five very subjective
categories of possible work hazards or work exposure. To be clear, this was just
an estimated distribution into categories created by the researcher’s review of
related literature and the researcher’s evaluation of the occupation job
description. There were no distinguishing differences among the samples when
occupations were placed into the categories; inside versus outside work, positive
or negative chemical exposure, sedentary or active occupation, and high stress
as opposed to low stress occupations. Therefore, occupation was not further
analyzed.
With a sample size of 83, frequency of partner smoking did not contain
enough variance to analyze. Only two cases of partner smoking were observed
and 23 samples were missing. The frequency of male patients who smoked was
51 non-smokers, four smokers, 5 to 10 cigarettes per day, and 28 missing
samples.
Out of 83 samples observed for male alcohol use, 48 samples responded.
The highest frequency was from 18 patients who recorded 0 drinks per day. The
second highest frequency, with 10 samples, was one drink socially. Responses
ranged from 0 drinks to 14 drinks socially. The researcher removed extreme
outliers and coded alcohol usage as yes or no. Alcohol use was defined as 1 to 5
drinks socially. Caffeine use contained 49 responses and 29 of the samples
recorded daily use. These variables were correlated to determine if a relationship
existed between male consumption and reproductive success.
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With 50 valid responses out of 83 samples, there were only seven reports
of bath/hot tub use. Frequency of chemical exposure had little information. Three
samples out of 83 reported chemical exposure to toluene, refrigerant, and
pesticides/herbicides. There was not enough information to be analyzed for
either variable.
2. To determine if there is a statistically significant relationship between
male age and reproductive success rate of male infertility patients who
have participated in ART treatments at a private human fertility clinic in the
southwestern region of the United States as measured by a randomized
retrospective evaluation of patient charts from 2011 to 2014.
The researcher used a point-biserial correlation coefficient to evaluate
biochemical pregnancy rate, a dichotomous variable, in relation to age and
semen characteristics. In addition, the type of ART treatment was analyzed for
correlation among pregnancy rate and male age using a point-biserial correlation
coefficient. Pearson’s product moment correlation coefficient was used to
analyze possible relationships between semen characteristics and male age.
3. To determine if there is a statistically significant relationship between
environmental lifestyle factors such as; male occupation, smoking, alcohol
use, caffeine use, recreational drug use, hot/bath tub use, steroid use,
high fever, and/or chemical exposure and reproductive success rate in
male infertility patients who have participated in ART treatments at a
private fertility clinic in the southwestern region of the United States as
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measured by a randomized retrospective evaluation of patient charts from
2011 to 2014.
A frequency analysis was performed using data from the semen sample
group. This section contained the majority of the variables from the patient
questionnaire and the response rates were not consistent. If there was not a
substantial amount of relevant data, the variable was not further analyzed.
Initial analysis of male patient data revealed a 62.3% response rate of the
male patients’ history of smoking. Five percent of male patients reported smoking
5 to 10 cigarettes per day and 61.4% reported not smoking.
Alcohol usage and amount displayed and 69.0% response rate. Caffeine
usage and amount showed a 64.0% response rate. The response rate for
recreational drug use was 64.0%, 1.0% of the sample reported cannabis use and
all other respondents reported no drug usage.
With a 63.0% response rate, medication initially looked to have valid data.
From the response group, the percent of samples that reported no medication
usage was 65.0%. Samples in the response group reported usage of 4.0% for
each of the following; Adderall, antidepressant, hormone related medication, and
asthma medication. The use of blood pressure medication was reported by
14.0% of the response sample. In addition, the use of herbs or vitamins was
reported by 31.0% of the response group.
Urological variables presented similar response rates, and due to lack of
variance in the data, a number of variables were not further analyzed. White
blood cells in the semen had a response rate of 64.0%, of which 98.0% reported
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having no history and 2.0% reported yes to having had white bloods cells in
semen. The response rate for prostate infection data was 65.0%, no history of
infection was reported by 96.0% and 4.0% reported having had a prostate
infection. In the data on recent high fever, 49.0% samples reported no and 51.0%
had no response. STD data displayed a 58.0% response rate, of that 81.0%
responded with no history, 14.0% reported having been treated for an STD, and
5.0% skipped the question. Difficulty with erection had a response rate of 62.0%;
of the samples, 90.0% said no, 8.0% said yes, and 1.0% skipped the question.
Difficulty with ejaculation had a response rate of 62.0%; of the samples, 70.0%
said no, 8.0% responded yes, and 22.0% skipped the question.
The remaining urological variables did not have enough variance in the
data to further explore; hormone treatment, vasectomy, surgery to the testicles,
undescended testicles, trauma to the testicles, and painful swelling of the
testicles. Overall these variables had an average of 60.0% for their response
rates. However, the majority of the responses stated no issue, and the average
answer of yes was approximately 2.0%.
The following variables were removed based on low frequency rate of
response and/or invalid data. Male diet was removed because out of a 50.0%
response rate, one sample recorded a special gluten free diet and the remaining
samples reported no special diet. Steroid usage was removed because the entire
52.0% response rate samples reported no use. With a 56.0% response rate for
hot/bath tub use, 78.0% responded no usage.
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4. To determine if there is a statistically significant relationship between
BMI and reproductive success rate in male infertility patients who have
participated in ART treatments at a private fertility clinic in the
southwestern region of the United States as measured by a randomized
retrospective evaluation of patient charts from 2011 to 2014.
When categorical BMI data was analyzed the sample of 70 consisted of;
0% underweight males, 13.5% normal weight males, 34.6% overweight males,
and 19.2% of males were classified as obese. BMI classification levels of male
patients were correlated with biochemical pregnancy, male age, ILCP, and
semen samples to meet this objective.
5. To determine if there is a statistically significant relationship between
infertility length with current partner and reproductive success rate in male
infertility patients who have participated in ART treatments at a private
fertility clinic in the southwestern region of the United States as measured
by a randomized retrospective evaluation of patient charts from 2011 to
2014.
Upon initial analysis, the researcher used a normal distribution analysis
and observed a maximum outlier of 210 months and a minimum outlier of 8
months, both were removed from the sample group. Additionally, as human
fertility treatment procedures increase in popularity, we must consider that not all
patients participate in treatment cycles due to infertility issues. Therefore, the
samples that recorded less than 12 month and were seeking treatment for things
such as gender selection of the offspring were removed as well. Two samples
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were removed with an answer of zero, stating that the couple was preparing for
male infertility, and one sample with an un-reversed vasectomy was removed.
A Pearson’s correlation coefficient in SPSS was used to evaluate for a
relationship between ILCP and male reproductive success. A point-biseral
correlation coefficient was used to analyze for a biochemical pregnancy
relationship and ILCP. No significant correlation was observed among any of the
variables. Further analysis could either stop here or ILCP could be converted to
categorical data. The researcher decided to further analyze ILCP by forming
three categories; ILCP 12 to 24 months, ILCP 25 to 48 months, and ILCP ≥49
months.
Statistical Analysis and Findings
In this section, results of correlational analyses are reported for the
dependent and independent variables. The research hypotheses are listed at the
beginning of each respective subsection, and are followed by an explanation of
the statistical analyses. The final section will contain an overview of the results in
a discussion.
1. Human males who have previously participated in clinical ART
treatments from 2011 to 2014 will have decreased reproductive success
as male age increases in these patients.
The researcher ran a point-biseral correlation coefficient to evaluate if a
significant relationship existed between biochemical pregnancy status and male
age at collection. At a value of r = -.196, a statistically significantly negative
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correlation was exhibited between biochemical pregnancy and advanced male
age at a confidence level of .05 (Table 3.3).

Table 3.3. Pearson product point-biseral correlation coefficient table exhibits a
statistically significant negative relationship between biochemical
pregnancy and age of male infertility patients who have participated in
ART treatments at a private human fertility clinic from 2011 to 2014
(Appendix F.4).
Point-Biseral Correlation Coefficient
Male Age at
Collection
Pearson Correlation
Male Age at Collection

Sig. (2-tailed)
N
Pearson Correlation

Biochemical Pregnancy

Biochemical
Pregnancy

1

-.196*

102

.049
102

-.196*

1

Sig. (2-tailed)

.049

N

102

102

* Correlation is significant at the 0.05 level (2-tailed).

As the researcher expected to find, female age demonstrated a negative
correlation with biochemical pregnancy rate and a positive correlation with male
age at time of collection. When comparing female age and biochemical
pregnancy rate the researcher performed a point-biseral correlation coefficient
generating a Pearson’s r value of r = -.209 at a confidence interval of .05. The
relationship between female age and male age at the time of collection was
analyzed using a Pearson’s correlation coefficient. With a value of r = .549 at a
confidence interval of .01, the two variables exhibit an obvious significant
relationship (Table 3.4).
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Table 3.4. Pearson product correlation coefficient exhibits a statistically
significant relationship between biochemical pregnancy rate, female
age, and male age of infertility patients who have participated in ART
treatments at a private human fertility clinic from 2011 to 2014.
The Pearson Product Moment Correlation Coefficient
Female
Age

-.209*

.549**

.035

.000

102

102

102

-.209*

1

-.196*

Pearson Correlation
Female Age

1

Sig. (2-tailed)
N
Pearson Correlation

Biochemical
Pregnancy

Sig. (2-tailed)

.035

N

102

102

102

.549**

-.196*

1

Sig. (2-tailed)

.000

.049

N

102

102

Pearson Correlation
Male Age at
Collection

Biochemical Male Age
Pregnancy at Collection

.049

102

* Correlation is significant at the 0.05 level (2-tailed).
** Correlation is significant at the 0.01 level (2-tailed).

Figure 3.1 demonstrates the decreasing percentage rates of biochemical
pregnancy success as male patient age increases. Results identified a 62.0%
biochemical pregnancy rate for male patients’ age 26 to 30 years old. Male
patients’ age 31 to 35 years old revealed a 59.0% rate, 36 to 40 years old a
32.0% rate, 41 to 45 years old a 36.0%, and 46 to 56 years old a 30.0% rate.
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Figure 3.1. Biochemical pregnancy percentage rates of male infertility patients
who have participated in ART treatments at a private human fertility clinic 2011 to
2014.
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Previous observations led the researcher to further evaluate the
relationship between male age and the type of treatment used for assisted
reproduction. Table 3.5 displays the frequency distribution of ART procedures
performed and recorded from the retrospective study sample. The researcher ran
bivariate correlations for each of the two ART treatments in relation to
biochemical pregnancy. Holding the ART treatment group constant for IVF
(n = 36), a point-biserial correlation was performed to determine if a significant
relationship between IVF biochemical pregnancy rates and advanced male age
existed. Reporting a value of r = -.491, IVF biochemical pregnancy rates and
advanced male age demonstrated a statistically significant negative correlation at
a highly significance level of .01 (Table 3.6).

Table 3.5. Frequency distribution of retrospective study sample ART procedures
performed at a private infertility clinic from 2011 to 2014.

ART Procedure

Frequency

Percent

Valid
Percent

Cumulative
Percent

IVF

36

35.3

50.0

50.0

ICSI

36

35.3

50.0

100.0

Total

72

70.6

100.0
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Table 3.6. Pearson’s point-biseral correlation coefficient table exhibits a
statistically significant negative relationship between IVF biochemical
pregnancy and age of male infertility patients who have participated in
ART treatments at a private human fertility clinic 2011 to 2014
(Appendix F.5).
Point-Biseral Correlation Coefficient
Biochemical
Pregnancy
Pearson Correlation
IVF Biochemical
Pregnancy

1

-.491**

Sig. (2-tailed)

.002

N
Pearson Correlation
Male Age at
Collection

Male Age at
Collection

Sig. (2-tailed)

36

36

-.491**

1

.002

N

36

36

** Correlation is significant at the 0.01 level (2-tailed).

The researcher went on to run an additional point-biserial correlation to
investigate if a significant correlation existed between ICSI biochemical
pregnancy rates and advanced male age. This time holding ART treatment
constant for ICSI, the results recognized an insignificant p value of r = .153.
Table 3.7 demonstrates the results of descriptive statistics used to analyze
semen characteristics from male patients included in the retrospective study
sample. Using a point-biserial correlation coefficient to evaluate for relationships
among biochemical pregnancy and each semen parameter, no significant
correlations were found. However, a Pearson’s coefficient demonstrated a
statistically significant negative correlation between male age and volume,
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r = -.338 at a confidence level of .01. Pearson’s correlation coefficient also
exhibited a statically significantly negative correlation among male age and
progressive motility at r = -.202 with a confidence level of .05. Table 3.8 displays
a complete list of the significant relationships found among male patient semen
characteristics.

Table 3.7. Descriptive statistics of semen characteristics collected
retrospectively from study sample male patients that participated in
private clinical infertility treatment cycles from 2011 to 2014.
Characteristics

Mean

Std. Deviation

N

Male Age (years)

37.7

6.1

104

Abstinence (days)

3.0

2.6

93

Volume (ml)

2.7

1.6

104

Concentration (million/ml)

39.1

32.2

104

Motility (%)

47.0

18.4

104

Progressive Motility

2.7

0.9

100

Percent Normal (%)

5.8

3.6

89

Total Motile Sperm
(specimen/million)

52.8

61.8

104

100

Table 3.8. Statistically significant bivariate correlations among semen
parameters collected retrospectively from study sample male patients
that participated in private clinical infertility treatment cycles from
2011 to 2014.
Pearson's
Correlation r

Significant
(2-tailed)

N

Male Age/ Volume

-.338**

.001

104

Volume/Total Motile Sperm

.399**

.001

104

Male Age/Progressive Motility

-.202*

.043

100

Progressive Motility/Motility

.769**

.001

89

Progressive Motility/Concentration

.500**

.001

100

Progressive Motility/Percent Normal

.288**

.007

89

Progressive Motility/Total Motile Sperm

.379**

.001

100

Progressive Motility/Abstinence

-.219*

.035

93

Motility/Abstinence

-.340**

.001

93

Motility/Concentration

.436**

.001

104

Motility/Percent Normal

.416**

.001

89

Motility/Total Motile Sperm

.476**

.001

104

Concentration/Total Motile Sperm

.704**

.001

104

Concentration/Percent Normal

.269*

.011

89

Percent Normal/Total Motile Sperm

.321**

.002

89

Correlations

* Correlation is significant at the 0.05 level (2-tailed).
** Correlation is significant at the 0.01 level (2-tailed).
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2. Human males who have previously participated in clinical ART
treatments from 2011 to 2014 will have decreased reproductive success
rates based on cigarette smoking.
Using a point-biserial correlation coefficient a statistically significant
positive relationship was observed between male smokers and sperm
concentration at a p value of r = .313 with a confidence level of .05. In addition,
using the same correlation coefficient, a statistically significant correlation
between smoking and progressive motility was exhibited at r = .294 with a
confidence level of .05 (Table 3.9). Using a cross tabulation table (Table 3.10)
with Cramer’s V coefficient exposed a statistically significant correlation between
male smokers and difficulty with ejaculation at a value of r = .465 with a
confidence level of .01 (Table 3.11).
3. Human males who have previously participated in clinical ART
treatments from 2011 to 2014 will have decreased reproductive success
rates based on alcohol usage.
Social alcohol usage was defined once the results were analyzed. Male
patient social alcohol usage was considered an average consumption of 1 to 5
drinks socially (Appendix F.6). No significant correlation was found in male
patients between consumption of alcohol socially and biochemical pregnancy.
However, when evaluating for male age and semen characteristics related to
social drinking, several significant correlations were identified. Using a Pearson’s
coefficient, male social alcohol usage and semen volume displayed a negative
statistically significant correlation at r = -.304, with a confidence interval of .05.
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Table 3.9. Pearson’s point-biseral correlation coefficient table exhibits a
statistically significant relationship between smoker, semen
concentration and semen progressive motility of male infertility
patients who have participated in ART treatments at a private human
fertility clinic 2011to 2014 (Appendix F.7a and F.7b).
Point-Biseral Correlation Coefficient
Progressive
Smoker Concentration
Motility
.313*

.292*

.020

.036

55

55

52

Pearson Correlation

.313*

1

.545**

Sig. (2-tailed)

.020

Pearson Correlation
Smoker

Sig. (2-tailed)
N

Concentration

N
Progressive
Motility

1

.000

55

83

79

Pearson Correlation

.292*

.545**

1

Sig. (2-tailed)

.036

.000

52

79

N

79

* Correlation is significant at the .05 level (2-tailed).
** Correlation is significant at the .01 level (2-tailed).

Table 3.10. Frequency distribution of retrospective study sample male patient
smokers and difficulty with ejaculation presented in a Cramer’s V
correlation coefficient contingency table.
Difficulty with Ejaculation*Smoker Contingency Table
Smoker
Non Smoker
Smoker
Difficulty with Ejaculation

Total

No

34

2

36

Yes

2

2

4

11

0

11

47

4

51

Skipped
Total
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Table 3.11. Cramer’s V correlation coefficient exhibits a statistically significant
relationship between male patient smokers and difficulty with
ejaculation.
Cramer’s V Correlation Coefficient

Value

Approx. Sig.

Phi

.465

.004**

Cramer's V

.465

.004**

Nominal by Nominal

N of Valid Cases

51

** Correlation is significant at the .01 level.

In addition, when using Pearson’s r correlation to compare male social
alcohol usage and total motile sperm per specimen a statistically significant
negative relationship was observed at a value of r = -.293, with a confidence
interval of .05 (Table 3.12).
4. Human males who have previously participated in clinical ART
treatments from 2011 to 2014 will have decreased reproductive success
rates based on caffeine usage.
No significant correlation was found among the relationship of caffeine
and biochemical pregnancy. However, a single statistically significant relationship
was observed correlating BMI and caffeine using a Pearson correlation, with a
value of r = .367 at a confidence level of .01.
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Table 3.12. Pearson product correlation coefficient exhibits a statistically
significant relationship between biochemical pregnancy rate, female
age, and male age of infertility patients who have participated in
ART treatments at a private human fertility clinic from 2011 to 2014.
The Pearson Product Moment Correlation Coefficient
Social Alcohol
Usage
Pearson
Correlation
Social Alcohol
Usage

Volume
-.304*

-.293*

.035

.043

48

48

48

-.304*

1

.342**

1

Sig. (2-tailed)
N
Pearson
Correlation

Total Motile
Sperm/Specimen

Volume
Sig. (2-tailed)

.035

N

Total Motile
Sperm/
Specimen

Pearson
Correlation
Sig. (2-tailed)

48

83

83

-.293*

.342**

1

.043

.002

48

83

N
* Correlation is significant at the 0.05 level (2-tailed).
** Correlation is significant at the 0.01 level (2-tailed).
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.002

83

5. Human males who have previously participated in clinical ART
treatments from 2011 to 2014 will have decreased reproductive success
rates as male BMI levels increased in these patients.
Using a point-biserial correlation coefficient there was no significant
correlation observed between the BMI and biochemical pregnancy rate at a p
value of r = -.018. A Pearson’s correlation coefficient revealed a non-significant
relationship between BMI and male age (r = .040), semen volume (r = .051),
semen concentration (r = -.004), sperm motility (r = -.088), progressive motility
(r = .042), percent normal (r = -.134), and pH (r = .008).
6. Human males who have previously participated in clinical ART
treatments from 2011 to 2014 will have decreased reproductive success
rate as infertility length with current partner increased in these patients.
Running a point-biseral correlation coefficient the researcher found no
significant correlation between biochemical pregnancy rate and ILCP (r = .038).
Via a Pearson’s r correlation coefficient the researcher also discovered a nonsignificant relationship between ILCP and male age (r = -.193), semen volume
(r = -.049), semen concentration (r = -.048), sperm motility (r = .058), progressive
motility (r = .101), pH (r = .213), and total motile sperm per specimen (r = .021).
However, a statistically significant correlation was observed between ILCP and
percent normal semen at a value of r = .304, with a confidence level of .05, using
a Pearson’s correlation coefficient (Table 3.13).
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Table 3.13. Pearson product correlation coefficient exhibits a statistically
significant relationship between ILCP and percent normal semen of
male infertility patients who have participated in ART treatments at a
private human fertility clinic from 2011 to 2014.
The Pearson Product Moment Correlation Coefficient
% Normal Semen
Pearson Correlation
% Normal Semen

Sig. (2-tailed)

.304*
.030

N

ILCP

1

ILCP

70

51

Pearson Correlation

.304*

1

Sig. (2-tailed)

.030

N

51

60

* Correlation is significant at the 0.05 level (2-tailed).

Discussion
Assisted reproductive techniques have become increasingly popular with
the current aging first time parental population. Although, one critical aspect that
has been overlooked for years is the effect of male age on reproductive success.
Previous decades of research have focused almost entirely on female infertility
factors. However, recent studies have started to demonstrate that males may be
affected in a similar manner. In a 2014 study, Brincat and colleagues claimed
that abstract paternal influences on reproduction are significant in causing about
half of infertile couples to turn to ART procedures.
Data from the current study demonstrated that male age does in fact have
a significantly inverse relationship with biochemical pregnancy rate. The results
demonstrated that as male age increased, fertility capabilities were shown to
decrease. The older the male patient, regardless of their female partner’s age,
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the less likely they were to get a positive biochemical pregnancy result. This is
not only important knowledge for clinicians; it is also important information to
share with the population of couples who plan on starting families later in life.
Previous research has shown that advanced female age is correlated with
reduced reproductive success. Therefore, the researcher expected a significant
relationship to be demonstrated in older female patients and biochemical
pregnancy rates. However, a noteworthy finding was the similarity of variance in
the significant relationships discovered between biochemical pregnancy rate for
female age and biochemical pregnancy rate for male age. In other words, the
current results revealed a very similar relationship in individual contribution of
advanced male age and advanced female age to reproductive success.
Furthermore, when the relationship between female age and male age was
correlated a highly significant relationship was found and should be further
analyzed in future studies.
Females have continually been reminded of the biological time clock
winding down on their reproductive years. However, current research has not
only started to focus on age related factors of male infertility, but on the entire
male lifestyle. Studies are beginning to acknowledge that age may not be the
only newly recognized factor contributing to male infertility. Although researchers
have accepted that there are more factors playing a role, determining those
mechanisms has been elusive. This issue was reestablished by the results of the
current study.
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Therefore, the current study first chose to further examine the question of
change in male reproductive capabilities as they increase in age. The
controversy lies in determining if the factor contributing to decreased male
reproductive success is in fact age. On the other hand, it is hypothesized that as
males age they actually become more susceptible to environmental lifestyle
factors that are hazardous to reproductive success.
Additionally, results from the present study demonstrated that in advanced
age males, IVF pregnancy success rates significantly decrease. In today’s fertility
industry, ICSI has become a common procedure used by clinicians to treat older
males or patients with known male infertility factors. The ICSI data from the
retrospective study supported the use of that practice. When researching male
fertility, consistency is extremely important considering there are so many
variables when working with human semen. Therefore, the researcher felt it was
beneficial to analyze the biochemical pregnancy rate while holding the ART
treatment constant due to the increased efficiency of ICSI.
When evaluating semen results the researcher found a similar decrease in
reproductive success as male patient age increased. Even with the small sample
size of the current study, data confirmed that as male patient age increased
semen volume decreased. The data also revealed an inverse relationship with
advanced male age and progressive semen motility.
Once a human female reaches a certain age there is an abrupt decrease
in reproductive capability. Conversely, newly focused research on the
reproductive capabilities of the human male proposes a slow senescence of
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reproductive decline as they age. The decrease in seminal volume observed in
the current study further supports the indication of a significant decline in
advanced age reproductive males.
Due to convenience and efficiency the fertility industry has adopted a
simple one or two based semen analysis procedure. This leaves clinicians with
an approximate 50.0% successful evaluation. The current study demonstrated an
absolute need for more male data, more male awareness, and more male
evaluation techniques. Changes will not happen overnight but the more
frequently male fertility factors are researched, the more exposure they will
receive.
When considering environmental threats, previous studies on the effects
of smoking have reported reduced sperm concentration and motility in male
cigarette smokers (Kunzle et al., 2003; Vine, 1996; Vine et al., 1996). The current
study results reported a similar observation. Results demonstrated a decrease in
semen concentration and progressive motility in those male patients who
reported smoking 5 to 10 cigarettes a day. The results additionally concluded that
male patients who reported smoking were also associated with ejaculation
difficulty.
We must take in to consideration that since this was a retrospective study,
missing data created a smaller sample size. When researching human semen
characteristics it is more desirable to have a larger sample size for a more
normalized average. In the current study, the sample of patients who
demonstrated adequate data to compare for a relationship between smoking and
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semen concentrations consisted of 55 males. For the relationship between
smoking and progressive motility, 52 male patients reported adequate data. A
future study with a larger sample size would be beneficial in examining the
increasing age of male smokers in contrast to decreasing semen concentration
and decreasing progressive motility.
The results of the current study also indicated that alcohol use in male
patients was, in fact, correlated to impaired semen quality. Since, the impact of
alcohol consumption on male fertility potential remains a controversial topic; the
results of the current study are an important addition to the research. The results
demonstrated that as male alcohol use increased seminal volume and total
motile sperm per specimen showed a significant decline. Again the researcher
observed two common semen variables that are reportedly affected by advanced
male age as well. Further research is needed to test for repeatable results and
correlations. Studies should be designed to evaluate the question of reduced
semen quality from the effects of advanced male age or the susceptibility to
alcohol consumption at advanced male age.
In the current research study, male BMI levels did not show a significant
relationship with biochemical pregnancy rate and semen evaluations. In a
previous study, Anifandis and colleagues (2013) reported similar results, finding
no evidence of male BMI correlating with sperm parameters. However, in the
Anifandis study, BMI did influence the quality of embryos produced in such a way
that impacted pregnancy rate (Anifandis, 2013). The design of the current study
would have failed to pick up on impaired embryo quality because retrospective
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data was only collected on embryos that were fertilized and then transferred.
Further studies need to be performed to isolate the effect of BMI on embryo
fertilization and quality prior to transfer.
This raises the question, if high BMI levels are claimed to influence the
quality of the embryo, how can researchers assume that BMI is not in some part
responsible for alterations in semen quality. One consideration, of this
assumption is that whatever factors are playing this detrimental role in embryo
production, are not being tested for in a common semen analysis.
Another consideration is the difference between the effects of being
overweight versus being obese. In 1998, the National Institutes of Health defined
overweight as an excess amount of body weight that may come from muscle,
bone, fat, and water. Obesity was defined as an excess amount of body fat. This
suggests there may be a difference in semen quality expressed between the two
BMI classifications. Research has demonstrated that increased lipid amounts
have been shown to act on the male reproductive axis. It is possible that the key
factor is the actual amount of fat.
In 2014, Rato and colleagues published a study that explained lifestyle
and unhealthy eating can negatively affect spermatogenesis, both at central and
gonadal levels. The group described that the overconsumption of high-energy
diets (HED) altered the function of the male reproductive axis and consequently
affects the testicular physiology, disrupting its metabolism and bioenergetic
capacity. The group emphasized that disruption of the tightly regulated metabolic
pathways leads to adverse reproductive outcomes, such as inefficient energy
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supply to germ cells, sperm defects, or spermatogenesis arrest (Rato et al.,
2014).
This leads to an interesting observation in the current study results. As
previously mentioned, the researcher observed an unusual amount of male
patients that very likely intentionally skipped the questions on difficulty with
erection and difficulty with ejaculation. Further evaluation of these skipped
samples, in addition to the samples who reported an erectile problem, revealed
an average male patient BMI of 31.7, which is considered obese. If, in fact, this
sensitive question is being skipped due to male discomfiture, we assume that
there is more than likely some level of an erectile dysfunction problem with the
male patient. Several investigators have reported that high BMI levels may
reduce male fertility and have associated it with reduced semen quality and
hormone alterations (Jensen et al., 2004; Kort et al., 2006; Fejes et al., 2005;
Fejes et al., 2006). In addition, a 2004 study published by Fung and colleagues
stated that overweight men may be at greater risk of erectile dysfunction which
could lead to reduced fertility.
The final results of the current study found no significant relationship
between ILCP and biochemical pregnancy rates or male patient age. The one
significant correlation observed among semen characteristics was the
relationship between ILCP and the percent normal semen. In 2006, Zhu and
colleagues reported that underlying infertility and time to pregnancy is a
proposed risk factor for adverse pregnancy outcomes, independent of maternal
age. However, Weinstein and Stark (1994) acknowledged that studies on the
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ageing of a male can be compromised by the ageing of his partner. Additionally,
the group contributed a decline in coital frequency to be associated with
prolonged co-habitation, (Weinstein and Stark) which could lead to a negative
effect on the percent of normal semen.
There are a number of researchers that believe time to conception can be
a useful epidemiological marker of fertility. Even so, it has to be used with caution
because it ignores couples who fail to conceive and is subject to a number of
sources of bias (Baird et al., 1986; Joffe and Li, 1994; Olsen et al., 1998; Spira,
1998; Tuntiseranee et al., 1998). Unlike the small sample size of the current
study, Ford and colleagues (2000) found significant correlation among older men
and ILCP by performing a large population study.
Unfortunately, by the time a couple gets to the fertility clinic today, most
are at the point of wanting a child immediately, not wanting to change a lifestyle.
As more research is done on male infertility factors, the issue is further
uncovered. Therefore, this will only increase public exposure to the discussion on
male infertility factors. Couples should be aware that the male partner is now
realized to be a large contributor to reproductive success. Additionally, couples
need to be informed that there are ways to proactively improve their own fertility
chances, as well as, specific lifestyle changes that will accomplish improved
reproductive success.
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CHAPTER IV: CLINICIAN RESEARCH SURVEY METHOD:
EXAMINING MALE INFERTILITY; THE ASSOCIATION BETWEEN
AGE, ENVIRONMENT, AND REPRODUCTIVE SUCCESS IN MALE
PATIENTS THAT HAVE PARTICIPATED IN ASSISTED
REPRODUCTIVE THECHNOLOGY
Introduction
Male infertility is a term that was rarely discussed just a decade ago.
Although, it is heard more frequently today, the term still carries considerable
taboo behind its meaning. Decades of research have highlighted female as the
focus of human infertility. It has been the female, not the male, who has been
consistently studied on the successes and failures of reproduction. Early studies
identified a number of female lifestyle factors that affected reproductive success.
Subsequent research led to an establishment of assisted reproductive treatment
methods, for specific infertility issues.
One form of assisted treatment, in vitro fertilization, is a common medical
procedure practiced today. Although, not so long ago, it was a mysterious
procedure that produced what were then only known as ‘test-tube babies.’ The
same unknown label has been associated with male infertility today. What we
currently view as foreign concepts may evolve into common practices, just as IVF
demonstrated in a few short decades.
Reproductive research has progressed exponentially in the past 50 years
and even still, we are continuously discovering additional factors. As couples wait
longer to start families, an increased demand for research in the area of male
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reproductive fertility is revealed. As our societal trends continue to evolve,
advanced male age must be considered in the human infertility discussion.
Previous data has provided limited research on male infertility factors for a
number of reasons. It is a continuous challenge to find adequate sample
populations for human male studies in places other than infertility treatment
centers.
Purpose and Objectives of the Study
The researcher selected an alternative approach by investigating the
relationship of male age and environmental lifestyle factors on assisted
reproductive technique success rates as observed from an infertility clinician’s
standpoint. The first objective was to compare the retrospective response rates
of male patients in the previous study to clinicians’ response ranks of the
importance of specific male factors.
Next, was to compare the percent of retrospective male patient data
available to male patient data observations made by clinicians in their own
professional experience. The purpose of addressing missing information was to
expose the amount and the importance of unreported male patient data. Through
the retrospective study, the researcher wanted to take an inventory on the
completion level of male patient records. Through the survey study, we wanted to
gain data on the clinicians’ experiences with incomplete male records. From the
results, we expected to increase some understanding of the reasons behind
missing data. Newfound information would help to encourage improved collection
methods. In addition, the study was designed to help determine if there was a
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pattern in the missing data, as well as possible ways to identify the purpose. For
example, a male patient may not answer a sensitive question because he is
uncomfortable with the topic or because he thinks the question is irrelevant to his
fertility issues.
The goal of the survey study was not only to evaluate the actual opinion of
professional clinicians, but to also compare the differences in opinions among
clinicians. This will help to exemplify the variation level of existing standards
among the infertility industry. Professional experience, from someone currently
working in the industry, should provide a different perspective than the
retrospective data results. The researcher designed the following objectives to
describe study sample characteristics and to identify correlation data:
1. To describe the level of importance of male infertility variables that
clinicians report as the most commonly observed in their professional
experiences in comparison to the retrospective male response data
collected on those same male infertility variables.
2. To describe the percentage of completed male medical records
available from the retrospective analysis of data and the percentage of
completed male medical records reported as seen by clinicians.
3. To determine if there is a statistically significant relationship among the
opinions of clinicians who participated in the voluntary male infertility
survey on topics such as; data availability and gender based ethical
treatment of patients.
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Materials and Methods
Research Design
The primary purpose of this study was to gain further insight on
controversial male infertility factors from the unique perspective of reproductive
clinicians. There is so much variability in practices and procedures throughout
the infertility industry that a general consensus of which is the most effective
remains unknown. The study was designed to collect clinical data in an
unconventional method through the analysis of infertility professionals’
responses. After a review of the literature, the researcher developed a series of
questions based on current disputed male infertility factors. Gender related
ethical practices present in today’s industry were also addressed in an
anonymous survey mailed to reproductive professionals.
The goal of the survey was to gauge male infertility factors from a different
perspective. Collecting observations from existing professionals in the fertility
industry, directed the survey identification of male infertility factors from a firsthand perspective. Survey results served to enhance research in this area by
acknowledging the personal experiences of professionals. Combining multiple
methods of evaluation; such as the clinician survey study in this chapter and the
retrospective study in the previous chapter, we believe the results will help to
create a better foundation for the basis of future research studies.
The unique approach of surveying scientists and physicians, through
social science research techniques, while subsequently comparing their opinions
to scientific data helped to create a more comprehensive method for data
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collection. The first two objectives of this study were specifically identified by the
researcher to describe the nature of the relationship between clinician opinions
and the statistical data collected from the review of literature and retrospective
study. This section of the research was designed to gain a broad sense of where
the issues of male infertility stand currently.
While, the deficient amount of research in this area provides a limitless
requirement for cause and effect studies to be performed. The approach of this
portion of the study was to gain knowledge on the important male variables that
are currently being observed in the industry. The next step on the continuum of
research can then be based off of the results obtained from the clinician survey.
By addressing clinicians directly, the study had two goals in mind. First, to
identify the variables of importance that practicing clinicians have reported from
their treatment experiences of male infertility patients. The second was to gather
information on the practices in male infertility treatment currently observed in the
industry today. As the topic has continued to spread, a number of unknowns
have been brought into the conversation. Not only is it important to identify the
detrimental cause and affect variables on male reproductive success. It is also
important to appreciate that the industry will be forced to re-evaluate ethical
differences in treatment among male and female patients.
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The researcher designed the following objectives and research hypothesis
to describe study sample characteristics and to identify correlation data:
1. To describe the level of importance of male infertility variables that
clinicians report as the most commonly observed in their professional
experiences in comparison to the retrospective male response data
collected on those same male infertility variables.
2. To describe the percentage of completed male medical records
available from the retrospective analysis of data and the percentage of
completed male medical records reported as seen by clinicians.
3. Clinicians who participated in the voluntary male infertility survey will
demonstrate a negative correlation among their opinions of infertility topics
such as; data availability and gender based ethical treatment of patients.
Approval to conduct this study was obtained from the Louisiana State
University Institutional Review Board, IRB# E8894 (Appendix D). Exemption was
granted under the compliance of the following guidelines; that participants cannot
be identified, directly or statistically, and the responses/observations could not
harm participants if made public. A waiver of signed consent was granted, with
the inclusion of the survey instructions stating that participation is voluntary. The
participants were informed that by completing the survey they were providing and
documenting their consent.
Population and Sample
The population of the study was defined as clinical professionals who are
currently associated with the human infertility industry. One outlet for survey
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distribution, EmbryoMail, is a national human infertility membership group.
Correspondence is directed through the group moderator and then forwarded on
to members of the group. Membership is strictly for professionals within the
infertility industry. Using this network, the researcher invited all qualified
members to complete the IRB approved male infertility clinician survey (Appendix
E).
In addition, approximately 20 Louisiana State University Alumni, currently
working in the human reproductive industry, were used as another sample
source. Members were emailed the same anonymous survey participation
invitation. Results came from random voluntary participation. The researcher had
no way of identifying participant personal information that was not asked by
specific survey questions.
The study sample consisted of 53 voluntarily and anonymous survey
participants. Clinicians who participated in the survey included 50.9% male
professionals and 49.1% female professionals within the industry. Of the
professionals that made up the study sample; 5.7% were Reproductive
Endocrinologists, MD; 24.5% were Reproductive Physiologists, PhD; 9.4% were
Andrologists; 56.6% were Embryologists; 1.9% were Urologists, MD; and 1.9%
were Reproductive Technicians (Figure 4.1).
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Figure 4.1. Percentage of occupations held by reproductive professionals who
participated in the male infertility clinician survey.
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Instrumentation and Research Procedure
The researcher used the program SurveyMonkey® to design and publish
a 36 multiple choice questionnaire. Male infertility questions were based on
topics from a review of the current literature. A pilot survey test was sent out to
various colleagues in the area whose answers were not to be included in the
results. On January 26, 2015, after positive confirmation of the instrument, an
email invitation was sent to the EmbryoMail moderator and the group of LSU
Reproductive Alumni.
Survey instructions were stated as follows: You are invited to participate in
the 20 to 25 minute brief online survey. If you only have experience with some of
the questions feel free to skip the ones that do not pertain to you and/or record
an alternative answer. Any and all input is welcome in order to gain as much data
from the human clinician side of the industry. Feel free to forward the survey link
to other colleagues you think may be interested in participating. Thank you in
advance for your assistance. To complete the survey click on the link below or
copy and paste into browser: Please complete by February 16, 2015.
https://www.surveymonkey.com/s/clinicalmaleinfertility.
As of February 16, 2015, survey data had been collected from 46
respondents. In a successful attempt to increase sample size, the researcher
sent out a reminder e-mail extending the deadline to March 13, 2015. An
additional seven participants were included. The final survey sample size totaled
at 53 respondents.
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Open ended answers and the suggestion for additional comments were
offered in 14 of the survey questions. These questions were incorporated to gain
additional feedback from the professionals on clinical practices that may not have
been included in the survey answer options.
Survey responses and e-mails received by the investigator were opened
with a secured internet connection. Participant information was received under
an identification number with no way for the researcher to identify a participants’
name or location. Additionally, a secure login was created by the researcher to
upload, edit, and obtain results of the survey.
Data Collection
Participant responses were collected and identified by the order in which
the survey was submitted. For example, the only information for Respondent #1
was that the participant began the survey 7:25 p.m. on January 26, 2015 and
completed the survey at 7:40 p.m.; a total time of 15:19 minutes.
The researcher was able evaluate response data for each participant
individually or as a whole sample group through the survey site. Both methods
provided useful in monitoring progress and allowed for the researcher to identify
additional comments from specific participants on their individual page(s). Survey
results were recorded by gender, occupation, and specific question response,
accessed only by the researcher.
The survey publisher program provided graphs based on descriptive data.
However, to meet the objectives of the study, the researcher reviewed each
survey sample and recorded their answers linking their profession and gender.
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This allowed the researcher to focus on specific relationships that otherwise
could not have been evaluated based on the design of the survey.
The researcher wanted address specific comparisons focused on
occupation in relation to data accessibility and gender in relation to ethical
questions. These survey questions can be viewed below in Table 4.1. In addition,
the researcher wanted to evaluate the clinicians’ opinions on, specific male
infertility factors, patient information gathered by the specific clinic, and male
infertility evaluation tests. The results of these questions were compared to
corresponding data from the retrospective.
After realizing the amount of male data missing in the retrospective study
patients, the researcher wanted to compare the clinicians’ personal experience
with this same issue. Percentages of completed male medical records were
compared for both study samples. Comparing the results for association or
disagreement allowed the researcher to evaluate the importance of missing male
data from two separate perspectives.
Male medical chart completion percentage was evaluated for the
observations given by the clinicians participating in the survey in percentage
completions. In addition, the researcher evaluated the retrospective study
medical charts for the amount of data missing. If an evaluation was completely
missing that sample was considered 100% incomplete. If the evaluation was
incomplete and/or missing data for three to five variables it was considered 25.0
to 50.0% complete. Complete evaluations and evaluations missing only one data
point were considered greater than 75.0% complete.
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Table 4.1. Male infertility clinician survey questions evaluated in relation to
occupation and gender.
Survey
Question (#)

Male Infertility Clinician Survey Questions

Question 1

What role do you play in reproductive health?

Question 2

Gender: Male or Female?

Question 4

In your current position, do you have access to and
review all descriptive data for each male patient
per cycle?

Question 7

In your current position, do you have access to
and review all semen data for each male patient
per cycle?

Question 16

In your current position, do you have access to
and review all urological data for each male patient
per cycle?

Question 19

In your current position, do you have access to
and review all exposure data in each male patient
per cycle?

Question 25

In your current position, do you have access to and
review all medical history data in each male patient
per cycle?

Question 32

Does reproductive healthcare need a better
communication system allowing the physician and
the laboratory physiologist to have equal access to
the all of the male patient’s exposure/environmental
and past medical information per cycle?

Question 34

In your professional opinion do you find it unethical
to provide fertility treatment for males after a certain
age?

Question 35

In your professional opinion, do you find that we are
adequately providing significant clinical information
to older male patients on the risks and ethical issues
of advanced age fertility treatments?
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Statistical Analysis
The main unit of observation for this study was reproductive clinicians who
voluntarily participated in an online survey. In some instances, these
observations were also compared to results from the previous retrospective
study. With Microsoft Excel 2010, descriptive statistics were used to determine
the mean percentages of the most commonly seen male infertility variables
observed by the professionals who participated in the survey. The percentage
means were then used to rank the top five variables that were reported by
clinician observations as important factors in male infertility.
Frequency rates and descriptive statistics were also used, in IBM SPSS
Statistics 22, to identify percentage means of male data response rates from the
retrospective study. The variables of importance identified by the clinician
observations were then compared to the mean percentages of the same
variables from the retrospective study. Since the study was measuring different
rates/ranks, there were no statistical procedures performed other than descriptive
statistics. Still, the researcher wanted to visualize the difference between what
variables are of importance to clinicians and what variables are actually being
reported by male patients.
In addition, descriptive statistics were used to determine the mean
percentages of male record completion that were reported by survey participants.
To compare the rates being observed by professionals in the industry and actual
study data collected on completed male records, retrospective completion data
was evaluated in association. Descriptive statistics had been previously applied
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in the retrospective study to determine the frequency and percentages of
completed male records reported. This allowed for a side by side comparison of
industry observations and retrospective clinic data to be loosely and cautiously
evaluated for similarities.
The researcher used Cramer’s V correlation coefficient, in SPSS, to
determine if there was a significant relationship between occupation and gender.
In addition, Cramer’s V coefficient was used to evaluate for a correlation between
data access and clinician occupation. Data accessibility was examined for five
different areas; descriptive data, semen evaluation data, urological data,
exposure data, and medical data.
Again in IBM SPSS, the researcher used Cramer’s V correlation
coefficient to examine the relationship between gender and ethical male
treatment practices such as; the need of a better clinician communication system
and adequate information provided on advanced age male reproductive risks.
When evaluating occupation and the need for a better clinical communication
system, the researcher also used Cramer’s V to determine a correlation. A Phi
correlation coefficient was used to determine if there was a significant
relationship between clinician gender and treatment cutoff age for males.
Results
This section begins with the results of survey questions that were not
addressed in the statistical analysis. No statistical implications were made for
these additional comparisons. However, the researcher thought it would be
beneficial to the exploratory nature of the research design to evaluate clinicians’
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opinions on these particular questions. In addition, response percentages from
the survey study are compared, side by side, to analogous results from the
retrospective study. The results of correlational analyses are then reported,
implicating the type of relationship between surveyed clinicians’ opinions, gender,
and occupation for the dependent and independent variables.
Figure 4.2 demonstrates the opinion percentage means of surveyed
clinicians on the effectiveness of basic semen analysis as a predictor of male
infertility. Out of 53 participants, 67.9% responded that basic semen analysis was
an effective predictor most of the time. Clinicians who reported semen analysis
as only occasionally effective totaled 26.4% of the response group. Notably, only
a small percentage of survey participants, 5.7%, reported that this analysis was
effective all of the time.
Participating clinicians’ opinions on the importance of DNA fragmentation
as a predictor of male infertility are exhibited in Figure 4.3. The mean
percentages of 52 respondents describe the professional opinions of those
surveyed on this male infertility factor. Result demonstrated that 32.7% have no
idea if DNA fragmentation was a predictor, 26.9% reported that occasionally it
was a predictor, 23.1% rarely thought DNA fragmentation was a predictor of male
infertility, 11.5% thought that most of the time this variable was an indicator, 3.8%
responded never, and 1.9% DNA fragmentation always indicated male infertility.
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Figure 4.2. Percentage means of clinician responses on the importance of basic
semen analysis as a male infertility predictor demonstrated by the response
ranks for survey question number nine.
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Figure 4.3. Percentage means of clinician responses on the importance of DNA
fragmentation as a male infertility predictor demonstrated by the response ranks
for survey question number ten.
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However, when asked what semen parameters the clinic tested for, DNA
fragmentation exemplified one of the lowest statics. The response rate for this
survey question was 100%. As shown in Table 4.2, clinicians reported semen
parameters tested at their clinics in the following order; volume, sperm count,
sperm motility, and progressive motility were tested by 100% of the clinics.
Progressive motility was reported to be tested by 90.6% of the clinics, while white
blood cell count was tested 88.7% of the clinics. Less than half of the clinics,
30.2%, tested for DNA fragmentation and 13.2% tested for acrosome integrity.

Table 4.2. Percentages of semen parameters routinely evaluated as reported by
the professional experience of surveyed clinicians.
Response
Percent

Answer Options

Response
Count

Volume

100.0%

53

Sperm Count

100.0%

53

Sperm Motility

100.0%

53

Progressive Motility

90.6%

48

Sperm Morphology

100.0%

53

White Blood Cell Count

88.7%

47

Acrosome Integrity

13.2%

7

DNA Fragmentation

30.2%

16

N of Valid Cases

53
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The results of participant opinions on the significance of male age on
impaired semen and/or sperm cells are presented in Figure 4.4. Approximately
six percent (5.7%) of clinicians admitted to having no idea on the effects of male
age as it related to impaired semen samples and no respondent (0%) believed
male age was completely responsible. However, 58.5% were in agreement that
male age had a somewhat significant effect on the integrity of semen and/or
sperm cells. The remaining participant responses were closely divided, with
18.9% of clinicians believing that male age had a lot to do with impaired semen
samples. On the other hand, 17.0% of clinicians believed that male age was a
factor of little significance.
When clinicians were surveyed on the significance of genetic and
epigenetic changes in sperm DNA, the results demonstrated an increased
agreement in contribution on male infertility (Figure 4.5). Approximately 80.1% of
professionals responded that genetics and/or epigenetics displayed somewhat or
a lot of significance on male infertility, 41.5% and 39.6%, respectively. Additional
results demonstrated that 9.4% of clinicians assumed that this variable had a
little significance on male infertility, 7.5% believed that these changes were
completely responsible for male infertility, and 1.9% had no idea of the
significance as related to male infertility.
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Figure 4.4. Percentage means of clinician responses on the significance of male
age contribution on impaired semen and/or sperm cells demonstrated by the
response rank to survey question number eleven.
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Figure 4.5. Percentage means of clinician responses on the significance of
genetic/epigenetic changes in sperm DNA on impaired semen and/or sperm cells
demonstrated by the response ranks for survey question number twelve.
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Male exposure and environmental factors were thought to have a lot of
significance on impaired semen and/or sperm cells as reported by 58.5% of
clinicians surveyed (Figure 4.6). Approximately, 32.0% of the participants
responded that male exposure and environmental factors were believed to have
somewhat of a significant effect on normal sperm production. Lastly, 5.7% of the
remaining opinion results demonstrated the belief that these factors had little
significance on impaired semen samples and 3.8% of clinicians reported having
no idea.
Considerably, when asked if access to more male patient lifestyle
information would enable the clinician to provide better care, 53.9% of survey
participants answered yes, 19.2% stated no, and 26.9% were undecided
(Appendix F.8). Survey participants also responded to the need of a better
clinical communication system for access to male records with 53.8%
professional agreement, 42.3% thought the current system was sufficient, and
3.9% were undecided about the need for a better clinical communication system
(Appendix F.9).
Objective 1
To describe the level of importance of male infertility variables that
clinicians report most commonly observed in their professional experiences in
comparison to the retrospective male response data collected on those same
male infertility variables.
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Figure 4.6. Percentage means of clinician responses on the significance of male
exposure and environmental factor(s) contributed to sperm impairments as cells
demonstrated by the response ranks for survey question number twenty.
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The most commonly seen descriptive variables that clinical professionals
reported in connection with male infertility were infertility length with current
partner at 70.8%, age at 45.8%, BMI at 29.2%, and weight at 16.7% (Table 4.3).
Height was added to the table because of its response rate in the retrospective
study. Seventy percent of male infertility patients evaluated in the retrospective
study reported data on height. Interestingly, only 2.1% of the clinicians surveyed
listed height as an important descriptive variable. However, BMI was ranked third
by survey responders, at 29.2%, among common variables associated with male
infertility. Therefore, one would assume that height should be just as important as
weight since BMI can be calculated if male patient records contain data on both.

Table 4.3. Percentages of the response rank of clinicians on the importance of
male infertility variable and the response rate of retrospective study
male infertility patients.
Male
Factor Variable

Survey
Response Rank %

Retrospective
Response Rate %

n = 53

n = 83

ILCP

70.8%

59.0%

Age

45.8%

98.0%

BMI

29.2%

60.0%

Weight

16.7%

65.0%

Height*

2.1%

71.0%

*Height was included because of retrospective response rate percentage.
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As mentioned above, ILCP was the most commonly reported variable by
survey participants at 70.8%. Retrospective data response rate for ILCP was
lower at 59.0%. However, the retrospective percentage needs to be considered
with caution, since some of the ILCP data was obtained from female partner
charts in order to have more data samples. By having done this the researcher
may have suppressed a larger difference that is not being expressed.
The most important semen characteristics that clinical professionals
reported in correlation to male infertility was sperm count at 84.6%, sperm
motility at 76.9%, sperm morphology at 75.0%, progressive motility at 46.2%, and
volume at 17.3%. Retrospective response rates were considered to be available
one hundred percent of the time (Table 4.4).

Table 4.4. Percentages of the response rank of clinicians on the importance of
semen evaluation characteristics and the response rate of
retrospective study male infertility patients.

Variable

Survey
Response Rank %

Retrospective
Response Rate %

n = 52

n = 104

Sperm Count/Concentration

84.6%

100%

Sperm Motility

76.9%

100%

Sperm Morphology

75.0%

100%*

Progressive Motility

46.2%

100%**

Volume

17.3%

100%

**n = 100
*n = 90
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It should be noted that the semen sample data listed for the retrospective
response rate did not come from patient responses. Semen evaluations are
routinely recorded in the male infertility patients’ medical charts by their
clinicians. Thus, with the exception of a few characteristics that are not evaluated
after a sample is frozen and thawed, semen data should be routinely available for
male infertility patients.
Data based on urology variables usually comes from the male patients’
personal responses or medical records from a prior urological evaluation. In the
clinician survey study, the most commonly seen urological variables reported in
correlation to male infertility were vasectomy at 77.8%, hormone treatment at
60.0%, surgery to testicles at 33.3%, undescended testicles at 33.3%, and
impotence at 28.9% (Table 4.5).
In the retrospective study, the researcher observed a number of missing
data points for these specific variables. When evaluating impotence, the
response rate was 54.0% of male patients in the retrospective study and the
clinicians surveyed rated it lowest in importance. However, it was noted by the
researcher that 15.0% of the retrospective patients had specifically skipped the
same question dealing with impotence while completing all other remaining
questions on the evaluation. Table 4.5 demonstrates the retrospective response
rates as they compared to the clinicians’ survey opinions. The retrospective
results demonstrated a male patient completion response rate for vasectomy at
66.0%, for hormone treatment 61.0%, for surgery to testicle(s) 63.0%, and for
undescended testicle(s) 63.0%.
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Table 4.5. Urological male infertility variables of importance. Survey percentages
describe response rank and retrospective percentages describe
response rate.

Variable

Survey
Response Rank %
n = 48

Retrospective
Response Rate %
n = 83

Vasectomy

77.8%

66.0%

Hormone Treatment

60.0%

61.0%

Surgery to Testicle(s)

33.3%

63.0%

Undescended Testicle(s)

33.3%

63.0%

Impotence

28.9%

54.0%

The most commonly seen environmental exposure variables that clinical
professionals reported in correlation to male infertility were smoking at 74.5%,
steroids for body building at 70.6%, recreational drug use at 58.8%, exposure to
chemicals at 51.0%, recent high fever at 39.2%, and alcohol use at 39.2% (Table
4.6).
Again the male patient retrospective response rate was listed in Table 4.6
to be viewed in relation to the survey responses. Smoking resulted in the largest
percent of retrospective data acquired at 66.0%; followed by steroids for body
building at 62.0%, recreational drug use at 61.0%, exposure to chemicals 60.0%,
recent high fever at 61.0%, and alcohol use at 59.1%.
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Table 4.6. Environmental exposure male infertility variables of importance.
Survey percentages describe response rank and retrospective
percentages describe response rate.

Variable

Survey
Response Rank %

Retrospective
Response Rate %

n = 52

n = 83

Smoking

74.5%

66.0%

Steroids for Body Building

70.6%

62.0%

Recreational Drug Use

58.8%

61.0%

Exposure to Chemicals

51.0%

60.0%

Recent High Fever

39.2%

61.0%

Alcoholic Use

39.2%

59.0%

Survey results revealed that the most commonly seen medical variables
encountered by clinicians in correlation to male infertility were medication use at
84.8%, recent illness/infection at 50.0%, BMI at 37.0%, and birth defects at
21.7% (Table 4.7). Results for the response rate of the retrospective study
showed 14.0% of the sample reporting medication use for high blood pressure.
This was the highest frequency of type of medication retrospectively collected
from male patient records. The complete percentage of patient data for
medication use was 60.2%. In addition, 62.7% reported a recent illness and
65.1% had available BMI rates (Table 4.7).
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Table 4.7. Medical male infertility variables of importance. Survey percentages
describe response rank and retro percentages describe response
rate.

Variable

Survey
Response Rank %

Retrospective
Response Rate %

n = 52

n = 83

Medication Use

84.8%

60.2%

Recent Illness/Infection

50.0%

62.7%

BMI

37.0%

65.1%

Birth Defects

21.7%

N/A

2. To describe the relationship between the amounts of completed male
medical records available from the retrospective analysis of data in
comparison with the amount of completed male medical records reported
as seen by clinicians and measured by an anonymous national online
survey.
Clinician survey participants described that 39.1% of their charts were
less than 25.0% completed, 34.8% of their charts were 25.0 to 50.0% completed,
and 26.1% of male chart data was considered greater than 75.0% completed.
Results of male patient chart completion evaluated in the retrospective study
reported that 45.0% were less than 25.0% completed, 23.0% was 25.0 to 50.0%
completed, and 32.0% were recorded as greater than 75.0% complete (Figure
4.7). These results are consistent with the observations of a number of current
research studies. In a 2011 study, Billari et al. reported that survey response
rates on reproductive age varied from 46.0 to 73.0%.
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Figure 4.7. Percentage of retrospective study male patient chart completion
levels (%) compared with percentage of male patient chart completion levels (%)
as observed and reported from clinicians surveyed.
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3. Clinicians who participated in the voluntary male infertility survey will
demonstrate a negative correlation among their opinions of infertility topics
such as; data availability and gender based ethical treatment of patients.
Results analyzed from a Cramer’s V correlation coefficient found no
significant relationship between gender and occupation with an r value, r = .326
(Table 4.8 and 4.9).

Table 4.8. Frequency distribution of the survey participants’ gender and
occupation presented in a Cramer’s V correlation coefficient
contingency table.
Gender*Occupation Contingency Table
Occupation
Gender

Repro Repro
Repro
Endo Phys Embryologist Andrologist Urologist Tech Total

Male

2

9

12

3

1

0

27

Female

1

4

18

2

0

1

26

Total

3

13

30

5

1

1

53

Table 4.9. Cramer’s V correlation coefficient exhibits a non-significant
relationship between gender and occupation.
Cramer’s V Correlation Coefficient

Value

Approx. Sig.

Phi

.326

.343

Cramer's V

.326

.343

Nominal by Nominal

N of Valid Cases

53
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Using a Cramer’s V correlation, there was no significant correlation found
between occupation and access to any of the data variables; descriptive at
r = .351 (Appendix F.10a, F.10b), semen at r = .235 (Appendix F.11a, F.11b),
urological at r = .317 (Appendix F.12a, F.12b), exposure at r = .251 (Appendix
F.13a, F.13b), or medical data r = .306 (Appendix F.14a, F.14b). The results of
this analysis were a bit surprising and contradictory to the participants’ response
of needing more data. Although, the researcher did not come across any
published research studies based on infertility patient record availability, personal
observation in the industry has indicated a difference.
The expected results for this correlation were that occupation status would
have a significant relationship when compared with access to patient data. The
results were expected to more closely reflect the respondents’ opinion of needing
a better communication system, which 53.8% of the professionals agreed upon.
Using a Cramer’s V correlation coefficient there was no significant
correlation found between gender and the need for a better clinical
communication system with a value of r = .284 (Table 4.10 and 4.11).
Furthermore, a non-significant relationship was identified when Cramer’s V was
used to analyze occupation and the need for a better communication system
(Table 4.12 and 4.13).
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Table 4.10. Frequency distribution of survey participants’ gender and opinions
on the need for a better communication system presented in a
Cramer’s V correlation coefficient contingency table.
Gender*Clinical Communication System Contingency Table
Clinical Communication System

Gender

Current System Need Better
Sufficient
System
Undecided

Male
Female

Total

Total

8

16

2

26

14

12

0

26

22

28

2

52

Table 4.11. Cramer’s V correlation coefficient exhibits a non-significant
relationship between gender and the need for a better clinical
communication system.
Cramer’s V Correlation Coefficient

Value

Approx. Sig.

Phi

.284

.122

Cramer's V

.284

.122

Nominal by Nominal

N of Valid Cases

52
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Table 4.12. Cramer’s V correlation coefficient exhibits a non-significant
relationship between occupation and the need for a better clinical
communication system.
Occupation*Clinical Communication System Contingency Table
Clinical Communication System
Occupation

Current System Need Better
Sufficient
System

Undecided

Total

Repro Endo

2

1

0

3

Repro Phys

3

9

1

13

Embryologist

14

15

1

30

Andrologist

3

1

0

4

Urologist

0

1

0

1

Repro Tech

0

1

0

1

22

28

2

52

Total

Table 4.13. Cramer’s V correlation coefficient exhibits a non-significant
relationship between occupation and the need for a better clinical
communication system.
Cramer’s V Correlation Coefficient

Value

Approx. Sig.

Phi

.359

.752

Cramer's V

.254

.752

Nominal by Nominal

N of Valid Cases

52
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As expected, when addressing the ethical topic of male infertility patient
cutoff age responses varied among the clinicians. In reference to the loose
establishment of female cutoff ages, survey participants were questioned on their
experiences with male cutoff ages. Regarding their own personal clinics, 94.2%
of survey participants responded that they did not enforce a male cutoff age for
infertility treatment. Furthermore, responses demonstrated that only 5.8% of the
professionals implemented a clinical male cutoff age as shown in Figure 4.8.
If participants responded yes to the previous question they were asked to
specify a male cutoff age. With a 10.0% response rate, clinicians reported
inconsistent guidelines on the need to set an age. In addition, the actual male
cutoff age currently enforced by their clinic was also highly variable. Responses
ranged from a suggested male age of 40 years old for semen donors only, to a
60 and/or 65 year old male patient age treatment limit. In addition, 2.0% of those
that responded explained that male patients over 40 years of age at their clinic
were only counseled on the increased risks of advanced male reproductive age.
Although these limited responses were not analyzed for significant
differences, it is important to note the response variation that existed among such
a small population. Since it is believed that the study sample is a normal
representation of the infertility industry population, the researcher found that
these results were reasonably generalizable to the industry as a whole. The
previous review of literature supported these results, as well, by citing examples
of inconsistent opinions and practices among clinicians in the fertility industry.
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Figure 4.8. Percentage of clinics that enforce a male infertility treatment cutoff
age as reported by clinicians surveyed.
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When clinicians were asked their ethical opinion of providing fertility
treatment for males after a certain age, 35.0% responded it was unethical and
64.0% responded it was not unethical (Table 4.14). Using a Phi correlation
coefficient, a significant relationship was not found among clinician gender and
their opinion to enforce a male treatment cutoff age, with an r value of r = .162
(Table 4.15).

Table 4.14. Frequency distribution of survey participants’ gender and opinions
on unethical treatment of advanced age male patients presented in
a Phi correlation coefficient contingency table.
Gender*Unethical Advanced Age Male Treatment Contingency Table
Gender
Unethical Advanced Age Male Treatment

Female

Male

Total

No

19

15

34

Yes

7

11

18

26

26

52

Total

Table 4.15. Phi correlation coefficient exhibits a non-significant relationship
between gender and opinions on unethical treatment of advanced
age male patients.
Phi Correlation Coefficient
Nominal by Nominal

Value

Approx. Sig.

Phi

.162

.244

Cramer's V

.162

.244

N of Valid Cases

52
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As previously stated, male infertility is a considerably understudied area of
research. In alignment with this circumstance and the low male response rates
reported in both studies; the researcher wanted to evaluate clinicians’ opinions in
regards to the ethical question of adequate information being provided. As a
whole, survey participants responded to the issue as expected (Table 4.16). An
impressive 63.0% of clinicians acknowledged that the industry was not providing
enough information to patients on the risks associated with advanced male age
reproductive treatments (Figure 4.9). As demonstrated in Table 4.17, a Cramer’s
V analysis, reported a p value of r = .120. The results from this correlation
established that clinician gender did not influence clinicians’ opinions on
adequate male information being provided to patients.
By comparing these two variables the researcher wanted to determine if a
relationship existed between clinician gender and the response to a gender
based question on ethical treatment. The researcher expected the results to
show that this variable was, in fact, a significant positive or negative factor, due
to the gender sensitivity of this question.
To identify the possible existence of a relationship between occupation
and adequate male information provided, the researcher again used a Cramer’s
V correlation coefficient. With an established p value of r = .310, survey results
demonstrated that clinician occupation did not influence the clinicians’ opinions of
adequate male risk factor information provided (Figure 4.18 and 4.19).
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Table 4.16. Frequency distribution of survey participants’ gender and opinions
on adequate male data provided presented in a Cramer’s V
correlation coefficient contingency table.
Gender*Adequate Male Data Provided Contingency Table
Adequate Male Data Provided
Gender

No

Yes

Undecided

Total

Male

15

7

4

26

Female

18

5

3

26

33

12

7

52

Total

Table 4.17. Cramer’s V correlation coefficient exhibits a non-significant
relationship between gender and adequate male data provided.

Cramer’s V Correlation Coefficient

Nominal by Nominal

Value

Approx. Sig.

Phi

.120

.688

Cramer's V

.120

.688

N of Valid Cases

52

153

70%

n = 53

Percentage of Clinicians (%)

60%

50%

40%

30%

20%

10%

0%
Yes

No

Undecided

Adequate Male Patient Information

Figure 4.9. Percentages of clinicians’ survey opinions on adequately providing
substantial information to patients on advanced age male reproductive risks.
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Table 4.18. Frequency distribution of survey participants’ occupation and
adequate male data provided presented in a Cramer’s V correlation
coefficient contingency table.
Occupation*Adequate Male Data Contingency Table
Adequate Male Information Provided
Occupation

No

Yes

Undecided

Total

Repro Endo

2

1

0

3

Repro Phys

9

4

0

13

Embyologist

18

5

7

30

Andrologist

3

1

0

4

Urologist

0

1

0

1

Reproductive Tech

1

0

0

1

33

12

7

52

Total

Table 4.19. Cramer’s V correlation coefficient exhibits a non-significant
relationship between occupation and adequate male data provided.
Cramer’s V Correlation Coefficient

Value

Approx. Sig.

Phi

.438

.441

Cramer's V

.310

.441

Nominal by Nominal

N of Valid Cases

52
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Discussion
The main purpose of including the clinician survey into this research
project was to gain a more realistic grasp on controversial issues in the male
infertility industry. Although, not much statistical significance can be taken from
this design, it gives the reader an idea of what is happening in the industry daily.
In addition, it highlights new areas of ideas on male infertility research. The key is
to connect what the clinicians are currently observing and the areas that need to
be researched.
The goal of this objective was to view the two rates, clinician response and
retrospective male patient data, side by side and evaluate for any possible
relationships. Survey percentages describe the response rank of clinicians and
retrospective percentages describe the response rate of male infertility patients.
Further research can be developed based upon variables that clinicians think
acknowledge as important to male reproductive success. Those variables can
also be compared with their availability from male patient responses to clinical
questionnaires, to assess question sensitivity.
While only 45.8% of the survey participants regarded male age as an
infertility indicator; the previous chapter study reported data that found a
significant correlation between male age and biochemical pregnancy rates.
Retrospective data also revealed a significant correlation between male age and
IVF pregnancy rates. However, it is important to observe from the survey results
that clinicians are not focused only on male age as an infertility factor. The
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results suggested that clinicians are observing additional male infertility and
environmental factors; just as current research has begun to demonstrate.
Participating clinicians reported that the variable of highest average of
male infertility factor importance observed from their perspective was infertility
length with current partner. However, the results from the retrospective study of
male patients were so variable that it provided no significance. These contrasting
results may be the expression of the difference in study design. A possible
suggestion is that clinicians obtain altered data from face to face patient care
when compared with the patient responses gathered from a questionnaire.
It is safe to assume that the missing retrospective data on ILCP in combination
with the already small sample size was a limiting factor in the previous study.
This may prove to be an important difference when comparing the results of the
two studies. Substantial research studies in this area should be designed around
the most effective methods of gathering patient data on infertility length.
Additionally, this may be an area where patients need access to more
fertility information. In their 2007 paper, Robinson and Ellis reported that one of
the probable causes for failure to conceive appeared to be mistiming of
intercourse. One way for clinicians to address this issue would be to provide
patients with increased knowledge on fertilization and ovulation in an effort to
reduce infertility length in some cases.
When comparing semen evaluation characteristics, the results of the two
studies expressed different main variables. Results from the retrospective study
reported semen volume and progressive motility as negatively correlated to male
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age. These age related variables are commonly reported among semen
evaluation research studies, as recognized in the review of literature. However,
only 17.3% of survey participants reported volume as an important semen
characteristic and the second to lowest importance rating was for progressive
motility (46.2%).
In the retrospective study, smoking was reported to have multiple
significant correlations with semen characteristics. Similarly, survey participants
reported smoking as the top variable affecting male fertility in their experience. A
number of research studies, such as Linsten et al. (2005), reported both smoking
and overweight to unfavorably affect male reproductive success after IVF cycles.
Linsten and colleagues (2005) went on to report that the negative impact of
smoking on the live birth rate in IVF treatment is comparable to an increase in
female age >10 years.
Vasectomy was listed as the most common seen urological factor in
relation to male infertility. However, out of 83 responses in the retrospective
study only six percent of male patients reported having a vasectomy. Two
percent reported having had hormone treatment as compared with 60.0% of
clinicians reporting its importance. One percent reported having surgery to
testicles as compared with 33.0% percent of clinicians reporting its importance.
One percent of the male patients reported having undescended testicle as
compared with 33.3% and 8.0% percent reported impotence as compared with
28.9% of clinicians reporting its importance.
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When participating clinicians were asked about the role DNA
fragmentation plays in male infertility, the majority, 33.0% reported having no
idea. In addition, DNA fragmentation represented one of the lowest semen
variables that clinicians reported testing. At 30.2%, less than half of the clinics
actually reported to testing for DNA fragmentation. Due to limited research on
DNA fragmentation, the opinions of clinicians may be reflecting the lack of
knowledge on alternative semen characteristics effecting male fertility. Further
analytical studies are needed to identify the relationship between DNA, semen
characteristics, and biochemical pregnancy rates.
Not all infertility researchers agree on the same ‘normal’ characteristics for
a semen analysis. The review of literature explained how most of the semen
variables tested for fertility are controversial. In the current survey clinicians
reported that semen quality is a high predictor of reproductive success. However,
66.0% of the group reported that a better diagnostics test is needed for semen
analyses. Sousa et al. (2011) are among some of the researchers that have
demonstrated advanced techniques to evaluate semen samples. Yet, a
subpopulation containing only fertile sperm has never been isolated. The
researchers explained that this was mainly due to the fact that we still cannot
completely describe what makes a competent spermatozoon (Sousa, et al.,
2011).
Although the researcher expected to see a difference in reporting based
on gender; the results of the current survey showed no correlation between male
and female clinicians as they responded to specific gender based questions.
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These results were in agreement with a 2011 human fertility age limit study
published by Billari and colleagues. When evaluating participants, gender of the
respondent was not a statistically different indicator in the perception of female or
male age deadlines (Billari et al., 2001). Some researchers have suggested that
as society advances, gender equality plays a role in the notion of fertility equality.
The majority of clinicians surveyed were in agreement that more male
information would be beneficial in the treatment process. Study results
demonstrated similar percentages between the experiences of clinicians and the
amount of retrospective data reported when analyzing the issue of missing male
data. A 2014 CDC consensus illustrated that the percentage of male data
reported to analyze was much less than the amount of female data available
(Center for Disease Control and Prevention, 2014).
A likely factor contributing to insufficient reporting is the stigma associated
with certain male medical conditions. In a 2003 review, Dudgeon and Inhorn
concluded that for men, infertility is a potentially humiliating and emasculating
stigma that had a more profound adverse impact on men than the same
diagnosis did for women. The group argued that in contemporary Western
societies, stereotyped masculinity denies vulnerability, promotes an appearance
of toughness and emotional control, minimizes the need for assistance from
others, and suggests a preoccupation with sex, which virtually leads men to view
male infertility the same as male impotence (Dudgeon and Inhorn, 2003).
Another proposed reason for so much missing data is the male patients’
lack of fertility knowledge on the importance of the question. For example, some
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clinics in the industry provide professional consultations to advanced age female
patients, while similar programs are not nearly as often provided for males.
Additionally, outside of the fertility world, reproductive problems and prenatal
care are generally associated with human females.
This raises the question, is the fertility industry providing adequate
information on male risk factors, such as advanced age and exposure. In
addition, are patients aware of the ethical issues associated with advanced age
fertility treatments? The response data from this survey suggests that 63.5% of
the professionals surveyed do not think adequate male infertility information is
being addressed with infertility couples. Although, this was not statistically
analyzed for significance, it can be viewed as a current evaluation describing the
professional practices in today’s human infertility clinics.
There are fertility clinicians within the industry who have a strong opinion
about paternal age and others that do not. Ultimately, it is up to the clinic and the
patient to decide upon treatment. Currently, few federal laws interfere with U.S.
citizens becoming parents. In the U.S. there is not one federal law in place that
enforces an age limit on becoming a parent. Therefore, it is not required but
some clinics practice female cutoff ages, while very few have male cutoff ages.
Surveying the views of clinicians in the current study provided an example
of industry practices. Ninety-four percent of professionals responded that they do
not have a male cutoff age. However, when asked if it was unethical to provide
fertility treatment for males after a certain age the percentage of clinicians who
responded yes rose to 35.0%, while 65.0% responded no. More research on
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advanced male age factors will help to provide additional needed clarity to the
issue of ethical patient treatment.
Due to the exploratory nature of the study, no significant conclusions were
drawn from the comparison of relationships among this data. Although the
sample size of the clinician survey study was small, the researcher felt that the
sample population was normally distributed. Therefore, opinions reported can be
generalized as comparable to those of clinicians throughout the industry.
Additionally, since there are so few industry standards enforced, gaining any
information on the current practices will be beneficial. The current study results
will contribute to the foundation of future male infertility research. Feedback from
the clinicians provided researchable information on the amount of male risk
factors and lifestyle factors currently being addressed with infertility couples. By
reporting patient data and performing new studies like the current survey,
valuable exposure can be added to the area of male infertility research.
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CHAPTER V: CONCLUSION
Summary
The focus of this research was the evaluation of male reproductive
success in regard to age, as well as environmental lifestyle exposures.
Biochemical pregnancy rate and semen parameters were the specific
concentrations of the study. In 2010, Sartorius and Nieschlag reported that lower
fertility rates and pregnancy-associated complications should not only be
associated with advanced maternal age but also with increased paternal.
Much controversy about male infertility and the influential factors can be
found among the current collection of literature. The present study was designed
as a two part evaluation. A retrospective collection of male data from a private
fertility clinic was combined with a national survey of infertility clinicians. The
strategy of using these two approaches was to gather information about male
infertility from different angles. The retrospective study served as an analysis of
patient data, while the clinician survey functioned as an exploration of opinions
within the industry. Combining the results of the two studies will provide
investigators with additional data to determine relevant areas of research to
investigate.
In 2011, Billari and colleagues pointed out that in light of the recent
increase in fertility at advanced ages, it is important to understand both the
factors that drive this increase and the factors that limit this increase. Biology and
reproductive technology have set ultimate limits on fertility, especially for females
(Billari et al., 2011). Male limits, on the other hand, are much less defined.
Recent research has shown that men do in fact have biological clocks affecting
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hormone levels, fertility, and sperm quality (Lambert et al., 2006; Lewis et al.,
2006). Although, opposed to females, male reproductive function alters slowly
over a period of years, albeit with age dependent alterations (Sartorius and
Nieschlag, 2010).
Increasing research on the topic of male fertility brings investigators closer
to defining the factors that improve male reproductive success and the factors
that hinder male reproductive success. With each study, the role of male infertility
becomes more clarified in its recognition as a dual contributor to a couple’s
reproductive success.
Implications, Recommendations, Limitations
Retrospective Study
Conclusion 1
It was concluded that advanced age males who participate in clinical ART
treatment cycles at a private human fertility clinic will have lower biochemical
pregnancy rates and lower IVF pregnancy rates. These results are supported by
a number of research studies. In a 2004 study, Kϋhnert and Nieschlag showed
increasing evidence that advanced paternal age is associated with changes in
reproductive functions on different levels; semen production, fertility, and
pregnancy outcome to name a few. These results are also in agreement with the
2006 study performed by de La Rochenbrochard and colleagues where the
group demonstrated that advanced paternal age was associated with lower IVF
rates.
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It was also concluded that advanced age males who participate in clinical
ART treatment cycles at a private human fertility clinic will have decreased
seminal volume and reduced progressive motility. Similarly, Rolf and colleagues
(1996) demonstrated that seminal volume and seminal fructose concentration
decreased with age, possibly due to a seminal vesicle insufficiency, since the
seminal vesicle contributes most to ejaculate volume. In 2006, Gagnon and de
Lamirande explained that factors leading to decreased sperm motility could be
found in altered functions of post-testicular glands such as the prostate and,
more probable, the epididymis, as the swimming ability of spermatozoa is
acquired during epididymal transit and motility is dependent on dilution into
seminal plasma.
Additionally, age-dependent alterations of the epididymis might lead to
disturbed mitochondrial functioning. An important part of epididymal sperm
maturation is the activation of sperm mitochondria (Aitken et al., 2007). The
mitochondria are essential for energy production and storage, which enables the
sperm to remain motile. In 2011, Sousa et al. suggested that differences in
sperm fertilization ability between ejaculates can be attributed to the number of
sperm in the ejaculate with functioning mitochondria.
The current study results concluded that advanced age males who
participate in clinical ART treatment cycles at a private human fertility clinic did
not experience unsuccessful semen characteristics for concentration, motility,
percent normal, and total motile sperm per specimen. These results are not in
agreement with prior research data from the same fertility clinic. The clinic
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previously concluded that sperm concentration, motility, and morphology
decreased as male age increased. The difference between the current study and
the previous clinical research was the sample size of male patients and the
length of time male patients were evaluated. The current study contained a
sample size of 104 male patients and evaluated cycles over a four year period.
The previous research contained a sample size of 16,156 male patients and
evaluated cycles over a nine year period.
Although no significant correlations were found when advanced male age
was compared with the patient’s response for difficulty with ejaculation, the
results led the researcher to believe that there is a definite need for further
studies in this area. It is believed that an abnormally high amount of male
patients specifically skipped the two questions related to difficulty with erection
and ejaculation. The amount missing data strongly suggests that this may be a
sensitive question for males to answer. Additionally, it raises the question of the
accuracy of the results in studies that included this variable.
Previous female studies have associated advanced age with decreased
implantation rates and pregnancy rates (Yarali et al., 2010; Jiao et al., 2002; Ishii
et al., 2012). In a 2010 study, Yarali and colleagues found that increased
miscarriages as well as decreased implantation rate were mainly responsible for
the poor performance of patients with advanced female age. Duran and
colleagues reported that although they observed a decrease in semen volume,
sperm motility, and fertilization rate with advanced male age, embryo quality,
clinical pregnancy, implantation, miscarriage, and live birth rates were not
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affected (Duran et al., 2010). The current study results demonstrated an altered
outcome.
This study was different in that it evaluated pregnancy rates and not
fertilization rates. It is important to point out that all of the embryos transferred in
the retrospective study cycles were fertilized. The detrimental effects were
expressed at implantation or at the early stages of pregnancy development. The
current study results found that advanced male age affected semen volume and
progressive motility, as well as, biochemical pregnancy rates. The study went a
step further by not only reporting decreased semen quality with advanced male
age but also reporting decreased pregnancy rates after embryo transfer with
advanced male age.
A recommendation for further retrospective research would be to obtain a
larger sample size. The same variables should be addressed, with the inclusion
of additionally identified factors. However, retrospective studies should be
performed independently for variables associated with embryo quality, semen
characteristics, and pregnancy outcome. Another recommendation for further
research would be to perform a prospective research study at a human fertility
clinic, addressing the same variables. Again a larger sample size would be
needed, but the advantage of having present access to the patients could clear
up some of the problems of missing data.
Conclusion 2
It was concluded that those male patients who reported to smoke more
than 5 to 10 cigarettes per day showed a decrease in sperm concentration and
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progressive motility. Additionally, it was concluded that male patients who
reported smoking were also associated with ejaculation difficulty. Previous
studies that have examined environmental factors and paternal fertility have also
demonstrated an association between cigarette smoke and sperm concentration.
In a 1992 review of semen quality studies conducted over a 50 year
period, Carlsen et al. reported that mean sperm concentration worldwide fell by
half. Giwercman and colleagues (1993) concluded that such a fast decline in
semen quality was probably due to environmental, rather than genetic factors.
The group suggested that in utero exposure to environmental oestrogens,
pollution, and lifestyle exposures, including cigarette smoking were possible
causes of this decline in quality (Giwercman et al., 1993). In an additional review,
Vine (1996) revealed that smokers’ sperm concentration was on average about
15.0% lower than that of non-smokers.
The current study results concluded that male patients who participate in
clinical ART treatment cycles at a private human fertility clinic demonstrated no
decline in biochemical pregnancy rate when reported to consume 1 to 5 drinks
socially. However, it was concluded that male patient alcohol usage of 1 to 5
drinks socially caused a decline in semen volume as well as total motile sperm
per specimen.
The results of male consumption of alcohol in association with decreased
semen volume are in agreement with the results of a 2014 study performed by
Jurewicz and colleagues. Previous reviews were also in agreement that higher
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age, smoking, and alcohol consumption were risk factors for poor semen quality
(Li et al., 2011; Sadeu et al., 2010).
Sartorius and Nieschlag (2010) claimed that although a contribution of
environmental factors to the deterioration of human semen parameters in
advancing age is readily accepted, solid evidence does not exist. Future studies
should take this into consideration. Larger study samples should be a major goal
in future research. Due to the amount of missing data and the variability of male
factors, such as semen characteristics, small samples may not be as effective in
exposing significant male infertility factors.
Conclusion 3
It was concluded that advanced age males who participate in clinical ART
treatment cycles at a private human fertility clinic will not have lower reproductive
success rates as male BMI levels increase. Conversely, Kort and colleagues
(2006) previously reported an inverse relationship between BMI and the total
number of normal-motile sperm cells per subject observed. Interestingly, the
group of men with a BMI greater than 25 kg/m2 had fewer normal chromatinintact motile sperm cells per ejaculate.
In the current study we evaluated for common semen characteristics and
biochemical pregnancy. However, other studies have suggested that BMI
affected all parts of male reproduction, the effect commonly seen in the
developing embryo. In 2014, Simon and colleagues showed that increased
sperm DNA damage adversely affected embryo quality starting at day 2 of early
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embryonic development and continuing after embryo transfer. This resulted in
reduced implantation rates and pregnancy outcome.
Rato and colleagues (2014) reported that testicular metabolic alterations
induced by increased adipose tissue may also lead to mitochondrial dysfunction,
which is closely associated to reactive oxygen species (ROS) overproduction,
and oxidative stress. ROS easily targets spermatozoa DNA and lipids,
contributing to decreased sperm quality (Rato et al., 2014).
Therefore, it can be assumed, that embryo production is compromised
because of sperm fertilization from a male with a high BMI level. Additionally
suggesting that if BMI plays a factor in decreased semen quality it is possibly
seen through DNA damage. In 2004, Tesarik et al., described how the sperm
activates its genome at the time of embryo genomic activation and this crucial
step determines the development of the embryo until the blastocyst stage. This is
quite possibly where the BMI factor presents itself.
The current study did not evaluate for DNA damage or embryo quality.
However, when erectile dysfunction was re-evaluated because of the amount of
intentionally skipped questions the researcher noticed a trend in increased male
patient BMI levels. Further research is needed to perform correlation studies on
the relationships of these variables. Using the same variables, with the addition
of embryo development and DNA damage, further studies should evaluate
variables from a larger sample size of male patients. In the meantime, to ensure
maximum fertility potential, male patients should still be advised to reduce body
weight.
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Conclusion 4
It was concluded that advanced age males who participated in clinical
ART treatment cycles at a private human fertility clinic will have a decline in the
percent of normal sperm as infertility length with their current partner increases.
These results are in agreement with previous studies which suggested that the
older a man was, the longer it may take his partner to conceive, regardless of her
age (Ford et al., 2000). More recent studies have emerged stating that underlying
infertility and time to pregnancy is another risk factor for adverse pregnancy
outcomes, independent of maternal age (Zhu et al., 2006).
Unlike the small sample size of the current study, Ford and colleagues
(2000) found significant correlation among older men and ILCP by performing a
large population study. The current sample size for ILCP was not only small but
extremely variable. Therefore, these results are to be considered with caution.
There is an extremely limited amount of research in this area. Further studies
need to pursue larger sample sizes and more accurate data responses.
Limitations
In addition to the limitations of a retrospective study design, there may
also be unidentified correlations due to the small sample size of the study.
Missing data contributed to another limitation of the study, correlation analyses
were carried out for sub-samples, further reducing the sample sizes. To try and
lesson these affects the researcher incorporated statistical procedures that
exhibited normal distribution and an absence of significant differences in means
when compared to the national population. Another limitation was the design of
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the study only looking at couples biochemical pregnancy rates and semen
characteristics. Researchers say the findings may actually underestimate the
effect of male age on infertility and future studies should also include embryo
development and live birth rates.
The small size of the sample can be considered a limitation to the current
study. Due, in part, to such a small study sample the results cannot be
adequately compared to previous studies that claimed paternal occupation
(Kenkel et al., 2001; Magnusdottir et al., 2005) and lifestyle factors (Jensen et al.,
2004; Povey et al., 2012; Sallmén et al., 2006) have an impact on semen
parameters.
Using only one clinic for the sample strengthened the internal validity of
the study but it came with limitations of getting a large enough sample size.
Larger samples are usually obtained by a retrospective survey over a number of
years. In that instance, the available data, complete or incomplete is all that the
researcher has available to record.
Another limitation may be the increased success rate of the clinic.
However, the researcher took measures to make sure that the sample was not
significantly different from the national population. When clinical samples were
statically compared to national population means there was no difference found.
Advanced success of the study clinic may act as another limitation by
overcoming some of the subtleties of male infertility factors. Even though
correlations were made, causal inferences could not because of the design of the
study.
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Additionally, the researcher extensively reviewed both patient medical
records of the sample couple to obtain as much information as possible. For
example, missing male ILCP was obtained from female partner records when
available. This was not done often, but it does contribute to the hindrance of the
true response rate of the male. In addition, there were a number of discrepancies
among male data, such as; males that listed different ages in separate
documents, males and females that listed different ILCP, males that changed
height and weight from one document to another, and the number of questions
skipped.
Finally, another limitation to consider would be the generalizability of the
study sample. However, the research group felt that securing internal validity was
of greater importance. In addition, the study clinic routinely provides treatment to
a large variety of patients from a large and diverse area among the southwestern
region of the U.S.
Clinician Survey Study
Objective 1 and 2
As anticipated, results of the clinician survey suggested areas of concern
for further research on male variables and practices within the industry based on
their experiences with male infertility patients. Specific male variables of
importance were identified from the opinion results of clinicians. Data for these
variables had also been collected in the retrospective study. By comparing the
results of the two studies, the researcher feels confident in suggesting that the
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variables clinicians identified as important, on average, only contained 50.0% of
complete male patient data.
The results are in agreement with a 2014 Centers for Disease Control and
Prevention consensus which illustrated that the percentage of male data reported
to analyze was much less than the amount of female data available. Therefore, it
is proposed that analogous research studies be performed to determine an
enhanced collection method for these specifically identified variables.
The current study also suggested that there is a notable lack of patient
knowledge regarding the importance and contribution of male infertility factors.
One possible theory for the reduced amount of male data is that patients are
unaware of the actual percentage of the male’s reproductive role. Therefore, both
males and females might assume it is unnecessary to provide complete
information on male patient questionnaires.
Another theory behind the missing data is the sensitive nature of
discussing male infertility. Researchers have explained that male patients
appeared to be more likely to confide in and desire information and emotional
support from infertility clinicians rather than from friends or mental health
professionals (Glover et al., 1994; Hammarberg et al., 2010; Brucker and
McKenry, 2004). Therefore, if patients are not getting adequate information on
male infertility factors from their doctor visits they are highly unlikely to learn
about fertility issues and lifestyle exposure factors through additional resources.
Results suggest that forthcoming studies use a combined method to
increase data collection, while providing increased patient knowledge on male
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infertility variables. For example, future clinical research surveys should be more
specific by individually labeling male reproductive threats. The proposed design
would also include the specific effects of each of these threats on male
reproduction.
Exploratory studies are one suggested design to further analyze the issue
of missing male data. Performing a retrospective study would help to identify the
response rate but would limit further analysis. A prospective clinical study could
also be designed to identify the response rate and then follow up with the male
patients on the reasons behind the missing data.
Although the researcher expected this finding, at such a large scope was
not intentional. The study was designed to protect for this by collecting as many
variables as possible; in the case that some might not provide a large enough
sample size. It was not expected for the researcher to find such a significant
amount of missing data. In addition, gathering data from male electronic medical
records was extremely inefficient and more time consuming than expected. The
original design of the retrospective data included a larger sample and was
confounded by the collection process of male data. The results for the clinician
survey suggest that professionals in the industry are observing similar response
rates from male patients.
Conclusion 1
It was concluded that reproductive infertility clinicians who participated in a
voluntary male infertility survey did not demonstrate a significant difference of
opinions on topics such as; data availability and gender based ethical treatment
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of patients. However, gender and the need of better communication system for
patient data was extremely close to having a significant correlation. Further
research should definitely be designed to address this relationship. Experimental
studies need to be performed on the comparison of male data access in each
occupation.
Limitations
The biggest limitation of this study was that the researcher was not in
complete control of who was selected to participate. Although the group invited to
participate in the survey were professionals in the infertility industry, the
researcher was reliant on a third party, EmbryoMail, to verify the legitimacy of
their credentials.
Another study limitation was the inability to identify the sample response
rate of survey participants, creating an extraneous variable threat. A review of the
literature demonstrated that previous survey studies have reported extremely
variable response rates. In a European social survey on fertility age limits, Billari
et al. (2011) reported a 46.0% response rate from one sample and a 73.0%
response rate from another. To overcome this and the fact that a specific group
was addressed, the researcher utilized descriptive statistics to prove normal
distribution among the sample. In addition, descriptive statistics were used to
show no significant difference from the national population. Still, another
limitation of descriptive research is that it cannot identify a cause and effect
relationship.
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As with the retrospective study, survey sample size is a limitation.
Although normally distributed, small variances may be hidden by the small
sample size studied. Another limitation is that the survey was only exploratory.
Further research needs to be performed to investigate qualitative and
quantitative clinical studies.
Evaluating the influence of age on reproduction has proven to be
extremely difficult and controversial. Conclusions remain vulnerable due to many
possible confounding cofactors. Sartorius and Nieschlag (2010) explained that
not only do individual subjects age at different rates, but effects of age on male
reproduction bay be caused by aging, or by mediators generated secondarily by
age-related cofactors.
As long as couples continue to advance with the current trend of delayed
childbearing, male infertility factors need to remain on the forefront. The
opportunities for research topics in the area are endless. Just as important, is the
opportunity to inform and educate reproductive age males on the risks and
benefits associated with their personal fertility. Although this is not expected to be
easily overcome, the stigma of males and their infertility need to be put aside to
better treat the infertility couple.
In a 25 European country survey male and female age limits were equally
associated by the opposite sex, when it came to their reproductive capabilities
(Billari et al., 2011). Billari and collaborators (2011) suggested one reason for this
may be that young people in Europe are more aware of recent medical insight
into the biological limits to childbearing for both males and females. Another
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reason may be that, for young people, notions of gender equality in their lives
may be of greater importance so they apply similar reproductive expectations to
women and men alike. For them, it is late parenthood rather than late
motherhood that should be avoided for reasons physical or otherwise (Billari et
al., 2011). This suggestion is promising for the continued acknowledgement of
male infertility factors.
There is a strong need for further research studies in all areas of male
reproductive physiology. The results of the current study and the review of
literature strongly suggest that this is not just a biological issue. Future research
needs to address male infertility in an all-encompassing manner including;
societal stigmas, religious beliefs, industry ethics, age limits, and a host of
environmental and lifestyle factors.
The design of the study should take into consideration the large amount of
patients that will be needed and the excess time required to evaluate records on
each patient. The present results suggest that researchers should expect to get
data from approximately 25.0% of the male records reviewed. Additional
research should focus on describing the nature of the missing data. New
collection methods should be attempted in an effort to get as much male data as
possible.
The researcher submitted a third study to the LSU IRB as a part of this
proposal that has not yet been pursued. The approved study is designed around
the creation and real time administration of a clinician survey. The instrument
would be similar to the study clinic questionnaire, except that patients would be
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administered the instrument by a professional. Information would be collected on
specific variables, such as the names of specific exposure chemicals.
In addition, this method could meet a second issue that needs to be
addressed, properly providing male infertility information to patients. Couples
would be informed on the types of fertility treatments available and what lifestyle
factors to be addressed promoting increased male reproductive success.
However, still to be determined is the correct provision of privacy or
anonymity for male patients. The results of the current study suggested that there
are a number of sensitive questions that receive no response from male patients.
Future research would need to determine the best way to get the most accurate
and available responses from male patients.
In a systematic review of research concerning patients’ perspectives on
fertility care, Dancet et al. (2010) demonstrated that only three of the 51 studies
had focused specifically on male experiences. The authors concluded that there
was a lack of data regarding men’s perceptions of care, particularly with regard to
invasive procedures (Dancet et al, 2010).
In their 2012 review, Dudgeon and Inhorn, evaluated 92 publications
through a search of available literature on the psychological and social aspects of
infertility in men. Although psychological and social aspects of infertility, fertility
treatment with assisted reproductive technologies, and infertility-related
childlessness have been investigated comprehensively in women, the
psychosocial consequences of infertility for men are less well understood (Greil
et al., 2010). Previously reported in a 2010 publication, Greil and colleagues
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explained that most of the participants in each male study were recruited from
clinical services and little was known about men who do not seek treatment. The
group also pointed out that among those who do in fact pursue treatment; a
number of male behavioral factors still remain unknown.
Data gained by the researcher from the current 2015 study supports both
statements in the above paragraph. Reflecting the 2010 Greil et al. review, the
2015 retrospective study samples were also comprised of a male patient
population that received clinical infertility services. In addition, the researcher’s
observations from the current study was consistent with Greil and colleagues’
2010 account, confirming that there are still a large number of unknowns and
incomplete information available for males who do participate in clinical services.
There are a number of past and present reasons that have led to the lack
of male patient information. However, results from the current study led the
researcher to focus on two of the possible current issues; male fertility stigma
and lack of contribution knowledge.
Based on their review of biological and cultural anthropological theories on
masculinity and human reproduction, Dudgeon and Inhorn (2012) concluded that
male infertility is more stigmatizing for men than it is for women. The authors
argued that infertility is potentially humiliating and emasculating to many men. As
a male, any association with infertility, virility, and sexual potency can lead to
perceived personal inadequacy (Dudgeon and Inhorn, 2012).
In Sweden, Hjelmstedt et al. (1999) found that 50.0% more men, than
women had not shared their infertility problems with others. The authors
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interpreted these results as reflecting the inherent frustrations of being in a
situation that is poorly understood and in which assured treatments are not
guaranteed (Hjelmstedt et al., 1999). While there is an emerging body of
evidence focused on the psychological and social aspects of infertility for men,
significant knowledge gaps remain (Greil, et al., 2010; Sherrod, 2006).
The current study results provided valuable information for further
research. Additionally, some of the results can be utilized by fertility clinicians
and infertility patients participating in clinical ART treatment cycles. These results
also support the growing body of research that is examining the effect of
advanced paternal age on male reproductive success.
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APPENDIX C: RESEARCH CONFIDENTIALITY AGREEMENT
CONFIDENTIALITY AND NONDISCLOSURE AGREEMENT
THIS CONFIDENTIALITY AND NONDISCLOSURE AGREEMENT (the “Agreement”) is
made and entered into as of ___________ between Fertility Specialists of Texas (“Company”)
and Jeanne L. Glaser, MS (“Researcher”).
1. PURPOSE
Company and Researcher wish to collaborate in a retrospective patient research study. Company
may disclose to Researcher certain confidential technical and patient information which Company
desires Researcher to treat as confidential.
2. CONFIDENTIAL INFORMATION
“Confidential Information” means any information disclosed to Researcher by Company, either
directly or indirectly in writing, orally or by inspection of tangible objects, including without
limitation patient records or personal information of patients, electronic records, images,
ownership information. Confidential Information shall also include without limitation the items
set forth in the Appendix attached hereto.
3. NON-USE AND NON-DISCLOSURE
Researcher agrees not to use any Confidential Information for any purpose except to fulfill
retrospective research data requirements as listed in Appendix. In addition, specific measures will
be taken to protect patient anonymity and all records in Researcher’s possession will be destroyed
at the completion of the study. Researcher shall not use any Confidential Information in any
manner detrimental to the business interests of Company. Researcher agrees not to disclose any
Confidential Information to any third parties. Researcher shall not disclose Confidential
Information to advisors of Researcher.
4. MAINTENANCE OF CONFIDENTIALITY
Researcher agrees that it shall take all reasonable measures to protect the secrecy of and avoid
disclosure and unauthorized use of the Confidential Information. Without limiting the foregoing,
Researcher shall take at least those measures that Researcher takes to protect its own most highly
confidential information. Researcher shall not make any copies of Confidential Information
unless the same are previously approved in writing by the Company. Researcher shall reproduce
Company’s proprietary rights notices on any such approved copies, in the same manner in which
such notices were set forth in or on the original. Researcher shall immediately notify Company in
the event of any unauthorized use or disclosure of the Confidential Information.
5. NO OBLIGATION
Nothing herein shall obligate Company or Researcher to proceed with any transaction between
them, and each party reserves the right, in its sole discretion, to terminate the discussions
contemplated by this Agreement concerning the business opportunity.
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6. NO WARRANTY
ALL CONFIDENTIAL INFORMATION IS PROVIDED “AS IS.” COMPANY MAKES NO
WARRANTIES, EXPRESS, IMPLIED OR OTHERWISE, REGARDING ITS ACCURACY,
COMPLETENESS OR PERFORMANCE.
7. RETURN OF MATERIALS
All documents and other tangible objects containing or representing Confidential Information and
all copies thereof which are in the possession of Researcher shall be and remain the property of
Company and tangible objects shall be promptly returned to Company. All electronic patient
records will be destroyed by Researcher.
8. NO LICENSE
Nothing in this Agreement is intended to grant any rights to Researcher under any patent, mask
work right or copyright of Company, nor shall this Agreement grant Researcher any rights in or
to Confidential Information except as expressly set forth herein.
9. TERM
This Agreement shall survive indefinitely, not just upon the completion of the study.
10. REMEDIES
Researcher agrees that any violation or threatened violation of this Agreement will cause
irreparable injury to the Company, entitling Company to obtain injunctive relief in addition to all
legal remedies.
11. MISCELLANEOUS
This Agreement shall bind and inure to the benefit of the parties hereto and their successors and
assigns, except that Researcher may not assign or transfer this Agreement, by operation of law or
otherwise, without Company’s prior written consent. THIS AGREEMENT SHALL BE
GOVERNED BY THE LAWS OF THE STATE OF LOUISIANA, WITHOUT REFERENCE
TO CONFLICT OF LAWS matter hereof. If any provision of this Agreement is found to be
illegal or unenforceable, the other provisions shall remain effective and enforceable to the
greatest extent permitted by law. Any failure to enforce any provision of this Agreement shall not
constitute a waiver thereof or of any other provision hereof. This Agreement may not be
amended, nor any obligation waived, except by a writing signed by both parties hereto. The
parties may execute this Agreement in counterparts, each of which is deemed an original, but all
of which together constitute one and the same agreement.
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ACCEPTED AND AGREED TO BY THE AUTHORIZED REPRESENTATIVE OF EACH
PARTY:
COMPANY:

RESEARCHER:

Fertility Specialists of Texas

Jeanne L. Glaser, MS

Signature: __________________________

Signature: __________________________

Title: ______________________________

University: _________________________

Date Signed:________________________

Title: ______________________________
Date Signed: ________________________

Appendix
List of other additional, particular items subject to confidentiality and non-disclosure:
1. See LSU Institutional Review Board Action on Exemption Approval Request.
2. See Brief Summary of the Project, A Retrospective Study: Examining the Male
Infertility Factor; The Association Between Age, Environment and Reproductive
Success.
3. See LSU Institution Review Board Application for Exemption from Institutional
Oversight.
4. See Consent Form Script: Retrospective Study (IRB waived consent form).
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APPENDIX D: IRB CLINICIAL SURVEY APPROVAL FORM
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APPENDIX E: IRB APPROVED CLINICIAN SURVEY

215

216

217

218

219

220

221

222

223

224

Research Survey Created by Jeanne L. Glaser, LSU AgCenter 2015
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APPENDIX F: IBM SPSS OUTPUT

1.

Male age at collection frequency normal distribution curve.
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2.

One-sample t-test analysis of the retrospective study sample average
pregnancy rate (44.0%) compared to the national ART pregnancy rate
average (39.0%).

One-Sample T-Test

t
Biochemical
Pregnancy

3.

1.036

National ART Pregnancy Rate Average = .39
95.0% Confidence
Interval of the
Difference
Mean
Df
Sig. (2-tailed) Difference Lower
Upper
101

.303

.051

-.05

.15

One-sample t-test analysis of the retrospective study sample average
male BMI level (29) compared to the national average male BMI level (29).

One-Sample T-Test
National Male BMI Average = 29
95.0% Confidence
Interval of the
Difference
t
BMI

-.633

Df
49

Mean
Sig. (2-tailed) Difference
.530

227

Lower

Upper

-.49180 -2.0525

1.0689

4.

Point-biserial correlation coefficient scatter/dot plot exhibiting negative
relationship between biochemical pregnancy and male age.
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5.

Point-biserial correlation coefficient scatter/dot plot exhibiting negative
relationship between IVF biochemical pregnancy and male age.

6.

Retrospective male patient alcohol usage.
Descriptive Statistics
Mean

Std. Deviation

N

Social Alcohol Usage

.6250

.48925

48

Volume

2.429

1.6007

83

47.1173

50.60242

83

Total Motile Sperm/Specimen
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7a.

Point-biserial correlation coefficient scatter/dot plot exhibiting negative
relationship between smoker and semen concentration.
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7b.

Point-biserial correlation coefficient scatter/dot plot exhibiting negative
relationship between smoker and semen progressive motility.
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8.

Would access to more male patient lifestyle information improve
your ability to provide better care?
Response
Percent

Response
Count

Yes

53.8%

28

No

19.2%

10

Undecided

26.9%

14

Total

52

9.
Does reproductive healthcare need a better communication system
allowing the physician and the laboratory physiologist to have equal
access to all of the patient information per cycle?
Response
Percent

Response
Count

Need a better system

53.8%

28

Current system is sufficient

42.3%

22

3.9%

2

Undecided
Total

52
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10a.

Occupation*Descriptive Data Access Contingency Table
Descriptive Data Access
Occupation

Always

Mostly Occasionally

Rarely

Total

Repro Endo

3

0

0

0

3

Repro Phys

4

1

4

4

13

Embryologist

17

7

3

3

30

Andrologist

4

1

0

0

5

Urologist

1

0

0

0

1

Reproductive Tech

0

0

0

1

1

29

9

7

8

53

Total

10b.

Cramer’s V Correlation Coefficient
Occupation*Descriptive Data Access
Nominal by Nominal

Value Approx. Sig.

Phi

.608

.187

Cramer's V

.351

.187

N of Valid Cases

53
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11a.

Occupation*Semen Data Access Contingency Table
Semen Data Access
Occupation

Always Mostly Occasionally Rarely Never Total

Repro Endo

3

0

0

0

0

3

Repro Phys

8

3

1

0

1

13

Embryologist

20

8

0

1

1

30

Andrologist

5

0

0

0

0

5

Urologist

1

0

0

0

0

1

Reproductive Tech

0

1

0

0

0

1

37

12

1

1

2

53

Total

11b.

Cramer’s V Correlation Coefficient
Occupation*Semen Data Access
Nominal by Nominal

Value

Approx. Sig.

Phi

.470

.926

Cramer's V

.235

.926

N of Valid Cases

53
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12a.

Occupation*Urology Data Access Contingency Table
Urology Data Access
Occupation

Always Mostly

Occasionally Rarely Never Total

Repro Endo

2

0

1

0

0

3

Repro Phys

4

1

7

1

0

13

Embryologist

10

8

6

3

1

28

Andrologist

1

1

3

0

0

5

Urologist

1

0

0

0

0

1

Reproductive Tech

0

0

0

1

0

1

18

10

17

5

1

51

Total

12b.

Cramer’s V Correlation Coefficient
Occupation*Urology Data Access
Nominal by Nominal

Value

Approx. Sig.

Phi

.634

.427

Cramer's V

.317

.427

N of Valid Cases

51
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13a.

Occupation*Exposure Data Access Contingency Table
Exposure Data Access
Occupation

Always Mostly Occasionally Rarely Never

Total

Repro Endo

2

0

1

0

0

3

Repro Phys

3

2

4

4

0

13

Embryologist

8

8

6

6

1

29

Andrologist

2

1

2

0

0

5

Urologist

1

0

0

0

0

1

Reproductive Tech

0

0

0

1

0

1

16

11

13

11

1

52

Total

13b.

Cramer’s V Correlation Coefficient
Occupation*Exposure Data Access

Value

Approx. Sig.

Phi

.501

.874

Cramer's V

.251

.874

Nominal by Nominal

N of Valid Cases

52
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14a.

Occupation*Medical Data Access Contingency Table
Medical Data Access
Occupation

Always Mostly Occasionally Rarely

Never Total

Repro Endo

2

0

1

0

0

3

Repro Phys

3

0

4

5

1

13

Embryologist

10

7

7

2

2

28

Andrologist

1

1

2

0

0

4

Urologist

1

0

0

0

0

1

Reproductive Tech

0

0

1

0

0

1

17

8

15

7

3

50

Total

14b.

Cramer’s V Correlation Coefficient
Occupation*Medical Data Access
Nominal by Nominal

Value

Approx. Sig.

Phi

.613

.537

Cramer's V

.306

.537

N of Valid Cases

50
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